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The telomere is a specialized simple sequence repeat found at the end of all linear chromosomes. It acts as a
substrate for telomere binding factors that in coordination with other interacting elements form what is
known as the shelterin complex to protect the end of the chromosome from the DNA damage repair
machinery. The telomere shortens with each cell division, and once critically short is no longer able to
perform this role. Short dysfunctional telomeres result in cellular senescence, apoptosis, or genome instability.
Telomere length is regulated by many factors including cis-acting elements in the proximal sequence which is
known as the subtelomere. The Riethman lab played a pivotal role in generating the reference sequence of the
subtelomere in both the human and mouse genomes, providing an essential resource for this work. Short high
throughput sequencing (HTS) reads generated from the simple repeat containing telomere or the segmental
duplication rich subtelomere cannot be aligned to a reference genome uniquely. They are filtered and excluded
from many HTS analysis methods. A ChIP-Seq analysis pipeline was developed to incorporate these
multimapping reads to study DNA-protein interactions in the subtelomere. This pipeline was employed to
search for factors regulating the expression TERRA, an essential long non-coding RNA, and to better
characterize their transcription start sites. ChIP-seq analysis in the human subtelomere found colocalization of
CTCF and Cohesin directly adjacent to the telomere and throughout the subtelomere specific repeats. Follow
up functional studies showed this binding regulated TERRA transcription at these sites. Extending these
analyses in the mouse genome showed very different patterns of CTCF and cohesin binding, with no evidence
of binding at apparent sites of TERRA transcription. Mouse subtelomere sequence analysis showed the co-
occurence of two repeats at sites of putative TERRA expression, MurSatRep1 and MMSAT4, one of which
was previously shown to be expressed in lincRNAs. The Telomere Analysis from SEquencing Reads(TASER)
pipeline was developed to capture telomere information from HTS data sets and used to investigate telomere
changes that occur in prostate cancer. TASER analysis of 53 paired prostate tumor and normal samples
revealed an overall decrease in telomere length in tumor samples relative to matched paired normal tissue,
especially sequence containing the exact canonical telomere repeat. Multimapping reads contain important
information, that when used properly, help elucidate understanding of telomere biology, cancer biology, and
genome regulation and stability.
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ABSTRACT 
TELOMERE AND PROXIMAL SEQUENCE ANALYSIS USING HIGH-THROUGHPUT 
SEQUENCING READS 
Nicholas Stong 
Harold Riethman, Ph.D.  
 The telomere is a specialized simple sequence repeat found at the end of all linear 
chromosomes.  It acts as a substrate for telomere binding factors that in coordination with other 
interacting elements form what is known as the shelterin complex to protect the end of the 
chromosome from the DNA damage repair machinery.  The telomere shortens with each cell 
division, and once critically short is no longer able to perform this role.  Short dysfunctional 
telomeres result in cellular senescence, apoptosis, or genome instability.  Telomere length is 
regulated by many factors including cis-acting elements in the proximal sequence which is known 
as the subtelomere.  The Riethman lab played a pivotal role in generating the reference 
sequence of the subtelomere in both the human and mouse genomes, providing an essential 
resource for this work.  Short high throughput sequencing (HTS) reads generated from the simple 
repeat containing telomere or the segmental duplication rich subtelomere cannot be aligned to a 
reference genome uniquely.  They are filtered and excluded from many HTS analysis methods.  A 
ChIP-Seq analysis pipeline was developed to incorporate these multimapping reads to study 
DNA-protein interactions in the subtelomere.  This pipeline was employed to search for factors 
regulating the expression TERRA, an essential long non-coding RNA, and to better characterize 
their transcription start sites.  ChIP-seq analysis in the human subtelomere found colocalization of 
CTCF and Cohesin directly adjacent to the telomere and throughout the subtelomere specific 
repeats.  Follow up functional studies showed this binding regulated TERRA transcription at these 
sites.  Extending these analyses in the mouse genome showed very different patterns of CTCF 
and cohesin binding, with no evidence of binding at apparent sites of TERRA transcription.  
Mouse subtelomere sequence analysis showed the co-occurence of two repeats at sites of 
putative TERRA expression, MurSatRep1 and MMSAT4, one of which was previously shown to 
	  vi	  
be expressed in lincRNAs.  The Telomere Analysis from SEquencing Reads(TASER) pipeline 
was developed to capture telomere information from HTS data sets and used to investigate 
telomere changes that occur in prostate cancer.  TASER analysis of 53 paired prostate tumor and 
normal samples revealed an overall decrease in telomere length in tumor samples relative to 
matched paired normal tissue, especially sequence containing the exact canonical telomere 
repeat.  Multimapping reads contain important information, that when used properly, help 
elucidate understanding of telomere biology, cancer biology, and genome regulation and stability. 
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CHAPTER 1: BACKGROUND 
1.1 Telomere Biology 
1.1.1 Telomere Structure 
In 1938 Herman Muller first hypothesized the presence of a terminal gene with the 
special function of sealing the end of a linear chromosome, which he termed the telomere.  
Drawing on years of work trying to understand the mechanisms of chromosome rearrangement 
after X-ray irradiation in Drosophila, he reasoned that if chromosomal breakage were to occur 
before rearrangement initiated, then it would be possible for the broken fragments to not find each 
other before the acentric fragment was lost in mitosis.  However having never observed any such 
fragments he concluded that the telomere was required for chromosome stability[1].  It was also 
observed in Zea Mays that chromosome breaks created by the divergent pulling of centromeres 
in a dicentric chromosome results in unstable ends, which go through repeated breakage-fusion-
bridge cycles[2].  The chromosome ends resulting from breaks are highly unstable and have a 
propensity to fuse leading to chromosomal rearrangements.  Telomeres found at natural 
chromosome ends are required for genome stability. 
 It was several decades before the structure of the telomere began to be unraveled with 
the advent of DNA sequencing.  Elizabeth Blackburn, a former graduate student of Fred Sanger, 
sequenced the telomeres of rDNA in Tetrahymena thermophilia by use of restriction 
endonuclease digestion and found a tandemly repeated nucleotide sequence 5’(CCCCAA)n 3’ 
repeated 20 to 70 times[3].  The telomeres of other ciliates with a large polyploid macronucleus 
were also found to contain G rich tandem repeats[4,5].  Eventually it was found that the human 
genome[6,7] and all vertebrates[8] have a telomere repeat of TTAGGG.  The number of tandem 
repeats and therefore the total telomere length varies from chromosome to chromosome and 
between individuals.  The length of telomeres in the human genome ranges from 3-20kb[6,9,10], 
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and is considerably longer in many other verterbrates, including in Mus musculus[9].  A universal 
feature of telomere sequences is a short single stranded overhang of the 3’ G rich strand[5,11].  
In the human genome this overhang is on average 200bp[12]  This genomic sequence is 
responsible for differentiating the ends of linear chromosomes from ends resulting from internal 
double strand DNA breaks. 
 Even before the sequence structure of the telomere was known, it was abstracted that 
the ends of the linear chromosomes could not be replicated completely.  The mechanics of the 
semiconservative DNA replication are unable to fully duplicate template stands of DNA.  DNA 
polymerase requires an RNA primer to begin DNA synthesis, which is later removed by RNAse.  
This combined with the directionality of DNA polymerase from 5’ to 3’ means the terminal 3’ end 
of both template strands cannot be duplicated [13–15].  Alexey Olovnikov and Jim Watson both 
independently described this as the end replication problem.  This results in the shortening of the 
resulting chromosome by at least 12-15bp, if the RNA primer is placed at the last base of the 3’ 
end of the template strand.  Olovnikov went further to argue that marginotomy of DNA (the 
shortening of replicated DNA in respect to the template), and the total loss of telogenes, leads to 
the elimination of aged cells, and speculated that it was responsible for the depletion of cell 
populations in the body and therefore a primary cause in disorders of aging[14].  The end 
replication problem leads to a 3’ overhang characteristic of telomere ends however only at the 
shortened end of the chromosome.  In addition the shortening due to the end replication problem 
is lesser than the observed average 200bp overhang in the human genome[12].  This indicates 
that telomeric single stand 3’ overhangs are maintained through exonucleic degradation[16,17].  
Telomere shortening occurs with DNA replication due to both the end replication and post 
replicative processing.  This has been observed after cell divisions in both in vitro and in 
vivo[18,19]. 
 The telomere is able to form a structure that protects it from being recognized as a 
double strand break by the DNA damage repair machinery through both the physical 
conformation of the telomere sequence and an association with a specialized protein complex.  
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The G rich tandem repeat of the telomere matches the sequence motif necessary to form G 
quadruplexes, a stable structure in which guanine residues form hydrogen bonds in a helical 
structure of one strand of DNA[20].   Given the single stand overhang at the telomere this 
conformation is energetically favorable[21].  There is extensive evidence for these structures 
occurring in vivo[22,23].  The single strand overhang is also able to invade the double stranded 
region of the telomere, forming a small single stranded displacement loop (D-loop) where the 
overhang disrupts the DNA duplex, and a large lasso-like loop (T-loop) at the chromosome 
end[24].  The formation of this loop depends on an interaction with telomere associated 
proteins[25]. 
1.1.2 Telomere DNA Interactions 
 A number of proteins have been shown to interact directly and in complex with the 
telomere sequence.  Two related proteins, telomeric repeat binding factor (TRF) 1 and 2 were 
found to bind the double stranded DNA fragments containing the telomere repeat[26–29].  TRF 1 
and 2 share a C’ terminal Myb related motif called the teleobox which is capable of recognizing 
the telomere repeat and differ in their N’ terminal dimerization domains[28].  A third protein able to 
directly interact with the telomere is protection of telomeres 1 (POT1), which binds directly to 
single stranded telomeric DNA[30,31].  hPOT1 is able to bind to both the single stranded 3’ 
telomeric overhang, and the single stranded DNA displaced in the D-loop[32].  TRF2 and POT1 
are required to maintain the structure of the T-loop[25,33].  Other telomere associated factors 
were discovered through their association with these telomere binding proteins, TIN2 interacting 
with TRF1[34] and Rap1 interacting with TRF2[35].  TPP1 was found to interact with both 
TIN2[36] and POT1[37,38].  These 6 proteins are found together in nuclear fractions[39] and 
together form what is known as the shelterin complex[40] which is required for telomere end 
capping.  A separate complex that associates with the telomere is known as the CST complex, 
made up of conserved telomere protection component 1 (CTC1), suppressor of CDC thirteen 1 
(STN1), and telomeric pathway with STN1 (TEN1)[41,42].  The CST complex interacts with the 
single stranded telomere overhang, however unlike in yeast where these genes were named, the 
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CST complex in human cells is required for DNA replication, restarting stalled replication 
forks[43,44].   
 While shelterin protects the telomere from being recognized as a double strand break 
normal telomere shortening occurs with each cell division.  In addition accelerated telomere 
shortening can occur due to oxidative stress[45] or polymerase pausing at sites of single stranded 
DNA damage leading to premature termination of DNA replication in the telomere[46].  To 
overcome these mechanisms of shortening the cell is able to extend telomeres.  Telomerase is a 
ribonucleoprotein that like the telomere sequence itself was first identified in Tetrahymena.  
Telomerase has terminal transferase activity that is able to directly add the telomeric repeat on to 
existing telomeres[47].  Telomerase is able to do this because it has an RNA component which 
contains the priming sequence for the addition of the whole telomere repeat on to the 
chromosome end[48].  Telomerase is also responsible for lengthening telomeres in the human 
genome[49].  The human RNA component of telomerase, hTR, contains an 11 nucleotide 
template region, (5’-CUAACCCUAAC), which is complementary to the human telomere 
sequence[50].  The protein component of telomerase is catalytically active and drives the reverse 
transcriptase activity of telomerase which adds the telomeric sequence[51,52].  This human 
telomerase reverse transcriptase (hTERT) subunit is the limiting factor in telomere lengthening.  
While hTR is expressed in all human tissues[53], hTERT is not expressed significantly in somatic 
cells[54,55]. 
 In cells with insufficient or negligible telomerase expression telomere length decreases 
with each cell division.  Before the discovery of telomeres it was already known that human 
fibroblasts have a limited replicative capacity[56] that is dependent on the number of population 
doublings[57].  It was shown early on that telomeres play a key role in senescence, as replicative 
capacity is highly predictable from telomere length[58].  Once a telomere is critically short it can 
no longer associate with enough shelterin components to form the structures necessary to protect 
the end of the chromosome[59].  In a normal cellular context this induces replicative senescence, 
preventing the cell from dividing further[60].    Senescent human cells have a DNA damage 
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response including increased p53 activity[61].  In mammalian cells this response to DNA damage 
is mediated through two protein kinases ATM and ATR.  ATM recognizes double strand breaks 
and ATR recognizes a single strand from a resected double strand break[62].  As part of the 
damage response ATM and ATR phosphorylate histone H2AX (known as gamma-H2AX)[63,64], 
promoting the accumulation of damage response factors 53BP1, MDC1, and the MRN complex.  
This accumulation of damage response elements can be found at individual critically short 
telomeres[65–67].  ATM and ATR also phosphorylate Chk1 and Chk2 respectively which can 
cause G1 and G2 phase arrest and are involved in the activation of p53 which inhibits cell cycle 
progression through downstream activation of p21[68].  In certain cell types and conditions this 
same p53 mediated signaling cascade can also lead to apotosis[65,69]. 
 In cells with shortening telomeres where cell cycle checkpoints are defective the repair 
machinery will act on telomeres to resolve the perceived damage through nonhomologous end 
joining (NHEJ) or homologous recombination.  The NHEJ factors DNA ligase IV and Ku70/80 
repair dysfunctional telomeres by creating end-to-end fusions[70–72].  It is also possible in the 
absence of the repressive presence of Ku70/80 for alternative micro homology mediated NHEJ to 
occur through PARP1 and ligase III[73,74].  This is readily seen in mouse cells when TRF2 is 
deleted in a p53 null background causing 30-50% of the telomeres to fuse, creating long trains of 
chromosomes[75].  The fusion of two chromosome creates a dicentric chromosome which leads 
to genome instability in a cycling cell.  During mitosis the dicentric chromosome can be pulled 
apart creating a bridge between daughter cells.  This bridge can itself be lethal if it compromises 
the formation of a cellular or nuclear membrane.  As the fused chromosome is pulled in different 
directions it is likely to break, leaving broken ends which are then repaired.  This leads to either 
random stable translocations where daughter cells can gain or lose genetic information, or 
produce another dicentric chromosome which will go through another breakage-fusion-bridge 
cycle[76–78]. 
 Since the telomere contains long stretches of identical sequence it is possible for 
aberrant homologous recombination (HR) to occur.  HR can occur where the end of the telomere 
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is interacting to form a t-loop, resulting in a truncated telomere and leaving the cleaved t-loop as 
telomere circle (t-circle).  The end of the telomere and internal double stranded telomere can form 
a Holliday junction which is cleaved.  The formation of t-circles is dependent on XRCC3 and 
NBS1, consistent with known mechanisms of HR[79,80].  HR can also occur between nascent 
chromosomes termed telomere sister chromatid exchange (T-SCE).  This unequal exchange of 
telomere sequence results in one telomere being elongated at the expense of a shortened 
telomere.   Some cells in crisis recover by activating a telomerase independent lengthening 
mechanism known as alternate lengthening of telomeres (ALT)[81,82].  ALT cells have increased 
rates of T-SCE[83].  ALT cells have high levels of t-circles and heterogeneous telomere lengths, 
including some very long telomeres, consistent with a HR mechanism[80,84].    
1.1.3 Telomeres and Disease 
 Dysfunctional shortened telomeres have a drastic effect on genome integrity and as such 
play an important role in a number of diseases.  The most drastic effects are those in which a 
monogenic lesion has a direct effect on telomere length.  The first of these disorders to be 
discovered was dyskeratosis congenita (DC).  Family studies originally found a mutation in a 
gene which was subsequently named dyskerin (DKC1)[85], a small nucleolar protein that binds 
and stabilizes RNA such as TR.  All patients with DC were found to have short telomeres[86].  As 
affected families exhibited differing modes of inheritance alternative mutations were found in 
TR[87,88].  Most cases of DC are due to mutations in DKC1, TR, TERT[89], and the shelterin 
component TIN2[90] however cases have been reported with mutations in four additional 
telomerase and telomere associated genes[91].  Patients have defects in highly regenerative 
tissues, such as skin and bone marrow.  In most cases organ failure occurs first in the bone 
marrow leading to aplastic anemia[92].  The related and more severe diseases Hoyeraal-
Hreidarsson and Revesz syndrome are due to the same deficiencies in telomere maintenance 
with a more severe telomere shortening and phenotype[92].  Patients with coats plus syndrome 
were found to have biallelic mutations in the CST complex gene CTC1[93].  These patients also 
have short telomere length[94].  Adult onset disease can also be attributed to telomerase 
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deficiencies caused by mutations in TR and TERT.  Mutations are found in 8-15% of familial and 
in 1-3% of sporadic idiopathic pulmonary fibrosis (IPF)[95,96], 3-5% of aplastic anemia[97–99], 
and some familial cases of liver cirrhosis[100].  These adult onset conditions are also 
complications that can occur in patients with DC [91]. 
 These conditions represent a spectrum of disease in which the most severe cases have 
the shortest telomeres[101].  As expected this results in deterioration or in the manifestation of 
symptoms over time as telomere length continues to erode.  Mutations that occur in TR or TERT 
are inherited in an autosomal dominant manner which is due to telomerase 
haploinsufficieny[102].  As telomerase is unable to sufficiently extend telomeres in germ cells 
affected families display genetic anticipation in which subsequent generations have more severe 
disease[89].  This results in the spectrum of disease occurring in one family, with earlier 
generations suffering from IPF later in life, and successive generations having complications of 
bone marrow failure occur at a younger age, and dykeratosis congentina in further 
generations[103].  Genetic anticipation is also seen in telomerase knockout mouse models.  In 
founder mice which have long (~50kb) telomeres severe defects in highly proliferative tissues 
only occur in the 5th and 6th generations[104–107]. 
 As telomeres shorten with each cell division it has long been hypothesized that they act 
as a mitotic clock, and are responsible for the effects of aging[108].  Age related telomere loss 
has been shown in diverse tissue types[109,110].  In stem cell pools it is apparent that this 
shortening occurs despite expression of telomerase, and leads to stem cell exhaustion[111,112].  
This loss of proliferative capacity has been linked to disease[112,113].  Telomerase knockout 
mice have a premature aging syndrome causing hair greying and loss, delayed wound healing, 
and short lifespan[106,114].  Short telomere lengths in endothelial progenitor cells[115] and 
leukocytes[116] are risk factors for coronary heart disease.  Short telomere lengths in leukocytes 
also correlate with coratid artery thickening[117] and risk of myocardial infarction[118,119].  Cells 
with shortening telomeres have been shown to secrete factors that represent biomarkers of aging 
and disease[120], independent of factors secreted by senescent cells[121] which also accumulate 
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due to telomere shortening and other factors leading to senescence.  In a model system of 
telomere shortening, the telomerase knockout mouse, continued replicative capacity granted 
through p53 mutation abates the telomere dysfunction phenotype, restoring reproductive capacity 
and allowing later generations of telomerase deficient mice[122].  However the loss of 
proliferative capacity is a suppressor of carcinogenesis. 
 Overcoming the effects of telomere shortening allows for limitless replicative potential of 
a cell, which occurs in cell immortalization and in developing neoplasms.  In a cell population that 
is not dividing as a result of telomere shortening mutation of p53 and RB by viral oncoproteins or 
other mechanisms allows further cell division resulting in further telomere erosion, genomic 
instability and likely cell death, a state known as crisis[123,124].  Cells that escape crisis have an 
activated mechanism to extend telomeres, usually through activation of telomerase.  Over 90% of 
cancers and immortalized cell lines express active telomerase[125,126].  In those immortalized 
cell lines and cancer cells that do not have activated telomerase telomere lengthening is achieved 
by the ALT mechanism[81,82,127].  Enabling a mechanism of telomere elongation is necessary 
for a developing cancer, as it is the only way to acquire limitless replicative potential, one of the 
six hallmarks of cancer[128].  Telomere lengthening alleviates genomic instability, resulting in 
near elimination of chromosome end-to-end fusions[129] and FISH signal free ends[130] 
observed in crisis cells.  Immortalized human fibroblasts that escape crisis have a shorter 
average telomere length than cells in crisis[129].  Telomerase most efficiently extends critically 
short telomeres[131] which leads to telomere length stabilization, not necessarily an average 
increase, resolving the telomere dysfunction caused by the an individual critically short 
telomere[132].  In cancer cells telomerase elongation is distributed across telomeres adding 50-
100 bp to maintain telomere length[133]. 
 Carcinogenesis is a multistep process in which cells sequentially acquire mutations which 
contribute to the ability of resulting cell population to continue its uncontrolled 
proliferation[128,134,135].  Genomic instability can accelerate this process by increasing the 
number of mutational events leading to an increase in proliferatively beneficial mutations[136].  In 
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the context of mutational deficiencies in DNA damage response elements, cells experiencing 
telomere dysfunction are able to avoid replicative senescence or apoptosis[122].  A model of this 
situation exists in telomerase knockout mice compounded with a homozygous or heterozygous 
p53 knockout.  In late generation mice with telomere dysfunction this continued cellular division 
creates bridge-fusion-breakage cycles leading to abnormal karyotypes.  These mice have 
accelerated rates of tumor formation, in different types of tissues.  In the heterozygous p53 
mutant mice carcinomas, mainly skin, breast, and gastrointestinal tract, are the main tumor 
type[137].  Analysis of these tumors shows non-reciprocal translocations between non-
homologous chromosomes, which can lead to copy number changes[138], and are a major cause 
of oncogene duplication and tumor suppressor deletion[139,140].  There is also evidence of non-
reciprocal translocation in human fibroblasts in response to telomere damage due to TRF2 
depletion leading to NHEJ[141]. 
 There is extensive evidence of telomere shortening in human cancers.  Early 
measurements such as telomere restriction fragment length, which uses southern blot to find an 
average bulk telomere length of a sample on a gel, showed breast and colon tumor samples had 
shorter telomere lengths than adjacent normal tissue[142–144].  More accurate measurement 
techniques have been developed through the use fluorescent in situ hybridization.  Using this 
technique PNA probe fluorescence is measured from individual telomere ends in an individual 
cell.  Short telomeres can be measured in invasive breast, prostate, and pancreatic cancers[145–
148].  Short telomeres can also be found in a majority of pre-invasive cancerous growths in 
bladder, cervix, colon, esophagus, and oral cavity, indicating that telomere shortening occurs in 
the early steps of carcinoma development[149].  Telomere length can also be measured using 
less laborious PCR based methods.  Average telomere length can be assayed by a quantitative 
PCR method which compares the amount of telomere sequence signal as measured by qPCR to 
the amount of signal generated from a single copy locus in the genome[150].  Individual 
telomeres can be directly PCR amplified by the use of the single telomere length assay (STELA), 
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however this is limited to telomeres on chromosomes with a unique subtelomeric priming 
site[151]. 
1.1.4 Subtelomere Structure  
Despite the crucial role telomeres play in genome stability and their contribution to cancer 
and disease, telomere length varies widely in the human population.  qFISH measurements of 
individual telomeres have shown that telomere length is heterogeneous[152,153], even between 
homologous chromosomes[154].  However the length profile is largely consistent in discrete 
tissues of an individual, and the profile is predominantly heritable[155].  Telomere length profiles 
are set in the zygote and maintained throughout life[156].  This telomere length regulation is 
controlled in part by cis-acting factors in the telomere adjacent sequence[157–159].  This directly 
adjacent sequence, the subtelomere, contains the telomere associated repeat (TAR) repeats 
which were described early on as being telomere adjacent in the human genome[160,161].  Parts 
of the TAR1 repeat are found within 2kb of nearly all telomeres, and similar sequences are also 
found in the pericentromere[162].  While the TAR repeats are found directly adjacent to the 
telomere, a larger proximal region, the first 500kb adjacent to each telomere makes up the 
subtelomere sequence.  In the human genome the subtelomere is a hotspot of recombination, 
with sister chromatid exchange enriched 160 fold in the terminal 100kb [163,164].  As such the 
subtelomere contains a high degree of segmental duplication.  These duplicated sequences are 
termed subtelomere duplicon blocks.  Patterns of duplicated blocks in the first 25kb of the 
subtelomere are shared between related subtelomeres, defining six subterminal duplicon families 
(A-F).  There are seven distinguishable single copy subtelomeres (7q, 8q, 11q, 12q, 14q, 18q, 
XpYp), and the rest are identifiable to their pertaining family[162].   
 The subtelomere repeat elements (SRE) are segmental duplications of sequence from 
other subtelomeres found on separate chromosome ends.  SRE sequence makes up 25% of the 
subtelomere and 80% of the most distal 100kb[165].  There is also extensive segmental 
duplication (SD) of sequences copied from loci in the internal genome.  The source of these 
duplicated sequences tend to be clustered around specific sites in the genome such as 
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pericentromic regions, and the ancestral chromosome fusion on chromosome two[166].  The 
segmental duplications in the subtelomere are larger and more abundant than elsewhere in the 
genome[167].  The subtelomere is also enriched in internal telomere sequence (ITS) sites.  
These are (TTAGGG)n-like sequences that are found through the genome, however they are 
enriched 25 fold in the subtelomere and tend to be longer and more similar to the perfect 
canonical telomere repeat[165].  In the yeast genome these ITS sites play a role in subtelomere 
transcriptional regulation and recombination, especially in the context of ALT telomere 
maintenance[168,169].  A similar role for these sequences has been hypothesized in the human 
genome[170,171].  The subtelomere also varies in the human population, it was one of the first 
genomic regions to be identified to contain copy number variants[172,173].  Variant combinations 
of subtelomere duplicons define diverse subtelomere alleles which can have an effect on 
subtelomere regulation and transcription[174]. 
1.1.5 Subtelomere Transcripts 
 The telomere and subtelomere were once thought to be maintained in a repressive 
heterochromatic state, as is the case in drosophila[175] and budding yeast[176] due to what is 
known as the telomere position effect; however studies exploring this effect in mammalian 
genomes have been inconclusive.  The subtelomere contains many transcripts including 
throughout the SRE.  While some appear to be noncoding or pseudogene copies, some contain 
open reading frames that can encode proteins[162]. An important subtelomere transcript in the 
human genome is a subclass of the Wiscott-Aldrich Syndrome Protein family, Wiscott-Aldrich 
Syndrome Protein and Scar homolog (WASH).  The WASH gene family is made up of different 
duplicated isoforms throughout the subtelomere, most of which end within 5kb of the telomere 
tract.  The WASH gene is an ancient conserved protein whose function is as an actin 
polymerization regulation factor and is an essential gene in Drosophila[177].  The subtelomere 
also contains large families of genes such as the immunoglobulin heavy chain genes, olfactory 
receptor genes, and zinc finger genes.  A large set of gene families within the subtelomere is a 
feature found in many eukaryotic genomes, in combination with the fact that the subtelomere is a 
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hot spot of recombination; it may be a mechanism by which new genes are generated[167,178].  
The subtelomere has also been shown to contain the transcription start sites of TERRA. 
 Telomeric repeat containing RNA (TERRA) is a long non-coding RNA that is transcribed 
from the subtelomere through the telomeric sequence.  It is highly conserved and has been 
detected in Homo Sapiens, Mus musculus, Danio rerio, plants, and yeasts[179,180].  TERRA 
transcripts contain both subtelomeric sequences and the canonical telomere repeat, but are 
heterogeneous in length, ranging from 100bp to 9kb[181,182].  Inhibition of RNA Polymerase II 
(RNAP2) abolishes TERRA transcription in human U2OS cells[182].  TERRA transcripts are 5’ 
capped by 7-methylguanosine[183], however only 7% of transcripts are polyadenylated[181,182].  
Subtelomere fragments that were previously isolated from 10q and XqYq[161] were used to show 
a CpG island (61-29-37 repeats) within the SRE sequence acted as a promoter sequence and 
was capable of transcribing a reporter gene placed between the 61-29-37 repeat and the 
telomere[184].  TERRA localizes to the nucleus where it forms discrete foci at 
telomeres[181,182].  TERRA associates with shelterin components TRF1 and TRF2 and 
heterochromatin found at telomeres[185,186].  In yeast TERRA overexpression has been shown 
to lead to shortening of the transcribed telomere through exonucleic activity[187], or DNA 
replication dependent loss[188].  TERRA has been shown to act in coordination with hnRNP A1 
to help loading of POT1 on single stranded telomere overhangs[189].  Knockdown of both 
TERRA and hnRNP A1 lead to significant increases in telomere dysfunction induced foci 
(TIF)[185,190,191].  TERRA expression is deregulated in human cancers, with some studies 
showing cancer cell lines and certain cancer types have decreased TERRA expression[192,193], 
and others showing increased TERRA expression overall, with loss of expression from certain 
subtelomeres[194].  TERRA transcription is tightly regulated in healthy cells. 
1.2 Cohesin and CTCF 
 Cohesin is a protein complex that is required for cohesion between sister chromatids.  
Cohesin has three main subunits, SMC1, SMC3, and RAD21, which form a ring structure that 
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holds distant or disjointed regions of the genome within the ring[195,196].  Cohesin also 
associated with accessory proteins SA 1, 2, and 3[197].  There is evidence that cohesin has roles 
beyond sister chromatid cohesion, and is involved in transcriptional regulation.  In yeast SMC 
mutants have disrupted insulator function[198] and in Xenopus and human cells cohesin is 
associated with chromatin at points in the cell cycle with no sister chromatid cohesion[199–201], 
and cohesin subunits are expressed in post-mitotic murine neurons where there will be no more 
sister chromatid cohesion[202,203].  Cohesin has been found to frequently colocalize with the 
zinc finger domain protein CCCTC binding factor (CTCF) in the mouse and human genomes, and 
these sites of colocalization are enriched in regions within 2kb of genes[202,204–206]. 
CTCF was originally found as a protein bound to the promoter region of the MYC 
oncogene[207].  CTCF has been identified as a transcriptional activator and repressor, as it has 
been found at sites between transcriptionally active and inactive chromatin[208–210].  CTCF 
binding is inhibited by CpG island methylation[211], and conversely CTCF binding inhibits denovo 
CpG methylation[212].  It has been postulated that CTCF is the main factor controlling spatial 
positioning of genomic segments, grouping disparate segments in condensing or decondensing 
nuclear territories[213].  Chromsome confirmation capture (3C) experiments have shown long 
range interactions play an important role in the expression of other repetitive sequences such as 
olfactory genes[214,215] and CTCF was shown to be involved in regulating gene expression 
through paternal imprinting at the IGF2/H19 locus by controlling long range interactions[216–218]. 
1.3 High Throughput Sequencing 
1.3.1 Technology 
The advent of high throughput sequencing (HTS) has transformed how we are able to 
study the genome, allowing in depth observation of variation, expression, regulatory function and 
epigenetics at a global scale.  Second generation HTS has relied on optical detection of 
fluorescently labeled nucleotides or luminescence from millions of individual DNA fragments 
simultaneously.  These small DNA fragments are generated from random fragmentation of the 
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genome either physically through sonication or enzymatically through restriction digests.  In order 
to generate a large enough signal suitable for detection identical copies of individual DNA 
fragments are generated and fixed at a single physical site that can be imaged.  To accomplish 
the amplification of these individual fragments universal priming sites are first ligated to the 
fragments before they are PCR amplified simultaneously.  The details of the PCR reaction 
conditions and how the fragments are fixed differentiate the existing technologies. 
The first HTS method that was developed was based on pyrosequencing, which was 
commercialized by 454.  This technology employs emulsion PCR (emPCR) to amplify individual 
fragments.  The fragments are captured by beads containing the complement of the annealed 
universal primer under conditions such that you would expect at most one fragment per bead.  
The PCR reaction can then amplify each fragment in an individual microreactor, coating the bead 
with copies[219].  Pyrosequencing takes advantage of the release of inorganic phosphate during 
DNA synthesis.  When nucleotides are added to a nascent strand of DNA they release an 
inorganic phosphate which can be measured by its conversion to visible light through enzymatic 
reactions [220,221].  Beads are sequestered in wells on a chip and washed with consecutive 
washes of dNTPs.  Fluorescent signals are captured, with homopolymers generating an 
increased signal[222].  As pyrsoquencing does not rely on recurrently terminating DNA synthesis 
it is able to generate the longest reads currently widely available.   
Life technologies platform, SOLiD, also employs the use emPCR, however the 
sequencing reaction does not rely on the measurement of bases incorporated by DNA 
polymerase, instead it measures the ligation of dye labeled complementary probes[223].  Once 
probes have been ligated the fluorescent signals are measured, the probes are cleaved from the 
fragment and new probes that interrogate the next base position are ligated.  The SOLiD platform 
has the advantage of using dinucleotide probes, therefore interrogating each base position 
twice[224].   
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The most popular HTS platform is technology was developed by Solexa which was later 
acquired by Illumina.  Instead of binding fragments to a bead as in ePCR, fragments are bound to 
primers that are covalently attached to a glass slide.  These fragments are then are then 
amplified directly on the slide by bridge amplification, generating clusters of amplified DNA 
distributed on the chip.  Illumina sequencing relies on reversible terminator chemistry, permitting 
the addition of one fluorescently labeled nucleotide in each cycle.  After unincorporated 
nucleotides are washed away, fluorescence is measured through imaging, and the terminating 
group is chemically cleaved, allowing for the next cycle of nucleotide addition[225].   
Further advances in HTS are allowing for direct sequencing of single molecules to 
eliminate the noise introduced by amplification (PacBio, Nanopore), and allowing for nonoptical 
measurements of base interrogation to allow for higher throughput (IonTorrent, Nanopore).  The 
second generation HTS technologies generate reads between 36 and 250 bases in length.  
These reads are too short and biased to find stretches of overlapping fragments for de-novo 
assembly of complex genomes, instead these reads are aligned to the existing reference 
sequence. 
1.3.2 Alignment 
 Alignment of sequences is a long standing problem in bioinformatics to enable to 
comparison of similar sequences throughout and between genomes.  The algorithms developed 
for fast alignment depend on a breakdown of a reference sequence into a specialized data 
structure, creating an index of the reference.  The most widely used long sequence aligners 
starting with BLAST use a hash table index[226].  This index maps the position of each k-mer 
sequence in the reference, which can then be used to find the positions of seed sequences which 
are then extended and joined and refined by a Smith-Waterman alignment[227,228].  Short read 
aligners have implemented different strategies to improve the speed and accuracy of aligning 
short query sequences to a large reference genome of the same species.  A spaced seed, with 
mismatches within the seed, is able to improve the sensitivity of hits[229].  The first Illumina 
alignment tool ELAND, SOAP, SeqMap, and MAQ use variations of this strategy[230–232].  
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Another strategy to allow both mismatches and gaps within the seed is to use q-gram filtering, 
which is implemented in SHRiMP[233].  Building a hash table of an entire reference genome 
takes a significant amount of space and holding it in memory for searching can be taxing on 
computational resources.  A different strategy for aligning sequences relies on suffix trees.   
These have the advantage of being able to be represented by more efficient data structures, a 
prefix array[234], and further compressed in structures that are based on the Burrows-Wheeler 
Transform[235], a FM-index[236].  Using an FM-index the human genome reference can be built 
to take up 2-8Gb of memory.  The most popular short read alignment algorithms, bowtie, SOAP2, 
and BWA use an FM-index strategy[237–239].  All these mapping strategies allow for 
mismatches and gaps in the final alignment to account for sequencing errors, and variation and 
mutation found in sample sequences compared to the reference.  However a major issue that 
arises in aligning these sequences is the presence of repetitive sequence in the reference 
genomes, for example nearly half of the human genome is repetitive sequence[240,241].  Reads 
generated from these parts of the genome that are completely identical at the length of the read 
generated cannot be mapped unambiguously.  The standard analysis pipelines do not consider 
these multimapping reads and instead focus only those reads which map uniquely.  This limits the 
application of the data sets in analyzing the telomere and subtelomere. 
1.3.3 Applications 
 Whole genome sequencing (WGS) has allowed for in depth observations of the variants 
and mutations that exist in the human population.  Many software tools have been developed to 
call single nucleotide polymorphisms (SNP)[242], small indels[243], and copy number variants 
(CNV)[244].  This has allowed us to find rare variants and denovo mutations, and study rare 
Mendelian disorders with small numbers of affected individuals.  It has also allowed for the study 
of cancer genomics and acquired mutations that are common to certain cancers, and the 
changes that occur in tumors over time as subclonal populations of cells expand and outgrow 
others[245].  This allows us to track the mutations driving the growth of the cancer, identifying 
potential targets for therapy. 
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 RNA-seq allows analysis of whole transcriptomes by sequencing of cDNA made from 
reverse transcription of poly(A) selected, or ribosome repeat depleted RNA[246].  The analysis of 
these datasets is similar to WGS, except that reads must either be mapped to the known 
transcriptome, or allow for large gaps within the genome mapping to account for transcript 
splicing.  Gene expression levels are then estimated by calculating the number of reads per 
kilobase of transcript per million reads.  The problem of multi-mapping reads is exacerbated in 
RNA-seq data as there are both gene families made up of similar psuedogenes, and a large 
degree of transcript heterogeneity in the form of alternatively transcribed and spliced isoforms of 
genes.  This problem has been addressed in most implementations of RNA-seq analysis, and a 
common strategy is to assign partial reads to all of its possible mapping positions.  ERANGE 
assigns location weighting based on the expression level of adjacent unique regions[246].  
Methods that quantify individual isoform levels, such as RSEM, go beyond this to assign partial 
reads to different isoforms representing the same mapping position[247,248]. 
 ChIP-seq is a method to measure protein-DNA interaction and epigenetic marks genome 
wide.  In Chromatin immunoprecipitation (ChIP) experiments DNA binding proteins are cross 
linked to DNA in vivo by treating cells with formaldehyde before the genome is fragmented.  
Antibodies targeted to the selected protein of interest, or directly targeting chromatin marks, 
immunoprecipitate the DNA-protein complex.  Once the crosslinks are reversed the resulting DNA 
fragments are used to build a HTS library that is enriched for the targeted protein or histone mark.  
The resulting sequenced reads are aligned to the reference genome in the same way as WGS 
datasets.  An important caveat of ChIP-seq dataset is that they are only enriched for the chosen 
protein or mark.  As such they are compared to an input or ChIP (IGG) control.  Regions 
statistically enriched for the sample are shown to interact with the selected protein.  All the 
standard ChIP-seq analysis tools only consider uniquely mapping reads, ignoring the repetitive 
parts of the genome. 
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1.4 Outline of Dissertation 
In	  chapter	  2	  I	  present	  the	  initial	  mapping	  and	  analysis	  of	  ChIP-­‐seq	  datasets	  to	  the	  15kb	  
of	  sequence	  proximal	  to	  the	  telomere	  in	  the	  human	  genome,	  which	  was	  my	  key	  contribution	  to	  
the	  Deng	  et	  al	  2012	  paper	  I	  co-­‐authored.	  	  CTCF	  and	  cohesin	  colocalization	  within	  2kb	  of	  the	  
telomere	  was	  found	  on	  the	  majority	  of	  human	  subtelomeres.	  	  The	  results	  of	  follow-­‐up	  functional	  
studies	  carried	  out	  by	  Zhong	  Deng	  in	  the	  Lieberman	  lab	  for	  this	  paper	  are	  summarized	  briefly,	  
and	  demonstrate	  the	  importance	  of	  CTCF	  and	  cohesin	  binding	  for	  TERRA	  transcription	  and	  
telomere	  stability.	  	  In	  chapter	  3	  I	  show	  the	  results	  of	  extending	  this	  analysis	  to	  the	  entire	  500kb	  
human	  subtelomere.	  	  A	  complete	  multi-­‐mapping	  ChIP-­‐seq	  analysis	  pipeline	  was	  developed.	  	  
ChIP-­‐seq	  results	  for	  a	  number	  of	  datasets	  were	  generated	  and	  are	  all	  available	  on	  a	  Wistar	  
mirror	  of	  the	  UCSC	  genome	  browser	  focused	  on	  the	  subtelomere.	  
In	  chapter	  4	  I	  extended	  the	  ChIP-­‐seq	  pipeline	  for	  use	  on	  murine	  samples.	  	  I	  describe	  the	  
sequence	  characteristics	  of	  the	  recently	  completed	  mouse	  subtelomere	  sequence,	  and	  the	  
differences	  between	  the	  human	  and	  mouse	  subtelomere	  repeat	  structure.	  	  A	  number	  of	  ChIP-­‐
seq	  datasets	  were	  analyzed	  to	  provide	  an	  online	  resource	  similar	  to	  the	  human	  subtelomere	  
browser.	  	  Additionally	  RNA-­‐seq	  datasets	  were	  analyzed	  to	  look	  for	  evidence	  of	  TERRA	  
transcription.	  	  Differences	  in	  human	  and	  mouse	  TERRA	  regulation	  and	  transcription	  are	  
explored.	  
In	  chapter	  5	  I	  present	  Telomere	  Analysis	  from	  SEquencing	  Reads	  (TASER),	  a	  pipeline	  to	  
capture	  telomere	  sequence	  information	  from	  HTS	  data	  sets.	  	  This	  pipeline	  was	  used	  to	  analyze	  
53	  paired	  tumor	  normal	  samples	  from	  the	  prostate	  cancer	  genome	  sequencing	  project.	  	  The	  
results	  of	  the	  analysis	  were	  used	  to	  show	  the	  feasibility	  of	  the	  strategy	  and	  show	  a	  trend	  in	  the	  
telomere	  changes	  that	  occur	  in	  prostate	  cancer.	  	  The	  telomere	  status	  was	  then	  used	  to	  classify	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samples	  as	  tumor	  or	  normal.	  	  In	  chapter	  6	  I	  conclude	  with	  an	  overall	  discussion	  of	  the	  
significance	  of	  this	  thesis	  work.	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CHAPTER 2: PROXIMAL 15KB ANALYSIS 
2.1 Introduction 
The ends of eukaryotic chromosomes form specialized chromatin structures that are 
essential for chromosome stability and genome maintenance[1]. The terminal TTAGGG repeats 
of mammalian telomeres bind to a set of proteins that are nucleated by the DNA-binding proteins 
TRF1, TRF2, and Pot1, and are collectively referred to as shelterin[2,3] or telosome[4,5]. These 
terminal repeat binding factors regulate telomere length homoeostasis and DNA damage repair 
processing at the chromosome termini[6]. Loss or damage of the terminal repeats can initiate a 
DNA damage response and trigger cellular replicative senescence[7,8]. DNA damage and 
senescence can also be elicited by mutation or depletion of telomere repeat binding proteins[9]. 
Dynamic remodelling of telomere repeat factors and telomere DNA conformation is also required 
for normal telomere length regulation and telomerase accessibility[10–13]. 
In addition to shelterin and telomerase, telomere maintenance depends on the proper 
assembly and regulation of telomeric chromatin[5,14,15]. Traditionally, telomeres have been 
thought of as highly heterochromatic structures associated with condensed chromatin and 
transcriptional silencing[14,16–18]. More recent studies have revealed that many eukaryotic 
telomeres, including human and yeast, can be transcribed, indicating that telomeric silencing is 
incomplete and telomere chromatin is dynamic[19–23]. The chromatin structure of telomeres is 
further complicated by the variations in the subtelomeric DNA structures, suggesting that 
telomeric heterochromatin structure and regulation may vary among different chromosomes[24–
26]. In budding yeast, telomeric silencing is mediated by Sir proteins that interact with telomere 
repeat binding factor Rap1[27]. In mammalian telomeres, nucleosomal arrays commonly 
associated with heterochromatin appear to be irregularly spaced or disrupted by telomere repeat 
binding factors[28,29]. Numerous interactions between shelterin and chromatin regulatory factors 
suggest that telomere repeat factors contribute to telomeric chromatin structure[30–35]. We have 
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previously shown that TRF2 can bind directly to telomeric repeat-containing RNA (TERRA) to 
recruit heterochromatin proteins including ORC and HP1 and maintain histone H3K9me3 
enrichment at telomeres[33]. TERRA expression is itself dependent on histone H3K4 
methyltransferase MLL[36], as well as DNA methylation status and CpG-island promoter found in 
many subtelomeric regions [37–39]. In fission yeast, the expression of TERRA and other 
subtelomeric transcripts are subject to diverse regulation by chromatin regulatory factors[40,41]. 
The dynamic interplay between shelterin, telomere chromatin structure, TERRA expression, and 
telomere biology appears to be an essential and universal component of chromosome stability. 
The chromatin organizing factor CTCF has been implicated in numerous aspects of 
chromosome biology, including chromatin insulation, enhancer blocking, transcriptional activation 
and repression, DNA methylation-sensitive parental imprinting, and DNA-loop formation between 
transcriptional control elements[42–44]. CTCF has been implicated in the transcriptional 
repression of the D4Z4 macrosatellite repeat transcript found ∼30  kb from the telomere repeats of 
chromosome 4q[45]. At D4Z4, CTCF interacts with lamin A and tethers the chromosome 4q 
telomere to the nuclear periphery [46,47]. A more general role for CTCF has been found in its 
ability to colocalize with cohesin subunits at many chromosomal positions[48–51]. Cohesin is a 
multiprotein complex consisting of core subunits SMC1, SMC3, Rad21, and SCC3 (referred to as 
SA1 or SA2 in humans), which can form a ring-like structure capable of encircling or embracing 
two DNA molecules[52,53]. Cohesin was originally identified as a regulator of sister-chromatid 
cohesion, but subsequent studies in higher eukaryotes indicate that they have functions in 
mediating long-distance interactions between DNA elements required for transcription 
regulation[54,55]. Cohesin subunit SA1 is recruited to telomere repeats by the shelterin protein 
Tin2, and this interaction is required for telomeric sister-chromatid cohesion and efficient telomere 
replication[56,57]. Tin2 can also promote heterochromatin formation through an interaction with 
heterochromatin protein HP1γ, but how this relates to sister-chromatid cohesion and cohesin 
function is not completely clear[34]. It is also not known whether CTCF can associate with 
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telomeres or subtelomeres in addition to binding the D4Z4 gene repeat, nor if it can interact with 
cohesin at these locations. 
The chromosome region immediately adjacent to the terminal repeats has been referred 
to as the subtelomere. In humans, the distal subtelomeres consist of a variety of degenerate 
repeat elements with a few discrete gene transcripts interspersed at various distances from the 
terminal TTAGGG repeat tracts[24–26,58,59]. TERRA transcription initiates from within the 
subtelomeres, and a promoter containing a CpG-island and subtelomeric 29- and 61-bp repeat 
element has been identified in plasmid reconstitution assays[38]. DNA methylation and DNA 
methyltransferases have been shown to inhibit TERRA expression since TERRA levels are highly 
elevated in cells where DNMTs have been genetically disrupted or depleted [38,60], as well as in 
Immunodeficiency-Centromeric instability-Facial abnormalities (ICF) Syndrome cells that are 
genetically defective in DNA methyltransferase 3B (DNMT3B) [37,39,61]. CTCF binding is known 
to be DNA methylation sensitive but it is not yet known whether CTCF associates with 
transcriptional regulatory elements important for TERRA regulation or telomere maintenance. 
Herein, we investigate the role of CTCF and cohesin at human subtelomeres and their role in 
regulating TERRA expression, telomere chromatin organization, and telomere DNA end 
protection. 
2.2 Methods 
2.2.1 ChIP-Seq data 
ChIP-Seq was performed using 1 × 107 BCBL1 cells per assay with either rabbit anti-
cellular SMC1 (Bethyl A300-055A-3) or CTCF antibody (Millipore 07–729), or control rabbit IgG 
(Santa Cruz Biotechnology), using Illumina-based sequencing as described[249]. 
The public CTCF data are from ENCODE data series GSE19622[250]. The RNAPII data 
are from data series GSE19484[251]. The Rad21 data are from ENCODE/HAIB data series 
GSE32465. All three datasets used were from LCL lines. 
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2.2.2 Mapping ChIP-Seq data to human subtelomeres 
The human subtelomere reference assemblies used for the mapping studies represent 
the most distal 15  kb of DNA sequence adjacent to the (TTAGGG)n terminal repeat tract for the 
indicated telomeres. Each assembly is oriented with the telomere end on the left with nucleotide 
position 1 corresponding to the first (CCCTAA) of the tract, which continues to the left of this 
position but was truncated for mapping consistency purposes. Some of these sequences were 
available in HG19 [165] whereas others were assembled by merging new fosmid sequence data 
with HG19 to bridge remaining gaps. In several instances, structural variants corresponding to 
alternative subtelomere alleles were also included in the set of subtelomere assemblies used 
here because they differed substantially from the original reference telomere. The full set of 
subtelomere assemblies are described in detail in Chapter 3. All of the sequences in the 
described orientation are available in FASTA format in Supplementary File S1. 
Reads were mapped to the 15kb subtelomere reference using bowtie[238]. Many 
subtelomeres are duplicon rich with duplicon-specific nucleotide sequence similarities ranging 
from 90 to 99% between individual members of duplicon families that occur on separate 
subtelomeres[162,164,252,253]. To deal with this issue, we required a perfect match to retain a 
read, and all perfect matches of a given read to positions within the reference assemblies were 
recorded. Multiply mapping reads were dealt with as described previously[254], by assigning 
weights to reads such that multiple mapping positions sum to one read. Mapping likelihood was 
added to the reads as the inverse of the number of mapping positions. Picard 
(picard.sourcefourge.net) was used to mark and remove pcr duplicates. Coverage maps were 
then constructed using the mapping likelihood as a weight and extending the reads to the 
appropriate fragment length in the data set. The coverage map was calculated at single base 
resolution. Enrichment profiles were made from comparing RPM values between sample and IgG 
control. RPM=(coverage at position)/(total reads in library/10^6). The complete read mapping 
statistics (including Unique versus Multimapping Reads) are available for each of the data sets 
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used in Supplementary File S2. All figures were generated on the subtelomere reference genome 
hosted at the Wistar mirror of the UCSC genome browser, http://vader.wistar.upenn.edu. 
2.3 Results 
2.3.1 CTCF, cohesin, and RNAPII binding to the CpG-island promoters in 
human subtelomeres 
Genome-wide analyses of CTCF, cohesin, and RNA polymerase II (RNAPII) have been 
performed in several different cell lines from various laboratories, including those generating the 
human ENCODE database [1–5]. In these published studies, the complete human subtelomeric 
DNA was not available for ChIP-Seq data mapping, with gaps immediately adjacent to the start of 
terminal repeat tracts for many telomeres[6]. We have generated complete assemblies of human 
subtelomeres for most of these chromosome ends and here we use these reference assemblies 
to map the read sequences from data sets, including our own, for CTCF, Rad21, SMC1, and 
RNAPII (Figure 2.1;Supplementary Figures 2.3 and 2.4). We found that most but not all human 
chromosome ends have a major CTCF-binding site within 1–2  kb from the TTAGGG repeat 
tracts. These CTCF sites consistently mapped to a region just upstream (centromeric) to the 
CpG-islands and 29  bp repeats, often overlapping 61  bp repeat element (Supplementary Figures 
2.3 and 2.4). In the few exceptions to this pattern, CTCF sites were observed at positions ∼10  kb 
from the TTAGGG repeats (7p, XYp) or several CTCF-binding sites with relatively low peak 
scores (3p, 7q, 8q, and 12q) (Supplementary Figure 2.4). We refer to these two different 
subtelomeres as type I (with major CTCF peaks at ∼1–2  kb) or type II (lacking obvious CTCF 
peaks proximal to the telomere repeat tracts). In almost all cases, including those of type II, we 
observed an overlap of CTCF-binding sites with cohesin subunit Rad21 (Figure 2.1; 
Supplementary Figure 2.3). We confirmed that CTCF and cohesin peaks overlap in different cell 
lines by performing an independent CTCF and SMC1 ChIP-Seq experiment in a B-lymphoma cell 
line (Supplementary Figures 2.3 and 2.4). Our ChIP-Seq showed a nearly perfect overlap of 
CTCF and SMC1 in these cells, and a strong correlation with CTCF and Rad21 binding in 
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multiple cell types. In contrast to CTCF and cohesin, RNAPII bound as a more diffuse peak most 
commonly at a position immediately telomeric to the CTCF-binding sites and more directly 
overlapping the CpG-islands. A schematic summary of the average binding pattern of CTCF, 
Rad21, and RNAPII relative to CpG-island, 29 and 61  bp repeats is shown inFigure 2.1B. 
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Figure 2.1 − Enrichment profiles for ChIP-Seq analysis of CTCF, cohesin, and RNAPII binding to 
human subtelomeres. Fragment density profiles were generated for samples and a matched IgG control as 
described in Materials and methods. The fold enrichment of sample over IgG is shown. (A) CTCF, RNAPII, 
and Rad21 binding in the first 15  kb subtelomeres of chromosome arms 10q, 13q, 15q, and XYq. The y-axis 
for each track is auto-scaled to highest peak in each chromosome region shown. (B) Model enrichment 
profile with peaks within the first 5  kb of the telomere tract. The CTCF peak is just centromeric to the CpG-
island, typically centred over a 61-mer repeat. The RNA Pol II tract is centred over the 29-mer repeat. The 
exact position of these peaks varies with the positioning of these genomic features relative to the start of the 
terminal repeat tract on each chromosome arm.  
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Due to the complex duplications in subtelomeric sequence, we permitted multimapping 
signals weighted according to the number of perfect subtelomeric mapping sites to contribute, 
along with uniquely mapping reads, to subtelomeric ChIP-seq signals. We found that the 
remaining unique signals recapitulated the ChIP-Seq peak positions in most cases when multiple 
mappings were eliminated (Supplementary Figure 2.3E), suggesting that most of the binding sites 
can be uniquely assigned to specific subtelomeres. Some unique signals are lost, as expected for 
perfect duplications. This was sometimes the case with the 29-mer repeats over which RNAPII 
signal is centred and which a portion of the CTCF and cohesin read peaks was formed at many 
subtelomeres. Supplementary Figure 2.3D illustrates this effect for the example subtelomeres 
shown in the Supplementary Figure 2.3E. At the same time, Supplementary Figure 2.3D also 
shows the clear enrichment of RNAPII ChIP-seq reads mapping to the 29-mer variable number 
tandem repeat (VNTR) over the IgG controls, a true binding peak that would have been missed if 
multimapping signal contributions were disallowed. 
2.3.2 CTCF binds directly upstream of the CpG-island and 29 repeat 
element found in subtelomeres 
To verify the ChIP-Seq data for CTCF, cohesin, and RNAPII, we performed conventional 
ChIP-qPCR with primers spanning the first 3  kb of the XYq (Figure 2.2A and B) and 10q 
(Supplementary Figure 2.5) subtelomeres in a B-cell lymphoma-derived cell line used for ChIP-
seq. As a control, we assayed TRF1 and TRF2 ChIP. As expected, TRF1 and TRF2 were 
enriched at positions closest to the TTAGGG repeats (primer set 1). ChIP assays with CTCF and 
cohesin subunits Rad21 and SMC1 revealed strong enrichment at the CpG-islands (primer set 2), 
while RNAPII was enriched at regions closest to the TTAGGG repeats (primer set 1), consistent 
with ChIP-Seq data indicating that RNAPII bound to broad peaks between CTCF–cohesin and 
the TTAGGG repeats. To determine if CTCF bound directly to subtelomere DNA, we assayed the 
ability of purified recombinant CTCF protein to bind candidate recognition sites in vitro by 
electrophoretic mobility shift assay (EMSA) (Figure2. 2C and D). Human CTCF protein was 
expressed and purified from baculovirus (Figure 2.2C). Candidate CTCF-binding sites from the 
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ChIP-seq peaks in subtelomere XYq, 10q, and 7p, as well as control oligonucleotides containing 
substitution mutations in the putative CTCF consensus sites, ΔXYq, Δ10q, and Δ7p, were 
synthesized as 46  mers for EMSA probes (Supplementary Table S3). Purified CTCF protein 
bound efficiently to the XqYq and 7p probes, less efficiently to 10q probe, but not to the mutated 
ΔXYq, Δ10q, and Δ7p probes (Figure 2.2D), indicating that these subtelomere ChIP-Seq peaks 
contain bonafide CTCF recognition sites. The relative binding affinities of these subtelomeric 
CTCF-binding sites was further quantified by a fluorescence polarization based competitor assay 
(Figure 2.2E). The wild-type CTCF-binding sites from XYq, 10q, and 7p showed robust 
competition against a FAM6-labelled probe containing a CTCF-binding site with high similarity to 
the consensus motif as defined previously[255]. Inhibitory constants (Ki) for each binding sites 
were equal to 11.82, 20.67, and 10.88  nM, respectively. On the other hand, the mutant ΔXYq, 
Δ10q, and Δ7p probes show linear relationship to increasing competitor with no plateau, 
suggesting a nonspecific inhibition of CTCF binding (Figure 2.2E). These findings indicate that 
the subtelomeric CTCF-binding sites have relatively high affinities for CTCF in vitro. 
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Figure 2.2 − Identification of CTCF-binding site elements in the 61-bp element of human 
subtelomeres. (A) Schematic of the type I subtelomere showing the relative positions of the 29- and 61-bp 
repeat element, CpG-island, and TTAGGG terminal repeats. (B) ChIP-qPCR for TRF1, TRF2, CTCF, 
RNAPII, Rad21, and SMC1 relative to IgG controls using primers for the XYq subtelomere at positions close 
(∼150  bp) to TTAGGG repeat (black), at CpG-island (red), or ∼3  kb from terminal repeats (green). Bar graph 
represents the average value of percentage of input for each ChIP from three independent PCR reactions 
(mean±s.d.). (C) Purified recombinant CTCF protein analysed by Coomassie staining of SDS–PAGE gel. (D) 
EMSA with CTCF protein binding to DNA oligonucleotide probes containing putative binding sites from 
subtelomere XYq, 10q, or 7p, as well as with oligonucleotides containing point mutations in CTCF 
recognition sites designated ΔXYq, Δ10q, and Δ7p. Free probe and bound probe were indicated with arrow. 
(E) Inhibitory constants (Ki) were calculated by titrating the same DNA probes used in EMSA against a 
FAM6-labelled probe with a known dissociation constant and measuring changes in CTCF binding via 
fluorescence polarization. Mutant (Δ) sites show a linear binding isotherm over the same concentration 
range of competitor, suggesting only nonspecific competition.  
 
30	  
	  
2.3.3 Summary of Results of Dr. Zhong Deng’s functional experiments in 
Dr. Paul Lieberman’s lab that were included in the Deng et al., 2012 
publication 
Using the CTCF and cohesin binding to subtelomeres suggested by initial mapping and 
analysis experiments as a starting point, Dr. Deng led a series of functional studies establishing 
the importance of subtelomeric CTCF and cohesin binding for TERRA transcription and genome 
integrity.  These experiments indicated that (1) CTCF recuits RNAPII to subtelomeres; (2) CTCF 
and cohesin stabilize TRF binding to subtelomere; and (3) CTCF and cohesin are required for 
protection of telomeres and prevention of telomere DNA damage signaling.  A subtelomere 
construct was used to show that both mutation of the CTCF binding site, and siRNA knock down 
of CTCF results in a decrease in TERRA transcription.  CTCF and RAD21 knock downs were 
also used to show a subsequent loss of RNAPII binding in the subtelomere.  Telomere damage 
foci were observed as a result of the depleted TERRA transcription.  Dr. Deng’s experiments are 
detailed in Deng et al. 2012 and are not included in this dissertation. 
2.4 Discussion 
2.4.1 A foundation for a chromatin atlas of the human subtelomeres 
Genome-wide studies on chromatin structure and histone modification patterns have 
been incomplete near human telomeres, due both to remaining gaps in the reference sequence 
adjacent to the start of the (TTAGGG)n tracts and to subtelomeric segmental duplication families 
near many telomeres. In this work, we provide a foundation for a more complete analysis of the 
human genome by examining regions of the human subtelomeres that had previously not been 
included in human genome-wide studies. Using new sequence data to complete most of the gaps 
adjacent to (TTAGGG)n tracts and stringent read mapping criteria (both described in detail in 
Chapter 3), we have established a human subtelomere map and genome browser for next-
generation DNA sequence analyses, including ChIP-Seq and RNA-Seq. Here, we mapped 
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several ChIP-Seq data sets to the most distal parts of human subtelomeres (Figure 
2.1; Supplementary Figures 2.3 and 2.4). We focused on CTCF and cohesin subunits because of 
their general importance in chromosome organization throughout vertebrate evolution. We found 
that CTCF and cohesin colocalized at a position immediately adjacent to the CpG-islands 
implicated in TERRA promoter regulation[184] (Figures 2.1 and 2.2). We confirmed this binding 
by generating a new experimental data set for CTCF and SMC1 ChIP-Seq in a B-lymphoma cell 
lines. In addition, we mapped RNAPII binding and found that it localized more broadly across the 
subtelomeres, but had an average enrichment at the telomeric side of the CpG-island promoter 
for TERRA expression. CTCF and cohesin bound just centromeric to the CpG-island, and were 
further investigated for their role in TERRA expression and telomere end protection. The genome 
browser and methods established for mapping next-generation sequence data to the subtelomere 
provides a foundation for building a more complete atlas of epigenetic marks and chromatin 
organization at human subtelomeres. 
2.4.2 Supplemental Figures 
Large multipage figure available as figure S1 at 
http://onlinelibrary.wiley.com/doi/10.1038/emboj.2012.266/suppinfo 
Figure 2.3 −  Summary of ChIP-Seq analysis of CTCF, cohesin, and RNAPII binding to type I human 
subtelomeres. Fragment density profiles were generated for samples and matched IgG controls as 
described in Methods. The fold enrichment of sample over IgG is shown. The Y axis for each track is auto-
scaled to highest peak in each chromosome region shown. Subtelomere identity is indicated in the top left of 
each panel. (A-D) CTCF_W and SMC1_W were newly generated ChIP-Seq data using human pleural 
effusion lymphoma cell line BCBL1. CTCF, RNAPII, and Rad21 were derived from human encode data sets 
using B-lymphoblastoid cell lines. (E) Example enrichment profiles for ChIP-Seq analysis, comparing the 
standard multi-mapping method used vs allowing only unique mappings. The top track of each dataset pair 
permitted multimapping in the indicated ChIP and control IgG dataset, and the bottom (designated by _U) 
permitted only unique mappings in both ChIP and IgG control dataset. Binding in the first 15 kb 
subtelomeres of chromosome arms 10q, 13q, 15q, and XYq are shown. 
	  
Large multipage figure available as figure S2 at 
http://onlinelibrary.wiley.com/doi/10.1038/emboj.2012.266/suppinfo 
Figure 2.4 −  Summary of ChIP-Seq analysis on type II human subtelomeres. Same as in Figure S1, 
except for subtelomeres that lack an obvious CTCF binding peak proximal to the terminal repeat tracts. 
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Figure 2.5 −  Validation of CTCF binding site at 10q human subtelomeres in BCBL1 cells. (A) 
Schematic of the 10q subtelomere showing the relative positions of the 29 bp repeat element, CpG island, 
and TTAGGG terminal repeats. (B) ChIP-qPCR for TRF1, TRF2, CTCF, RNAPII, Rad21, and SMC1 relative 
to IgG controls using primers for the 10q subtelomere at positions close (~400 bp) to TTAGGG repeat 
(black), at CpG island (red), or ~2 kb from terminal repeats (green). Bar graph represents the average value 
of percentage of input for each ChIP from three independent PCR (Mean + SD). 
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CHAPTER 3: HUMAN SUBTELOMERE ANALYSIS 
3.1 ABSTRACT 
Mapping genome-wide data to human subtelomeres has been problematic due to the 
incomplete assembly and challenges of low-copy repetitive DNA elements.  Here, we provide 
updated human subtelomere sequence assemblies that were extended by filling telomere-
adjacent gaps using clone-based resources.  A bioinformatic pipeline incorporating multi-read 
mapping for annotation of the updated assemblies using short-read datasets was developed and 
implemented.  Annotation of subtelomeric sequence features as well as mapping of CTCF and 
cohesin binding sites using ChIP-seq datasets from multiple human cell types confirmed that 
CTCF and cohesin bind within 3 kb of the start of terminal repeat tracts at many, but not all 
subtelomeres. CTCF and cohesin co-occupancy was also enriched near Internal Telomere-like 
Sequence (ITS) islands and the non-terminal boundaries of subtelomere repeat elements (SREs) 
in transformed lymphoblastoid cell lines (LCLs) and human embryonic stem cell (ES) lines, but 
not significant in the primary fibroblast IMR90 cell line.  Subtelomeric ITS islands were found to 
be frequent sites of artifactual mappings using short-read datasets due to the similarity of their 
sequences to those in terminal repeat tracts; TERF1 and TERF2 ChIP-seq peaks called at ITS 
sites could not be confirmed by ChIP-qPCR analysis of those sites. By contrast, subtelomeric 
CTCF and cohesin sites predicted by ChIP-seq using our bioinformatics pipeline (but not 
predicted when only uniquely mapping reads were considered) were consistently validated by 
ChIP-qPCR. The co-localized CTCF and cohesin sites in SRE regions are candidates for 
mediating long-range chromatin interactions in the transcript-rich SRE region.  A public browser 
for the integrated display of short-read sequence-based annotations relative to key subtelomere 
features such as the start of each terminal repeat tract, SRE identity and organization, and 
subtelomeric gene models was established (vader.wistar.upenn.edu/humansubtel).   
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3.2 INTRODUCTION 
Subtelomeric DNA is crucial for telomere (TTAGGG)n tract length regulation and 
telomeric chromatin integrity. A telomeric repeat-containing family of RNAs (TERRA) is 
transcribed from subtelomeres into the (TTAGGG)n tracts [181,183,182] and forms an integral 
component of a functional telomere; perturbation of its abundance and/or localization causes 
telomere dysfunction and genome instability [181,185].  Telomere dysfunction caused by critically 
short telomere DNA sequence or by disruption of telomeric chromatin integrity induces DNA 
Damage Response pathways that cause cellular senescence or apoptosis (depending on the 
cellular context) in the presence of a functional p53 tumor suppressor pathway [256]. Only one or 
a few critically short telomeres in a cell are sufficient to induce DDR-mediated senescence or 
apoptosis [66,257]. Senescence or apoptosis of somatic cells can disrupt tissue 
microenvironments, and senescence or apoptosis of stem cell populations can prevent proper 
replenishment of rapidly dividing cellular lineages, both impacting aging phenotypes and age-
related diseases including cancer [258–261]. 
Subtelomeric DNA elements regulate both TERRA levels and haplotype-specific 
(TTAGGG)n tract length and stability [157–159,184,185], with accumulating evidence for specific 
epigenetic modulation of these effects [184,185,262–264]. Heterogeneously-sized TERRA 
transcripts with as yet ill-defined transcription start sites and potential splice patterns originate in 
many, perhaps all human subtelomere regions [181,183,265], with the sizes of the larger 
transcripts (greater than 15 kb) suggesting structural overlap with some transcribed subtelomeric 
gene families [167,266].  While many details of the dynamic interplay between shelterin, telomere 
chromatin structure, TERRA expression, and telomere biology remain unclear, recent work from 
our group indicates that CTCF and cohesin are integral components of most human 
subtelomeres, and important for the regulation of TERRA transcription and telomere end 
protection [265]. 
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The chromatin organizing factor CTCF has been implicated in numerous aspects of 
chromosome biology, including chromatin insulator, enhancer blocker, transcriptional activator 
and repressor, DNA methylation-sensitive parental imprinting, and DNA-loop formation between 
transcriptional control elements[213,267,268].  In addition to its role in TERRA regulation, CTCF 
has been implicated in the transcriptional repression of a subtelomeric D4Z4 macrosatellite 
repeat transcript ~30 kb from the telomere repeats of chromosome 4q [269].  At D4Z4, CTCF 
interacts with lamin A and tethers the chromosome 4q telomere to the nuclear periphery 
[270,271].  A more general role for CTCF has been found in its ability to colocalize with cohesin 
subunits at many chromosomal positions [202,204–206].  Cohesin is a multiprotein complex 
consisting of core subunits SMC1, SMC3, RAD21, and STAG1 or STAG2,  which can form a ring-
like structure capable of encircling or embracing two DNA molecules[272,273].  Cohesin was 
originally identified as a regulator of sister-chromatid cohesion, but subsequent studies in higher 
eukaryotes indicate functions in mediating long-distance interactions between DNA elements 
required for transcription regulation [274,275].  Cohesin subunit STAG1  is recruited to telomere 
repeats by the shelterin protein TINF2, and this interaction is required for telomeric sister 
chromatid cohesion and efficient telomere replication [276,277]. STAG1  binds directly to 
telomere repeat DNA through a unique AT hook, and overexpression of STAG1 alone is sufficient 
to induce cohesion at telomeres independently of cohesin ring components [278]. By contrast, co-
localized cohesin ring components and CTCF both contribute to subtelomeric TERRA 
transcriptional regulation and telomere end protection [265].  
In humans, telomere regulation occurs in the context of subtelomeric DNA segmental 
duplications known as Subtelomeric Repeat Elements (SRE), which comprise about 80% of the 
most distal 100 kb and 25% of the most distal 500 kb in human DNA [165,279]. SRE regions of 
human chromosomes contain mosaic patchworks of duplicons [162,280,281] apparently 
generated by translocations involving the tips of chromosomes, followed by transmission of 
unbalanced chromosomal complements to offspring [164]. Along with highly elevated sister 
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chromatid exchange (SCE) rates in subtelomeres [163], these studies indicate that human 
subtelomeres are duplication-rich hotspots of DNA breakage and repair. 
Here, we have generated improved human subtelomere assemblies by sequencing 
additional subtelomeric clones and revising the reference sequence of distal subtelomere regions. 
A bioinformatic pipeline for annotation of the updated subtelomere assemblies using short-read 
datasets is developed and implemented.  A public browser for the integrated display of short-
read-based annotations relative to key subtelomere features such as the start of each terminal 
repeat tract, SRE identity and organization, and subtelomeric gene models is established and 
used to investigate cohesin and CTCF binding in SRE regions.  
3.3 METHODS 
3.3.1 Fosmid library screening, 
Methods and materials for these experiments are described in text associated with 
Supplementary Tables 3.3-3.6 and Supplementary Figures 3.5 and 3.6.  
3.3.2 Updated subtelomere assemblies.  
Supplementary Table 3.5 describes the complete clone-based subtelomere assemblies 
as well as their relationship to current clone-based Tiling Path Files (TPFs) being used to update 
the human reference sequence.  The hybrid genome was built by tying the updated subtelomere 
assemblies into hg19 at their connection point.  These points were found by using BLAST [282] to 
align the most centromeric 10kb of sequence from each subtelomere assembly with hg19 
sequence.  The blast results produced one perfect 10kb hit in the expected orientation, forward 
for p arm subtelomeres and reverse for q arm subtelomeres.  The positions of these hits were 
then used to extract the non-subtelomeric portion of the hybrid genome using BEDTools [283].  
The sequence of each 500 kb subtelomere assembly is provided as a concatenated FASTA file in 
Supplementary Materials. The joining coordinates for connecting hg19 to the subtelomere 
assemblies are listed in Supplementary Table 3.8. 
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3.3.3 Sequence Feature Annotation.   
SRE and SD annotation were carried out as described previously [162]. Duplicon 
boundaries were defined as the end positions of duplicon blocks. Boundaries within 40 bp of each 
other were combined at a position corresponding to the weighted average of the number of 
boundaries they incorporate, and declared a single boundary for analysis purposes.  Paralogy 
tracks were generated by first comparing the representative blocks identified by Linardopoulou et 
al. (2005) with the updated assemblies, and then adding blocks corresponding to new SRE 
segments shared in the manner described by [164]. Existing Block 19 was broken into two 
separate blocks based upon the SRE/1-copy boundary generated by 17q sequence, which was 
not available to Linardopoulou et al. (2005). Representative sequences for paralogy blocks 19a, 
19b, 45, 46, 47, 48, and 49 are provided as a concatenated FASTA file in supplementary file 2. 
Subtelomere sequence assemblies were analyzed with RepeatMasker [284] and Tandem 
Repeats Finder [285].  Ensembl transcripts [286], and RefSeq genes [287] were aligned to 
subtelomeres using Spidey  [288].   
3.3.4 Short-read-based Annotation Pipeline.    
Datasets analyzed in this study are listed with their specific sample and control GEO 
accessions, as well as the specific antibodies used and their sources, in Supplementary Table 
3.9.  The LCL-associated datasets for CTCF, RAD21 and SMC1 were the same as described 
previously [265].  Additional data sets were downloaded as raw data FASTQ files from the 
ENCODE project [289] through the UCSC portal.  H1-hESC_CTCF_Be and HMEC_CTCF_Be 
are from the Bernstein lab (GSE29611 series) at the Broad Institute.  IMR90_CTCF_Sn, 
IMR90_RAD21_Sn, IMR90_POLR2A_Sn, and H1-hESC_RAD21_Sn correspond to the Snyder 
lab data from Stanford (GSE31477 series).  H1-hESC_RAD21_My, H1-hESC_CTCF_My, and 
H1-hESC_POLR2A_My correspond to the Myers data from Hudson Alpha (GSE32465 series). 
Reads were aligned to the hybrid genome using BWA 0.6.2 [239], allowing multimapping 
up to 101 locations (-n 101).  BWA does not prioritize multimapping reads and alternate mapping 
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locations are not included as reads but instead are listed in an XA tag.  Alternate positions were 
then expanded from the XA tag to one mapping position per line.  A mapping likelihood (ml) tag 
was added as the inverse of the number of mapping locations.  It is still possible to only consider 
uniquely mapping reads by analyzing only those reads with an ml tag equal to one.  Fragment 
length was estimated by cross correlation implemented in the SPP ChIP-seq mapping program 
[290].  bedGraph coverage files were created from the mapping positions by extending read 
mappings to the estimated fragment size.  Fragment coverage for each position was calculated 
as the sum of ml values of fragments overlapping that position, and then averaged over a 20bp 
sliding window.  Adjacent positions were given the same value if the coverage was within 0.1.  To 
simplify fold change calculations values less than one were given a pseudo count to be equal to 
one.  Fold enrichment tracks were built between control (Input or IgG) and sample to be used as 
a signal track, normalizing the control dataset to the size of the sample.  Negative values were 
used to show stronger signal in the control.  A pseudo count of one was used in locations were 
there was no mapping for the sample or control.  A smoothing window of 500 bases was used on 
all control datasets.  Peak calls were made using MACS 2.0.10 using the sample and control 
bedgraphs.  First bdgcmp –m ppois, was called setting ppois as the method, calculating p value 
tracks.  Peaks were called using bdgpeakcall –l 50 –c 4, setting minimum peak length to 50, and 
a p value significance cut of 4 (10-4) [291].  Overall quality and mapping metrics for the datasets 
were determined as described [292] and are included in Supplementary Table 3.9.  
TERF1 and TERF2 datasets.  Publicly available datasets from Simonet et al. 2011 (GSE26005) 
were downloaded and analyzed.  These are color space reads mapped on the AB SOLiD System 
3.0.  The color space reads were mapped using SHRiMP 2.2.3 [233], allowing for reads mapping 
up to 101 mapping positions (-o 102).  Once mapping positions were determined the pipeline 
followed was the same as other ChIP-seq data sets.  However cross correlation analysis failed at 
finding a fragment size so the selected fragment size of 200 bases was used (Supplementary 
Table 3.9).   Additional TERF1 and TERF2 ChIP-seq datasets were generated for LCL as 
described in [249], using rabbit antibodies to TERF1 and TERF2 which were generated against 
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recombinant protein and affinity purified.  The 100bp Illumina reads in these datsasets were 
trimmed from both the 3’ and 5’ends up to the first high quality base (>PHRED 30).  Telomere 
and telomere-like simple repeats were identified RepeatMasker [284].  
3.3.5 Subtelomere Browser.  
The Subtelomere Browser can be found on a mirror site of the UCSC Genome Browser 
maintained by the Wistar Bioinformatics Facility (vader.wistar.upenn.edu/humansubtel).  The 
entire subtelomere region of interest is displayed by typing it in the format chrNp:1-500000 or 
chrNq:1-500000. The subtelomere browser has similar navigation and mapped dataset selection 
functionalities as the UCSC Genome Browser [293]. The updated subtelomere assemblies in 
FASTA format are found in Supplementary File 2 and can be found on the Riethman lab web site 
(http://www.wistar.org/sites/default/files/protected/htel_1-500K_1_10_12_v4_3_12fasta.TXT).  
3.3.6 Peak/boundary association enrichment calculation.   
Peak/boundary association enrichments were defined as the ratio of the number of peaks 
observed in defined boundary window regions (across all SRE sequence space) to the expected 
number of peaks within these window regions if the total number of peaks in the SRE sequence 
space were distributed evenly.  Some boundaries were within the allowable window of each 
other; in these instances a peak was associated with more than one boundary, although no 
additional weighting was added to the boundary association of these peaks.  To calculate a p 
value a one sided binomial test was performed, using the expected percentage as the probability 
of success, the associated number of peaks as the number of successes, and the total number of 
peaks in the SRE as the number of trials. Terminal boundaries and their associated peaks were 
excluded when calculating P values for peak association with ITSs.   
3.3.7 Chromatin Immunoprecipitation (ChIP) assay.  
ChIP assays were performed with the protocol provided by Millipore with minor 
modifications as described previously[185].  Briefly, LCLs were crosslinked in 1% formaldehyde 
with shaking for 15 minutes, and DNA was sheared to between 200- to 400-bp fragments by 
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sonication with a Diagenode Bioruptor.  Quantification of ChIP DNA at subtelomeric regions was 
determined using quantitative PCR (qPCR) with ABI 7900 Sequence Detection System (Applied 
Biosystems).  qPCR was performed in triplicates from three independent ChIP experiments and 
PCR data were normalized to input values.  Primer sequences used for qPCR were designed 
using Primer Express (Applied Biosystems), and listed in supplementary Table 3.12.  Each primer 
sets was validated by using melting curve analysis, in which one major dissociation peak was 
observed.  ChIP DNA at telomeres was assayed by dot blotting with g-[32P]ATP labeled probes 
specific for telomere (4 x TTAGGG) or Alu repeats 
(cggagtctcgctctgtcgcccaggctggagtgcagtggcgcga).  After hybridization, the blot was developed 
with a Typhoon 9410 Imager (GE Healthcare) and quantified with ImageQuant 5.2 software 
(Molecular Dynamics).  Antibodies used in ChIP assay include: rabbit polyclonal antibodies to 
CTCF and RAD21 (Millipore). Rabbit antibodies to TERF1 and TERF2 were generated against 
recombinant protein and affinity purified. 
3.4 RESULTS 
3.4.1 Gap-filling and detection of distal telomeric structural variants  
In order to fill remaining telomere-adjacent gaps from our previous reference subtelomere 
assembly [43], we sampled telomere-adjacent DNA from deep fosmid clone libraries prepared 
from sheared genomic DNA samples [39,46,47].  Since each fosmid from these libraries had 
been end-sequenced using Sanger methods, we computationally searched for (CCCTAA)n 
sequence (the DNA sequence and orientation expected from fosmids ends located within 
telomere terminal repeat tracts) and selected the (CCCTAA)n-positive group of clones for further 
analysis. Each mate-pair read associated with a (CCCTAA)n read was mapped to our lab’s 
previous assembly [43] to create a deep-coverage resource of mapped fosmid clones containing 
telomere-adjacent DNA. Using this mapping information, representative single clones that 
spanned gaps in the assembly were selected and sequenced (Table 3.1). Included in this group 
of clones were two structural variants identified in the mapping studies that, while capturing 
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telomere-adjacent DNA for these chromosome ends, removed some SRE sequence from our 
previous assembly (analogous to the sequenced 16p allele relative to the longer mapped variant 
16p alleles [48]).  A second allele for the distal 4q subtelomere, which shared high sequence 
similarity with distal 10q [49] was also sequenced, as was a yeast artificial clone (YAC)-derived 
sequence we identified which filled a 12q gap. Finally, the mapped telomere fosmid resource was 
used to complete 8q and 18q telomere-adjacent sequences that contained sequence ambiguities 
and mis-assemblies immediately adjacent to the (TTAGGG)n tract in the previous assembly [43]; 
these errors were retained in hg19.  Further details relating to fosmid library screening and 
characterization, the mapped telomere fosmid resources available from this work, and direct 
sequencing from distal telomere fosmids is provided in Supplementary Materials (Mapped 
Telomere Fosmid Resource, Supplementary Figures 3.5 and 3.6, Supplementary Tables 3.3-3.6).  
 
3.4.2 Updated Subtelomere Assemblies 
Rather than simply extending our previous assembly, we combined our new sequences 
with all other available fully sequenced subtelomere clones in NCBI to create an updated clone-
based assembly of human subtelomere regions (Supplementary Table 3.7). We used, to the 
extent possible, contiguous segments of the existing hg19 assembly for the preparation of our 
 Table 3.1 −  Subtelomeric sequences from telomeric clones 
	  42	  
500 kb sized subtelomere assemblies, only altering regions where our data indicated substantial 
change was required. The subtelomere regions that changed relative to hg19 are shown in Figure 
3.1; eighteen telomere-adjacent regions were altered, 15 by addition to or replacement of hg19 
sequence and 3 by truncation of hg19 sequence. For all telomeres not showing change relative to 
hg19 in Fig 3.1, the distal-most telomere gaps and clone gaps (where they existed immediately 
adjacent to telomere gaps), represented in hg19 by a long string of N’s, were removed. Distal 
telomere tract sequence was also removed, so that coordinate 1 of each assembly corresponds 
to the start of the terminal repeat tract on the strand oriented towards the centromere (to maintain 
a consistent starting coordinate for subtelomere annotation). For the seven telomeres whose 
reference sequences do not extend to the terminal repeat (6p, 8p, 1p, 11p, 3q, 9q, 20p) 
coordinate 1 corresponds to the most distal base of the subtelomere assembly. The five 
acrocentric short arm telomeres are not represented in our assemblies; while they are known to 
contain a characteristic SRE organization closely related to distal 4p [50], they cannot be 
distinguished from each other and assemblies adjacent to them are unavailable. Thirty-five of the 
telomere assemblies extend to the start of the terminal telomere repeat tract, and those that do 
not can be defined relative to the start of the terminal repeat tract by comparison with known SRE 
organizations and independent mapping data [43,44].  
Figure 3.1 shows the distal parts of the assemblies, encompassing all SRE regions. The 
one-copy DNA at the centromeric end of each assembly corresponded to and was connected to 
hg19 at the coordinates shown in Supplementary Table 3.8. In a few cases large segments of 
hg19 subtelomeric sequence were removed in our assemblies (e.g., removal of about 520 kb of 
distal hg19 sequence at the 1p subtelomere), but in most cases the updated assemblies were 
similar to those in hg19 with the exception of the most distal DNA segments. The resulting “hybrid 
genome”, comprised mostly of hg19 sequence but modified by incorporation of our new 
subtelomere assemblies, allowed consistent genome-wide annotation that takes into account the 
entire reference sequence.  The subtelomere browser described below displays only the first 500 
kb of each chromosome arm from the annotated hybrid genome.  It is important to note that the 
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subtelomere assemblies are not from single haplotypes. The hg19 genome assembly is 
comprised of clones from the DNA of many individuals, and the sequences we have added are 
from four additional individual genomes (Table 3.1, see description of the mapped telomere 
fosmid resource in Supplementary Information);  it is important to consider these limitations in the 
interpretation of read-mapping results (see Discussion). 
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3.4.3 Subtelomere Annotation 
The hybrid genome was used to annotate subtelomeric sequence features as described 
in Ambrosini et al (2007), and to map several ChIP-seq datasets of particular interest to 
subtelomere function [19]. Figure 3.2 illustrates these annotations for the first 250 kb of the 19p 
subtelomere.  Both coding and non-coding transcripts are abundant in SRE regions; while some 
are clearly functional, most are not well-characterized [21,40,51,52].  
Figure 3.1 − Sequence organization of updated subtelomere sequence assemblies. The assemblies 
are oriented with the telomere on the left and aligned to maximize paralogous blocks of SREs following the 
methods described in Linardopoulou et al. (2005). Regions of the assemblies differing from hg19 are 
indicated by the black brackets above the altered region of the assembly. An internal gap in the 1q assembly 
is indicated by the magenta line segment. The pseudoautosomal region of Xq and Yq shares the same 
reference sequence and is indicated by the thick gray line distal to the dotted line. Blocks 43 and 44 are 
shown as subtelomere paralogs because they are duplicated at the 2q site of an ancestral telomere fusion; 
other internal paralogies are not shown or analyzed here. A selection of named transcripts mapping primarily 
to the indicated blocks is listed; a much larger number of uncharacterized transcripts and ncRNAs is not 
shown here but is annotated on the subtelomere browser. The average percentage of identity shared by 
copies of paralogous blocks is indicated by the groupings to the left of the color key. The positions of 
telomeres, ITSs, and CTCF/cohesion colocalization sites in the three cell types examined in detail are as 
indicated in the figure. 
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Figure	  3.2	  − 	  Subtelomere	  annotation	  features. The first 250 kb of the 19p subtelomere assembly is 
shown to illustrate key features of subtelomere sequence organization annotated on our browser. 
Coordinate 1 on the browser corresponds to the centromeric end of the terminal repeat tract [i.e., the last 
(CCCTAA)n repeat unit before subtelomere DNA starts]. The 207-kb-long SRE region on 19p is subdivided 
into duplication modules (“duplicons”) defined by segments of similarity (>90% nucleotide identity, >1 kb in 
length) between 19p and other subtelomeres (Ambrosini et al. 2007). Each rectangle represents a separate 
duplicon. Duplicated segments are identified by chromosome (color) as described previously (Ambrosini et 
al. 2007); additional details included on the live browser but omitted for the sake of clarity include the subject 
subtelomere identity, starting and ending coordinates of the duplicon in the subject subtelomere sequence, 
and the percentage of nucleotide sequence similarity of non-RepeatMasked sequences from the duplicon 
segment of the subject subtelomere to 19p (vader.wistar.upenn.edu/humansubtel). Each SRE boundary is 
indicated on a single track (SRE_boundaries), as are the internal telomere-like sequence (ITS) islands as 
defined in Methods (red ticks in the CCCTAA track). Gene models for transcripts included in the RefSeq 
(shown) (Pruitt et al. 2012) and Ensembl (hidden in this figure) (Flicek et al. 2012) transcript databases were 
mapped using Spidey (Wheelan et al. 2001). The paralogy track corresponds to the blocks, as shown in 
Figure 3.1. Enrichment profiles for four ChIP-seq data sets originally mapped only to subterminal DNA 
sequences (Deng et al. 2012) are displayed. (Inset) Close-up view of an internal SRE boundary region 
showing the association of the boundaries with an ITS (red rectangle on top line) and enrichment peaks for 
CTCF, cohesin subunits SMC1A and RAD21, and RNA polymerase II large subunit (POLR2A). 
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A paralogy map for SRE regions was prepared based upon the paralogy blocks defined 
previously [44] to facilitate graphic visualization of similar sequence segments occurring in 
multiple telomeres (see Figure 3.1, and methods).  Previously defined paralogy blocks covered 
most SRE regions, but we identified 5 new blocks and divided Block 19 into two sub-blocks 
because of subtelomeric sequence not available to Linardopoulou et al. (2005). Paralogy blocks 
as defined by Linnardopoulou (2005) were developed as graphic visualization tools and have 
inexact borders with lower boundary resolution than the duplicons defined by Ambrosini et al 
(2007). In addition, the paralogy blocks share slightly higher % nucleotide sequence similarity 
than the duplicons defined by Ambrosini et al. (2007), because the paralogy blocks include high 
copy repeat sequence for this analysis whereas the duplicon analysis of Ambrosini et al (2007) 
uses only non-repeat-masked sequence for sequence comparisons.  
The mapping of short-read data sets to human subtelomere regions requires special 
consideration because of the recent segmental duplication content.  To deal with this challenge 
we used a strategy of assigning a mapping likelihood (ml tag) to reads equal to the inverse of its 
genome-wide mapping positions; in effect, splitting up a read and mapping an equal portion of it 
to all of its possible sites of true mapping [53,54].  Using this alternative mapping strategy we then 
build fragment densities to display on enrichment tracks and to call peaks (see methods).  
Concurrently, a track for each sample was built using only uniquely mapping reads (with an ml 
tag of 1), for comparison with the multi-read track. The multiread tracks are shown in the figures; 
tracks for uniquely mapping reads can be found in the subtelomere browser 
(vader.wistar.upenn.edu/humansubtel).   
Using this pipeline, enrichment profiles for four of the ChIP-seq datasets originally 
mapped only to telomere-adjacent DNA sequences [19] are displayed in Fig. 3.2 on the 
subtelomere browser after mapping to the entire hybrid genome using the multi-read mapping 
approach, then displaying the distal 500 kb on the subtelomere browser (see Methods).  The 
same subterminal binding enrichments for CTCF, SMC1A, RAD21, and RNA polymerase II large 
subunit (POLRA2) which were found and validated by ChIP-qPCR in our previous work [19] are 
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evident in the current annotation (less than 3 kb from the telomere tract at 19p in Fig. 3.2; see 
Supplementary Fig. 3.8 for other telomeres). In addition, enrichment peaks for these proteins 
throughout the 19p subtelomere region are shown in Fig. 3.2 (see Supplementary Fig. 3.8 for 
other subtelomeres). The inset highlights an internal SRE boundary region shared by many 
duplicons, showing the proximity of these boundaries with an ITS (red rectangle on top line) and 
enrichment peaks for CTCF, cohesin subunits SMC1 and RAD21, and POLR2A.  Interestingly, 
the sequences adjacent to this ITS share similar but non-identical features with sequences 
adjacent to terminal (TTAGGG)n repeat tracts.  The POLR2A peak is positioned over a 
degenerate version of the subterminal 29-mer element [19]; this ITS-adjacent binding site 
corresponds to a 23-mer element which, like the 29-mer repeat, is CpG rich.  The CTCF/cohesin 
peaks span an extended 61-mer repeat array (7.3 copies in the ITS-adjacent sequence, vs 
between 2 and 4 copies at most subterminal sites), but only 44 of 61 bases on the consensus 61-
mer sequences are shared between subterminal and internal copies. The pattern of CTCF, 
cohesin, and POLR2A binding to these internal sequences is nearly identical to that found 
adjacent to terminal repeats [19];, even though the sequences have diverged substantially.  In 
fact, the sequences adjacent to this ITS are more similar to several other subtelomeric ITS-
adjacent sequences (90%) than they are to any subterminal copies (85 %).  
3.4.4 SRE Boundary Enrichments 
Publicly available CTCF and cohesin subunit ChIP-seq datasets from human ES cells 
and primary diploid fibroblasts (IMR90) were mapped in the same fashion and compared with the 
LCL data.  All of the datasets used in this study and their mapping characteristics are 
summarized in Supplementary Table 3.9.  Broadly speaking, similar patterns of CTCF and 
cohesin binding to the terminal boundary regions (defined as within 3 kb of the (TTAGGG)n 
repeat tract) were observed in LCL, ES, and primary fibroblast (IMR90) cell types, although the 
relative peak heights sometimes varied substantially (Fig. 3.3; Supplementary Fig. 3.8). For 
example terminal boundary RAD21 enrichment peaks were almost always visible at some level in 
the bedGraphs of the expected subtelomeres, but for some datasets many of the peaks did not 
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reach the MACS significance threshold set for peak-calling subtelomere-wide (p <1.0E-4; 
Supplementary Table 3.10).  Many, but not all CTCF and cohesin sites across the SRE regions in 
LCLs were also detectable in the ES cell lines and in IMR90 (Fig. 3.3; Supplementary Fig. 3.8).  
Differences in library quality and depth, as well as differences in the antibodies used for ChIP-seq 
(Supplementary Table 3.9) are expected to have an effect on binding enrichments. However, 
easily discernible proportional differences in peak heights as well as clear instances of differential 
peak presence/absence between cell types may be indicative of true differential binding.  These 
candidate differentially binding sites are easily detectable visually (e.g., compare relative CTCF 
peak heights and relative RAD21 peak heights on distal 6q in Fig. 3.3, and in all subtelomeres in 
Supplementary Fig. 3.8 and on the subtelomere browser (vader.wistar.upenn.edu/humansubtel).  
Most CTCF binding sites have been thought to be invariant between cell types, but a recent study 
suggested significant plasticity in CTCF occupancy at a majority of sites genome-wide, with 41 % 
of the variable occupancy sites linked to differential CpG methylation [55]. Similarly, a subset of 
cohesin binding sites are known to display cell-type specificity, co-localizing with tissue-specific 
transcription factors [56].  In this context, it will be intriguing to follow-up our initial annotations 
here with detailed studies of the differential CTCF and cohesin occupancy of binding sites in the 
telomere-adjacent regions, and their potential implications for telomere length and stability.  
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Figure 3.3 − Example of an annotated subtelomere with CTCF and cohesin binding enrichment peaks 
from multiple cell types. The first 160 kb of 6q is shown in our browser. The PCR assay track marks the 
primer sites used for ChIP-qPCR (see Fig. 3.4). In addition to the ChIP-seq data sets shown in Figure 3.2 
for LCLs (Deng et al. 2012), enrichment profiles for CTCF and RAD21 are shown following mapping of the 
ENCODE Project ChIP-seq data sets from the pluripotent human embryonic stem cell line H1-hESC and the 
primary fibroblast cell line IMR90. 
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Visually noted apparent association of CTCF and cohesin peaks with some SRE 
boundaries was analyzed systematically using only significant peaks called for each dataset by 
MACS [57].  The terminal SRE boundary was defined as the start of the terminal (TTAGGG)n 
tract; since the CTCF and cohesin binding sites associated with terminal repeat tracts are 
consistently less than 3 kb from this boundary [19], we initially used a 3 kb window to scan all 
SRE boundaries for CTCF and cohesin subunit peaks.  Peak association enrichments are the 
observed ratio of peaks in the boundary window regions to the expected peak number within 
these windows if the total number of peaks in the SRE regions were distributed evenly.  Some 
boundaries are within the allowable window of each other; in these instances a peak can be 
associated with more than one boundary, although no additional weighting is added to the 
boundary association of these peaks.  To calculate a p value for the enrichment of peaks in 
boundary regions a one sided binomial test was performed.  
 
This analysis confirmed the strong association of CTCF and cohesin sites with the 
terminal boundaries in the cell types examined, and also revealed a strong association of CTCF 
and cohesin sites with ITSs in all datasets except for IMR90 RAD21 (Table 3.2). There were 
Table 3.2 −SRE boundary enrichments 
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weaker and often statistically insignificant associations of CTCF and cohesin sites with internal 
SRE/SRE boundaries in the individual data sets from these cell types (Table 3.2).  However, 
boundary analysis of just the strictly co-localized peaks for CTCF and cohesin subunits showed 
significant associations with SRE/SRE boundaries for LCLs and ES cells, but not for the primary 
fibroblast cell line IMR90 (Table 3.2).  The positions of all co-localized CTCF and cohesin peaks 
occurring in at least one of these three cell types are shown relative to SRE organization in Figure 
3.1.   
3.4.5 Experimental validation of ChIP-seq peaks by ChIP-qPCR 
Several recent reports have suggested that some human ITSs bind shelterin components 
TERF1 and TERF2 [58,59], which seems plausible given the demonstrated ability of TERF1 and 
TERF2 to interact with the very short TTAGGGTT motif in some contexts [60,61].  This could 
have important functional implications and suggest potential long-range interaction of ITSs with 
telomeres.  We therefore mapped TERF1 and TERF2 ChIP-seq datasets we prepared from 
LCLs, as well as publically available TERF1 and TERF2 ChIP-seq datasets from a transformed 
BJ fibroblast cell line [59]. Enrichment peaks localizing to many subtelomeric ITSs were initially 
found for both TERF1 and TERF2, in both cell types.  However, in each case the mapped reads 
contributing to the peak did not have a normal distribution (Supplementary Figure 3.7A), the 
consequence of a pile-up of reads mapped on both strands underneath a central peak region 
being extended to the ChIP fragment length, resulting in peak shoulders that do not correspond to 
true fragment ends (see methods).  The reads mapping to ITSs were comprised of telomere-like 
repeat arrays.  While these reads map “uniquely” according to sequence aligners, this is only in 
relation to the rest of the reference genome.  Neither hg19 nor our hybrid genome include 
proximal regions of terminal repeat tracts, known to contain extended regions of telomere-like 
sequences interspersed with pure (TTAGGG)n repeats [62].  When telomere and telomere-like 
sequences were specifically removed from the datasets, peaks at all subtelomeric ITSs 
disappeared (Supplementary Figure 3.7A).  Examination of read orientations underneath a typical 
ITS peak compared to a true CTCF enrichment peak shows that reads responsible for ITS peaks 
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are piled up in random orientation, whereas a true enrichment peak has reads oriented 
nonrandomly towards the peak of the enrichment (Supplementary Figure 3.7B and 3.7C).  In 
addition, true binding sites should be marked by noticeable enrichments in sequences flanking 
the central binding sites, but these enrichments were not found.  
To test experimentally the computationally predicted subtelomeric CTCF and RAD21 co-
localization sites in SRE regions and whether the called TERF1/TERF2 ChIP-seq peaks 
described above correlate with TERF1 and TERF2 binding, we carried out a series of ChIP-qPCR 
experiments summarized in Figure 3.4 and in Supplementary Figure 3.9. In Figure 3.4A, the co-
localized CTCF and RAD21 sites in segments of the 6q and 16q SRE regions were examined; 
each of these sites were not called as peaks when only the uniquely mapping read sets were 
considered, but peaks were called at these positions using our multiread mapping pipeline.  Each 
of the CTCF and RAD21 binding sites predicted by ChIP-seq mappings (primer positions 
2,4,5,6,8,9,10) show the expected enrichments upon ChIP-qPCR relative to the control primer 
sets (3 and 7).  In addition, the telomere-adjacent sites at primer positions 1 and 2 show the 
expected TERF1 and TERF2 enrichment very close to the terminal repeat tracts [19], whereas 
more distant subtelomeric sites at positions 3-10 show only background TERF1 and TERF2 
levels. In Figure 3.4B, the expected CTCF and RAD21 enrichments are also seen in assays 
corresponding to co-localized CTCF and RAD21 sites predicted by ChIP-seq (positions 
2,4,5,6,8).  The telomere-adjacent Xq sites at positions 1 and 2 detect the expected TERF1 and 
TERF2 enrichments [19], but the position at 17p corresponding to an ITS with called TERF1 and 
TERF2 ChIP-seq peaks (position 5) shows only background levels of TERF1 and TERF2 binding. 
The Xq ITS adjacent to position 3 lacked a ChIP-seq enrichment peak in the TERF1 and TERF2 
datasets, yet the ChIP-qPCR showed slight enrichment for TERF2, possibly because it is 
relatively close (9 kb) to the Xq telomere. Additional ChIP-qPCR assays from 19p  and 11p show 
no correlation between ITS-associated ChIP-seq peaks called in the TERF1 and TERF2 datasets 
and binding enrichment by ChIP-qPCR, while showing anticipated ChIP-qPCR enrichments at 
CTCF and RAD21 co-localization sites predicted by ChIP-seq (Supplementary Figure 3.9).  Thus, 
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we conclude that CTCF and RAD21 binding sites in SRE regions predicted by ChIP-seq 
multiread mappings are true binding sites, but that the ITS-associated ChIP-seq peaks called in 
the TERF1 and TERF2 datasets cannot be used to predict true TERF1 and TERF2 binding.  
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Figure 3.4 − ChIP-qPCR analysis of subtelomeric DNA protein binding sites predicted by ChIP-seq 
data set mappings. Candidate sites of CTCF, cohesin, TERF1, and TERF2 binding were analyzed by 
ChIP-qPCR. Segments of the 6q and 16q (A) and the Xq and 17p (B) subtelomeres are shown, with the 
coordinates (in bp) shown at the top and the subtelomere paralogy regions indicated on the respective 
segments. The positions of ITSs are indicated by red rectangles extending from the segments; an ITS with 
called TERF1 and TERF2 ChIP-seq enrichment peaks is marked with a red asterisk. The positions of 
colocalized CTCF and cohesin (RAD21) peaks called in LCLs are shown as green dots (if not called in other 
cell types) and as blue dots (if also called in ES and/or IMR90 cells). A diamond beneath a dot indicates a 
site where no ChIP-seq peak was called when only uniquely mapping reads were considered. Numbered 
ticks show the positions of primer sets used in the ChIP-qPCR experiments, and correspond to the 
numbered ChIP-qPCR results shown for CTCF, RAD21, and TERF1 and TERF2 graphed as the percentage 
of input DNA. The bar graphs represent the average of percentage input (mean ± SD) for each ChIP from 
three independent ChIP experiments. Ticks numbered 1 and 2 are qPCR assays for DNA immediately 
adjacent to the telomere, used here as positive controls for TERF1 and TERF2 binding (primer positions 1 
and 2) and a positive control for a previously validated subtelomeric CTCF/RAD21 colocalization site (primer 
position 2). 
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3.4.6 CTCF datasets from additional primary and cancer cell lines 
To test whether the terminal boundary and the ITS CTCF peak associations seen in the 
cell types described above are also seen in additional cell types, we mapped publically available 
CTCF ChIP-seq datasets from four primary cell lines (HMEC, human mammany epithelial cells; 
SAEC, small airway epithelial cells; HRE, human renal cortical epithelium; and HRPEpiC, retinal 
pigment epithelial cells) and four immortal cell lines (MCF-7, mammary gland adenocarcinoma; 
A549, lung carcinoma; HEK 293, embryonic kidney cells transformed by Adenovirus 5 DNA; and 
WERI-Rb-1, a retinoblastoma line).  Boundary analysis indicated a similar number of 
subtelomeric CTCF binding sites and a similar range of P-values for terminal boundaries and ITS 
associations with peaks (Supplementary Table 3.11) as were found in ChIP-seq datasets for 
LCLs, human ES cells, and IMR90 (Supplementary Table 3.10).  As with the individual CTCF 
datasets for LCLs, ES cells, and IMR90, non-terminal SRE/SRE boundary associations with just 
CTCF peaks were usually not significant in the cell lines. Cohesin ChIP-seq datasets were not 
available for most of these cell lines, so we could not determine co-localized CTCF and cohesin 
binding sites and test their boundary associations. While most of the same CTCF peaks were 
called near the terminal boundary and the ITSs, visual comparison of peaks showed clear 
differences in relative levels of peak enrichments between the cell lines 
(vader.wistar.upenn.edu/humansubtel), as well as some differentially called peaks.  These 
preliminary observations merit follow-up with much larger datasets as well as experimental 
validation. 
3.5 DISCUSSION 
With this work, we have revised and updated human subtelomere assemblies such that 
34 of the 41 genetically distinct chromosome ends extend to the start of terminal repeat tracts 
(Fig. 3.1).  This represents a significant advance over the previous human subtelomere 
assemblies [40,43]. We also provide a multi-read mapping pipeline that enables the systematic 
analysis of distal chromosome regions using short-read sequencing based methods, leveraging 
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the wealth of public genome-wide datasets available to help understand subtelomere and 
telomere function.  We have also established a public browser 
(vader.wistar.upenn.edu/humansubtel) that integrates novel aspects of subtelomere sequence 
organization with short-read sequence based annotations, and displays this information in a 
manner optimized for understanding potential functional properties associated with the 
annotations relative to the telomere terminal repeat  tract as well as subtelomeric sequence 
features.  As additional annotation is added, we believe it will become an increasingly valuable 
resource for the telomere and chromosome biology communities.  
The updated subtelomere reference assemblies are subject to caveats as are all regions 
of the reference human genome sequence; they are comprised of DNA segments derived from 
multiple individuals and for any sequenced clone only one allele is represented. This means that 
the depicted reference allele sequences may not completely match that of corresponding 
subtelomere alleles from other source genomes. Much of the natural variation in human 
subtelomeres is due to differential placement of SRE regions at specific subsets of 
subtelomeres[21,44], and this may complicate interpretation of ChIP-seq signal strengths at 
specific high-similarity SRE sites when comparing datasets from non-isogenic source genomes. 
For example, a CTCF peak  predicted by multiread mapping in a high-similarity SRE segment of 
the reference assembly is expected to have a higher enrichment level  in a dataset from a 
genome with more copies of the SRE segment than a dataset with fewer copies of the SRE 
segment. Copy numbers of all known highly similar SRE blocks vary by a factor of two or less in 
the human population, although most vary by considerably less than 2-fold  [44,52]; depending on 
the SRE segment in question, a doubling or halving of an enrichment value at a peak may not be 
meaningful for a given dataset. Prior knowledge of SRE copy number in the respective source 
genomes would help to mitigate this issue. Even with these limitations, the more complete 
sequence representation of our assemblies, especially in the distal subtelomere regions, has 
already permitted novel annotation leading to experimental validation and functional insights into 
telomere biology [19], which we have extended here.  As new technologies capable of adding 
	  58	  
complete alternative long-range subtelomere haplotypes to the reference assemblies are 
developed, these sequences will be annotated and incorporated into our browser. 
The use of our multi-read mapping approach for ChIP-seq short-read datasets had a very 
large impact on the annotation of candidate binding sites in SRE regions; most candidate CTCF 
and RAD21 binding sites in SRE regions were missed (between 70 % and 90 % of called peaks, 
depending on the dataset) when only uniquely mapping reads were considered. This is illustrated 
dramatically in Figure 3.4, where all of the sites predicted by the multi-read mapping in the SRE 
regions were missed in the analysis considering only uniquely mapping reads. Comparison of the 
multi-read mapping tracks and the unique read mapping tracks on the bedGraphs in the 
subtelomere browser for the same experiment often revealed a small unique read peak 
corresponding to a much larger and robust multi-read peak for SRE sites, indicating that some 
fraction of the reads were mapping uniquely to the site but the unique enrichment peak was too 
weak to be called statistically significant. However, as we showed previously [19], in SRE regions 
with very high sequence similarity to paralogs there was no detectable enrichment in the uniquely 
mapping datasets.  
Because peaks detected using the multi-read mapping method represent an average of 
enrichments over all genomic sites to which the reads map, there is the potential for prediction of 
false positive peaks called due to extremely high true binding at one or a few sites causing called 
peaks at all of them. This is a limitation of the approach and an important caveat to consider in 
the interpretation of the results. Short-read based annotations in SRE regions or, for that matter, 
any region of the genome, are models. While perhaps revealing valuable insights into 
subtelomere biology, they ultimately require independent validation. The ChIP-qPCR results of 
predicted CTCF and RAD21 peaks shown in Fig 3.4 provide strong validation of the ChIP-seq 
binding predictions in SRE regions; however, even here ChIP-qPCR primer sets in very high 
similarity duplicated regions sometimes cannot distinguish all individual copies (see 
Supplementary Table 3.12).  
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Somewhat to our surprise, we did not find evidence for specific TERF1 or TERF2 binding 
to ITS sites. Interestingly, however, we found evidence for enrichment of CTCF and cohesin 
subunit binding adjacent to ITS  boundaries, in addition to the binding sites near terminal 
(TTAGGG)n sites noted previously (Table 3.2; [19]).  When we considered only the CTCF and 
cohesin subunit peaks that co-localized exactly (see Figure 3.1), the significance of association 
with telomere-adjacent DNA  and ITSs typically increased, while the co-localized peak 
association with SRE/SRE boundaries reached significance for the ES and LCL lines but not for 
IMR90 (Table 3.2). Strong cohesin sites co-localizing with CTCF have been implicated in long-
range chromosomal interactions [56], suggesting co-localized cohesin/CTCF sites may mediate 
DNA looping and long-range DNA interactions as well as regulate transcription [56,63,64].  Even 
in the potential absence of direct shelterin interactions between ITSs and telomeres, it is possible 
that CTCF/cohesin interactions between binding sites associated with the terminal boundaries 
and internal binding sites such as the ITS-associated ones could mediate events impacting 
telomeres as well as the regulation of subtelomeric gene families.  For example, long-range 
cohesin/CTCF-mediated interactions involving the telomere-adjacent cohesin/CTCF 
colocalization sites implicated in TERRA regulation [19] may provide a means to coordinate the 
regulated transcription of TERRA from subtelomeric loci, similar in principle to the coordinated 
regulation of other complex loci and multigene families by cohesin and CTCF [56].  Using our 
subtelomere browser and bioinformatics pipeline to leverage the rich public resource of additional 
short-read datasets for further annotation of these regions may point to focused experiments to 
test this hypothesis and help to tease out candidate functional sequences involved in subtelomere 
biology.   
3.6 DATA ACCESS 
DNA sequence for gap-filling clones and clone 
fragments were submitted to the NCBI GenBank (https://www.ncbi.nlm.nih.gov/genbank/) 
with the following accessions:: AC215217, AC215219, AC213859, AC213860, AC215218, 
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AC213861, AC215220, AC215221, AC225782, AC225782, AC215524, AC215522, AC226150, 
KF477190, KF477189, KF477188, KF477185, KF477187,  KF477186, KF477184 (see Table 3.1). 
The TERF1 and TERF2 ChIP-seq datasets generated as part of this study were submitted to the 
NCBI GEO (http://www.ncbi.nlm.nih.gov/gds) with the following accessions: GSM1328844 and 
GSM1328845. Each of the 500 kb subtelomere reference assemblies are available as a 
concatenated FASTA file in Supplementary File 1. New SRE paralogy blocks 45-49,19a, and 19b 
are available as a concatenated FASTA file in Supplementary File 2. The subtelomere browser 
link is (vader.wistar.upenn.edu/humansubtel).    
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3.8 Supplementary Information 
3.8.1 Supplementary Figures 
Fosmid	  End	  Sequence	  (FES)	  mapping,	  gap-­‐filling,	  and	  detection	  of	  telomeric	  structural	  variants	  
A set of end-sequenced fosmid libraries derived from sheared human genomic DNA were 
screened for clones containing the telomere terminal repeat sequence (TTAGGG)n.  Because of 
the orientation of this repeat at all terminal repeat tracts, the distal end-sequence from a 
telomere-terminal fosmid will always contain a (CCCTAA)n pattern.  We initially computationally 
screened the G248 and the ABC7 fosmid libraries for the presence of (CCCTAA)n in their end-
sequences. The G248 library was prepared to validate the original human reference genome 
assembly [279], then was used to detect genomic structural variation [294]. The ABC7 library was 
the first structural variation fosmid library for which complete paired end-sequence data were 
available [295,296].   
Analyses of (CCCTAA)n-containing end-sequence reads and mapping of their mate-pair end 
sequences to subtelomeric  DNA showed that requiring a perfect (CCCTAA)4  match reliably 
identified authentic telomere-containing fosmid  clones (Supplementary Table 3.3; Supplementary 
Table 3.4). Both of these libraries contained fewer (CCCTAA)n sequences than expected from 
their 12x clone coverage (Supplementary Table 3.3), and both were clearly skewed towards loss 
of (CCCTAA)n sequences upon quality processing of sequence traces to remove low-quality 
bases; inspection of individual traces showed that a high fraction of CCCTAA -containing 
sequence reads were poor quality and short, but many of the poor-quality reads clearly contained 
terminal (CCCTAA)n by visual inspection of the sequence trace patterns.  Matches corresponding 
to internal (CCCTAA)n-like islands were very rare, probably because these islands are known to 
be quite small (less than 250 bp) and somewhat degenerate [165], and the expected overall 
sequence coverage by the sequenced fosmid ends is low (about 0.5x).  By comparison, the target 
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size of terminal repeat tracts expected to contain mostly perfect (CCCTAA)n in lymphoblastoid 
cell line DNA is roughly 3-12 kb [297].  
The mate pairs of (CCCTAA)-containing fosmid end sequences from 183 fosmids from the G248 
library and 353 fosmids from the ABC7 library were mapped back to reference subtelomere 
assemblies [162]; all but a few mapped either uniquely to a known subtelomere assembly or to a 
known SRE.  These mappings identified some fosmids that should bridge existing subterminal 
gaps in the reference sequence and additional fosmids that appeared to represent structural 
variants of SRE regions (Supplementary Table 3.4); each of these clones were fully sequenced 
(Table 3.1).  In addition, a 12q half-YAC-derived cosmid that bridged a gap in the distal 
subtelomeric 12q assembly was sequenced (Table 3.1).   
Additional experiments confirmed that underrepresentation of telomere regions in the roughly 12- 
fold coverage G248 and ABC7 libraries was mainly due to the relatively poor quality and short 
length of the (CCCTAA)n-containing sequence reads (see Supplementary Table 3.3 and 
Supplementary Fig 3.5). Restriction mapping of multiple clones from each telomere 
(Supplementary Fig 3.6) and analysis of sequence reads from subterminal duplicon/terminal 
repeat junctions showed that (CCCTAA)n tract deletions were confined entirely to regions within 
the terminal repeat tract itself, and subterminal sequences were not affected by the (CCCTAA) 
sequence deletion (Supplementary Fig. 3.6). This observation is consistent with earlier 
observations in yeast [298] and E. coli (Riethman, unpublished) that (CCCTAA)n tracts longer 
than about a 1000 bp are not maintained in either host. 
An additional seven structural variation libraries were screened computationally for (CCCTAA)n in 
end sequences, identifying telomere clones (Supplementary Table 3.5), and the mate-pair 
mappings were analyzed relative to the available human reference assemblies [162]. Mate-pair 
mappings from the three libraries with the highest coverages in identified (CCCTAA)n sequence 
(ABC7, ABC8 and ABC14) were characterized in detail (Supplementary Table 3.6).  In addition to 
the variants described above for ABC7, potential truncation alleles for XpYp were identified in the 
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ABC8 and ABC14 libraries, and a potential new allele for the 17p telomere was identified in 
ABC14. No additional structural variants could be identified on the basis of unique mate-pair 
mappings. However, differential clustering of mate-pair reads with SRE regions of the previous 
reference assembly [162] in these libraries (Supplementary Table 3.6) suggest large SRE-
associated structural variation amongst these genomes [266] that will require long-range 
analytical methods to characterize further.  While the exact localization of many of the SRE-
mapping telomeric fosmids is not possible using mate-pair mappings, this information in 
combination with known similarities amongst subtelomere duplicon families and the depth of 
clone coverage indicates that all or nearly all telomere-terminal fragments are represented 
amongst the (CCCTAA)4 –selected clones from each library.  In addition, these mapped telomere 
fosmid resources can be used to refine sequences and further explore allelic variation near 
specific telomeres.  For example, the 8q and 18q telomeres both retain sequencing ambiguities 
and potential mis-assemblies immediately adjacent to the (TTAGGG)n tract in the current version 
of the reference sequence (hg19).  High-resolution mapping and sequencing of the distal portions 
of telomere fosmid clones (Supplementary Figure 3.6 legend) from the ABC8 and ABC14 libraries 
identified several related but distinct alleles corresponding to each of these telomeres (Table 3.1).
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Figure 3.5 − G248 fosmid coverage of 2p subtelomere.  Experiments showed that the apparent 
differences and underrepresentation of telomere regions in the roughly 12- fold coverage G248 and 
ABC7 libraries was mainly due to the criteria used to declare a (CCCTAA)n hit in the initial 
computational screens and the often relatively poor quality and short length of the (CCCTAA)n-
containing sequence reads.  
To illustrate this, the terminal 100 kb of 2p reference sequence was used to query the G248 end-
sequence library (after processing reads from the library to remove low-quality regions of traces). 
Megablast parameters used to match the reads were (-D 3 –p 95 –W 12 –t 21), and the BLAST output 
results were stringently refined so that only hits with a % identity greater than or equal to 98 % and 
alignment length greater than or equal to 100 bases were retained.  The raw sequence reads of the 
mate pairs of all of these telomerically oriented near-perfect single matches mapping to within 40 kb of 
the 2p telomere were examined; 5 corresponded to the original (CCCTAA)n hits from the initial screen 
using Quality-filtered reads (red), 3 had recognizable (paired or greater) (CCCTAA)n motifs but the 
reads were removed from the library during the trace quality trimming procedure (blue diamonds) and 
two lacked any mate pair in the database, suggesting failed sequencing reads So the actual depth of 
clone coverage is similar to what one would expect for a 12x , 40 kb random shear library close to an 
absolute end of a source DNA fragment.  The positions of end-sequence matches for the non-
(CCCTAA)n ends of the terminal fosmids (from 27 kb to 40 kb from the start of the (TTAGGG)n tract) 
likely reflects the variable stretches of (TTAGGG)n sequence originally present in the size-selected 
fosmid clones; the fosmids with an end-sequence mapping closest to the telomere tract carried the 
longest (TTAGGG)n stretch, those the farthest from the telomere carried the shortest, but in every 
case all but the most proximal 300 – 800 bp of the telomere tract was deleted. Our paired end 
mappings (blue) also revealed additional fosmid coverage throughout the region in addition to that 
found in the UCSC browser (green line segments), perhaps because we did not mask interspersed 
repeats in our end-sequence mapping procedure. These experiments showed that, for both the G248 
and ABC7 libraries the relatively stringent criteria used for declaring a (CCCTAA)n hit resulted in 
roughly 5-6 fold coverage of terminal fosmids, and by relaxing these criteria slightly and making use of 
end-pairs mapping to distal subtelomere regions we could increase the coverage to 8-10 fold. 
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Each of the mapped terminal G248 fosmids and a selection of the terminal ABC7 fosmids 
(provided by Evan Eichler) were fingerprint-mapped. Those mapping to a single telomere yielded 
overlapping fingerprints, with the exception of 4q which yielded two sets of fingerprints and 4p 
which yielded several sets of related overlapping fingerprints (perhaps due to the contribution of 
acrocentric short-arm telomeres, which are known to have sequences highly similar to 4p; 
Youngman et al., 1992). The fingerprint contig maps obtained for G248 fosmids mapping to 
several completed subtelomere assembly ends agree with each other and with the mapped 
Figure 3.6 − Stability of Subterminal DNA in Fosmids 
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position of the non-(CCCTAA)n mate-pair reads on the subtelomere reference assembly 
(Suppplementary Fig 3.6). In each case, the telomeric end of the fosmid insert contains a short (< 
1 kb) stretch of mostly (CCCTAA)n sequence (usually with some non-canonical hexamer repeats 
as well; Baird et al., 1995) immediately adjacent to the fosmid cloning site. Since the libraries 
were constructed from sheared DNA that was size-selected, most of the terminal fosmid clones 
must have lost some fraction of their initial (CCCTAA)n tract to a length that could be stably 
maintained in the fosmid, typically 300 bp to 800 bp.  Both the restriction mapping and the 
sequence reads of the subterminal duplicon-terminal repeat junction from sets of independently 
isolated fosmids mapping to single loci indicate that (CCCTAA)n tract deletions were confined 
entirely to regions greater than 300 bp telomeric of the subterminal duplicon-terminal repeat 
boundary, and subterminal sequences were not affected by the (CCCTAA) sequence deletion. 
This observation is consistent with the size of remaining human telomere tract lengths seen on 
terminal telomere fragments cloned in yeast, and indicate that (CCCTAA)n tracts longer than 
about a kb are not maintained in either cloning system. 
Sequencing	  of	  distal	  ends	  of	  Terminal	  Fosmids	  	  
Directed sequencing was used to obtain data on subterminal sequences for selected 
fosmid clones. We followed a protocol similar to that of Raymond et al. (2005) using purified 
fosmid DNA and BigDye Terminator sequencing using custom primers corresponding to known 
human subterminal sequences.  Initial reactions were primed from sites across the subterminal 5 
kb of DNA immediately adjacent to the start of the telomere repeat tract. Over most of this region, 
high-quality reads > 600 bp were obtained. However, in regions immediately adjacent to the start 
of the terminal repeat tract, including a very CG-rich region and the beginning of the hexamer 
repeat tract itself, the read lengths were well below this average, often in the 200 – 250 base 
range. We found that a simple modification of the sequencing protocol to include a 5-min 
controlled-heat denaturation step of the template prior to addition of cycle sequencing reagents 
(Kieleczawa, 2006) doubled the read lengths in most cases.  We were able to obtain reads 
extending about 300 bases into the hexamer repeat tract from an adjacent subterminal priming 
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site for multiple fosmids mapping to the same telomeres, and from this sequence could 
distinguish not more than two sets of closely related sequences from these fosmids for a given 
source genome (i.e., either G248 or ABC7). This gives us further confidence that, while the 
fosmids clones lose the distal part of the initially ligated telomere tract in the cloning and 
propagation of the fosmid in bacteria, the subterminal and immediately adjacent beginning of the 
terminal repeat tract are not affected by this deletion and carry an accurate copy of the 
subterminal genomic DNA. 
This general strategy of directed sequencing off of these terminal fosmid templates was 
used to acquire high-quality sequence from fosmids containing alleles of the 8q and 18q 
subterminal sequence.  Custom primers made according to the sequence of a reference allele 
were used to generate the first round of sequence reads from both strands and, following 
assembly, gaps and low-quality regions were filled by a second round of directed sequencing 
based on the assembly of the first round of reads. In cases where the gaps were too large to be 
filled by single reads, PCR amplicons spanning the predicted gap were prepared from the variant 
fosmid and sequenced.  This method can be made quite efficient, especially since custom 
primers corresponding to high sequence identify regions of paralogous subterminal repeats can 
be used for multiple clones carrying similar subterminal sequences (Riethman 2008b).  
	  
68	  
	  
  
Figure 3.7 − TERF1 and TERF2 ChIP-seq peak analysis. 3A. Artifactual enrichment peaks at an 
Internal Telomere-like Sequence (ITS).  Enrichment tracks from TERF1 and TREF2 ChIP-seq of DNA 
from LCLs are shown.  Green: enrichment peaks for TRF1 (top) and TRF2 (bottom) based upon 
positions of uniquely mapped reads in the sample vs the control datasets. Blue: enrichment profile for 
same datasets following removal of telomere-like reads.  3B. TERF1 ChIP-seq read pile-ups at an ITS. 
TERF1 ChIP-seq reads mapped to an ITS prior to removal of telomere-like sequences. Note the random 
orientation of reads in the pile-ups and the abnormal peak shape. 3C. CTCF ChIP-seq reads mapping to 
a true binding site. Note the strand-specificity of the reads contributing to the central peak. 
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Large multipage figure available as figure S4 at 
http://genome.cshlp.org/content/24/6/1039/suppl/DC1 
Figure 3.8 −  Annotated Subtelomeres (screen shots of all subtelomeres) 
 
 
Figure 3.9 − ChIP analysis of CTCF, RAD21, TERF1, and TERF2 binding at subtelomeric candidate 
sites predicted by ChIP-seq dataset mappings. A) ChIP-qPCR analysis of factors binding at 19p and 11p 
subtelomeres in LCLs. Segments of the 19p and 11p subtelomeres are shown, with the coordinates (in bp) 
shown at the top and the subtelomere paralogy regions indicated on the respective segments.  The positions 
of  ITSs are indicated by red rectangles extending from the segments;  an ITS  with called TERF1 and 
TERF2 ChIP-seq  enrichment peaks is marked with a red asterix. The positions of co-localized CTCF and 
Cohesin (RAD21) peaks called in LCLs, ES, or IMR90 cells are shown as green (LCL only) or blue dots (all 
three cells), and a diamond  beneath a dot indicates a site where no ChIP-seq peak was called when only 
uniquely mapping reads were considered. Numbered ticks show the positions of primer sets used in the 
ChIP-qPCR experiments, and the bar graphs represent the average of % input (mean + SD) for each ChIP 
from three independent ChIP experiments. qPCR assays for DNA immediately adjacent to the 11q telomere 
(primer sets 11q-1 and 11q-2) were used here as positive controls for TERF1 and TERF2 binding and a 
positive control for a previously validated subtelomeric CTCF /RAD21 co-localization site (11q-2).  B) Dot-
blotting was used as a control to validate the efficiency of TERF1 and TERF2 ChIP.  ChIP DNA were dot-
blotted, and assayed by hybridization with either 32P-labeled (TTAGGG)4 or  32P-labeled Alu probe.  Upper 
panels: a representative dot-blots was shown in duplicates; Lower panels: Quantification of dot-blots for 
indicated antibodies.  Bar graph represents average values of % input for each ChIP (Mean + SD) from 
three independent ChIP experiments 
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Library	   Library	  Size	   (CCCTAA)1	   (CCCTAA)2	   (CCCTAA)3	   (CCCTAA)4	   (CCCTAA)6	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	  
G248	  raw	   2,300,845	   454,900	   483	   213	   183	   151	  
G248	  q-­‐processed	  	   1,737,926	   266,435	   328	   179	   157	   133	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	  
ABC7	  raw	  	   2,152,783	   480,751	   732	   397	   353	   305	  
ABC7	  q-­‐processed	   1,539,295	   233,354	   311	   159	   138	   114	  
Table 3.3 −  Telomere sequence screen of end-sequences from the G248 and ABC7 fosmid 
libraries.The number of reads with perfect matches identified for each (CCCTAA)n multimer from 1 to 6 is 
shown for the raw trace reads and for traces processed to remove low-quality bases. The end-sequence 
reads for fosmids fom the G248 and ABC7 libraries were downloaded from the NCBI Sequence Trace 
Archive. The sequence traces were quality-trimmed both from the 5’ end and the 3’ end , until a 30-base 
window contained  at least 28 bases with a  Phred Q value greater than or equal to 30. A simple pattern-
match algorithm was used to identify perfect (CCCTAA)n stretches of at last the length shown in each 
column, in either the raw read or the quality-processed read. Both libraries contained fewer (CCCTAA)n 
sequences than expected from 12x clone coverage, and both were skewed towards loss of (CCCTAA)-
containing sequences upon quality processing of sequence traces. The green boxes indicate the number of 
(CCCTAA)n-containing reads which matched at least (CCCTAA)4;  nearly all of the mate-pairs of these 
reads mapped back to subtelomeric sequence in  reference assemblies. 
	  
Tel	   G248	  
fosmids	  
mapped	  
uniquely
*	  
G248	  Fosmids	  Span	  
a	  terminal	  gap	  in	  
Reference	  
Sequence	  	  
New	  
Structura
l	  Variant	  
ABC7	  
fosmids	  
mapped	  
uniquely
*	  
ABC7	  Fosmids	  Span	  
a	  terminal	  gap	  in	  
Reference	  Sequence	  	  
New	  
Structural	  
Variant	  
	   	   	   	   	   	   	  
1p	   -­‐	   	   	   -­‐	   	   	  
1q	   6	   -­‐	   	   6	   -­‐	   	  
2p	   5	   -­‐	   	   3	   -­‐	   	  
2q	   0	   -­‐	   	   2	   +	   +	  
3p	  	   0	   -­‐	   	   5	   +	   +	  
3q	   0	   -­‐	   	   0	   -­‐	   	  
4p	   19	   -­‐	   	   33	   -­‐	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4q	   3	   +	   	   5	   +	   	  
5p	   4	   -­‐	   	   5	   -­‐	   	  
5q	   0	   -­‐	   	   0	   -­‐	   	  
6p	   0	   -­‐	   	   0	   -­‐	   	  
6q	   0	   -­‐	   	   0	   -­‐	   	  
7p	   0	   -­‐	   	   2	   Truncation	   +	  
7q	   3	   -­‐	   	   9	   -­‐	   	  
8p	   0	   -­‐	   	   0	   -­‐	   	  
8q	   4	   -­‐	   	   5	   -­‐	   	  
9p	   0	   -­‐	   	   0	   -­‐	   	  
9q	   0	   -­‐	   	   0	   -­‐	   	  
10p	   0	   -­‐	   	   8	   +	   	  
10q	   2	   -­‐	   	   3	   -­‐	   	  
11p	   0	   -­‐	   	   0	   -­‐	   	  
11q	   3	   -­‐	   	   5	   -­‐	   	  
12p	   0	   -­‐	   	   4	   +	   +	  
12q	   2	   +	   	   0	   	   	  
13q	   6	   +	   	   8	   +	   	  
14q	   2	   +	   	   5	   +	   	  
15q	   0	   -­‐	   	   0	   -­‐	   	  
16p	   4	   -­‐	   	   0	   -­‐	   	  
16q	   0	   -­‐	   	   0	   -­‐	   	  
17p	   0	   -­‐	   	   0	   -­‐	   	  
17q	   0	   -­‐	   	   0	   -­‐	   	  
18p	   1	   -­‐	   	   7	   -­‐	   	  
18q	   3	   -­‐	   	   3	   -­‐	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19p	   0	   -­‐	   	   0	   -­‐	   	  
19q	   4	   -­‐	   	   6	   -­‐	   	  
20p	   0	   -­‐	   	   0	   -­‐	   	  
20q	   0	   -­‐	   	   3	   Truncation	   +	  
21q	   3	   -­‐	   	   3	   -­‐	   	  
22q	   3	   +	   	   8	   +	   	  
Xp/Yp	   3	   -­‐	   	   4	   -­‐	   	  
Xq/Yq	   5	   -­‐	   	   3	   -­‐	   	  
Block	  1	   8	   	   	   18	   	   	  
Block	  2	   6	   	   	   7	   	   	  
Srpt	   49	   	   	   127	   	   	  
Total	  
mappe
d	  Reads	  
148	   	   	   306	   	   	  
No	  
mate	  
pair	  seq	  
13	   	   	   33	   	   	  
Table 3.4 −  Mate-pair mappings of telomere fosmid end sequences  from G248 and ABC7 to the 
human reference assembly.  The mate pairs of (CCCTAA)-containing fosmid end sequences from 183 
fosmids from the G248 library and 353 fosmids from the ABC7 library were mapped back to the reference 
subtelomere assemblies; all but a few mapped either uniquely to a known subtelomere assembly or to a 
known subtelomeric duplicon. Subtelomeric Blocks 1 and 2 correspond to specific classes of SREs 
characterized previously which contain DNA < 40 kb from the (TTAGGG)n tract at many subtelomeres 
(Ambrosini et al.,2007). Srpt identifies all other classes of SRE; telomeres in Supplementary Table 3.4 with 0 
mate-pair matches have SREs that extend beyond 40 kb from the (TTAGGG)n tract and are thus only 
represented by fosmid ends in SREs. Comparison of these mate-pair mappings with the reference 
assemblies identified fosmids that should bridge existing subterminal gaps in the reference sequence and 
additional fosmids that appeared to represent structural variants of subterminal regions.  The roughly 6-fold 
coverage increase of mappings for 4p is likely due to the contribution of acrocentric short-arm telomeres, 
which are known to have sequences highly similar to 4p (Youngman et al., 1992). One fosmid clone from 
clearly variant and/or gap-containing locus was sequenced. 
	  
Library Library Size (CCCTAA)4 
Clones per 
allele 
        
G248 2,300,845 183 1.9 
G248 q-
processed 1,737,926 157 1.7 
ABC7 2,152,783 353 3.8 
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ABC7 q-
processed 1,539,295 138 1.5 
ABC8 3,888,476 784 8.5 
ABC9 2,084,892 112 1.2 
ABC10 2,121,489 238 2.5 
ABC11 1,966,644 110 1.2 
ABC12 2,366,708 215 2.3 
ABC13 2,057,345 132 1.4 
ABC14 2,089,193 619 6.7 
Table 3.5 −  (CCCTAA)4 - containing end sequences in Structural Variation Fosmid Libraries.  The 
number of reads with perfect matches identified for (CCCTAA)4   in the raw trace reads is shown. Dividing 
the number of (CCCTAA)4-containing reads by 92 telomere alleles per genome gives the estimated clone 
coverage per telomere allele from this screen, assuming random coverage of telomere alleles. The relative 
efficiency of each screen in recovering (CCCTAA)n-containing clones depended primarily upon the quality of 
telomeric end-sequence available for that library, except for ABC8 which contained twice the number of 
clones as the other structural variation libraries. 
	  
Tel ABC7 ABC7_clustering Comments ABC8 
ABC8_Cl
ustering 
Comm
ents ABC14 
ABC14
_cluster
ing 
Comm
ents 
  
 # 
mate-
pair 
reads 
some reads binned 
by  BLAST but not 
mapped within 
subtel (poor seq) 
 
  # 
mate-
pair 
reads 
   
 # mate-
pair 
reads  
   
1p 0           0     
1q 6 
2_15-16K, 4_21-
24K   
9 
8_30-
40K, no 
clustering 
  15 
27-
38K, no 
clusteri
ng 
  
2p 7 
1_24K, 6_33-38K   
13 
12_30-
35K, 
1_38K 
  17 
32-
41K, no 
clusteri
ng 
  
2q 0           0     
3p 5 
4_16-24K, 1_33K   
10 
10_14-
30K, no 
clustering 
  7 
26-
33K, no 
clusteri
ng 
  
3q 0           0     
4p 28 
5_18-20K, 22_26-
36K   
42 
6_18-
20K, 
34_25-
41K 
  46 
27-
38K, no 
clusteri
ng 
  
4p4q 20 
15--26K, no 
clustering   23 
13-26K, 
no 
clustering 
  2     
4q 0     1     1 14K   
4q10q 7 
3_16-18K, 1_34K   
28 
15_14-
25K, 
3_36K, 
2_82K 
  25 
3_18K, 
10_28-
29K, 
9_34-
37K 
  
5p 10 
31-37K, no 
clustering   
9 
9_20-
39K, no 
clustering 
  7 
31-
43K, no 
clusteri
ng 
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5q 0           0     
6p 0           0     
6q 0           0     
7p 3 
3_96-105 
truncat
ed 
allele(
s)   
    0    
7q 4 
1_20K, 3_35-40K   
9 
8_21-
35K, no 
clustering 
  0     
7q_12q 6 
4_27-30K, 1_40K   
10 
10_23-
38K, no 
clustering 
  5 
33-38, 
no 
clusteri
ng 
  
8p 0           0     
8q 9 
2_24-25K, 7_31-
41K   
18 
14_29-
40K, 
2_42-48K 
  10 
39-
43K, no 
clusteri
ng 
  
9p 0           0     
9q 0           0     
10p 1     1     1 35K   
10p18p 14 
20-32K, no 
clustering   
22 
22_25-
38K, no 
clustering 
  7 
28-
38K, no 
clusteri
ng 
  
10q 3 3_20-25K   5 4_24-25K   0     
11p 0           0     
11q 10 
9_27-36K, 1_41K   
13 
9_25-
40K, no 
clustering 
  20 
32-
40K, no 
clusteri
ng 
  
12p 2 2_8K         0     
12q 1     8 3_28-31K   1     
13q 8 
1_15K, 7_20-28K   
23 
20_14-
29K, no 
clustering 
  11 
23-
29K, no 
clusteri
ng 
  
14q 7 
24-30K, no 
clustering   
15 
14_22-
29K, no 
clustering 
  6 
30-
37K, no 
clusteri
ng 
  
15q 0           0     
16p 2 
32-33K   
10 
1_13K, 
9_22-35K   26 
31-
41K, no 
clusteri
ng 
  
16q 0           0     
17p 0 
    
  
    4 
46-
53K, no 
clusteri
ng 
New 
17p 
allele  
17q 0           0     
18p 0     0     1 39K   
18q 5 1_19, 4_27-32   7 
7_24-
31K, no   20 
22-
34K, no   
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clustering clusteri
ng 
19p 0     0     0     
19q 9 
27-36K, no 
clustering   
8 
1_18K, 
7_29-40K   12 
31-
41K, no 
clusteri
ng 
  
20p 0     0     0     
20q 5 
72-85K, no 
clustering 
truncat
ed 
allele(
s) 0 
    0    
21q 4 
3_28-31K, 1_40K   
21 
20_23-
38K, no 
clustering 
  11 
35-
40K, no 
clusteri
ng 
  
22q 9 
26-37K, no 
clustering   
17 
17_23-
36K, no 
clustering 
  9 
27-
39K, no 
clusteri
ng 
  
XpYp 6 
2_119-
120K_trunc, 
4_DXYS20region 
unrelia
ble 
FES 
mappi
ngs s 
DXYS
20 
minisa
tellite 20 
18_104-
109K, 
1_113K 
truncat
ion 
alleles 
18 
108-
119K, 
no 
clusteri
ng 
Trunc
ation 
alleles 
XqYq 3 
32-42K   
19 
19_25-
42K, no 
clustering 
  28 
30-
44K, no 
clusteri
ng 
  
                    
Srpt_Bl
ock1 28 
3_1K, 25_7-23K   
76 
16_4-
11K, 
61_14-
25K 
  58 
1_12K, 
57_17-
25K 
  
Srpt_Bl
ock2 16 16_1-14K   58 58_1-14K   44 
44_3-
14K   
Srpt_9p 18 
24-36K, not 
clustered   
34 
32_26-39   49 
30-
40K, 
unclust
ered 
  
Srpt_6q 35 
7_35-39K, 20_49-
68K, 8_122-132K   
79 
1_24K, 
15_34-
42K, 
39_55-
67K, 
5_122-
124K 
  29 
11_34-
39K, 
9_63-
66K, 
9_124-
129K 
  
Srpt_2q 15 
10-19K, 
unclustered   
21 
21_14-
19K   50 
13-
21K, 
unclust
ered 
  
Srpt_8p 2 
16K   
2 
1_8K, 
1_36K   23 
20_24-
27K, 
3_36K 
  
Srpt_12       31 5_1-3K,   2 9K   
	  76	  
p 24_8-17K 
Srpt_1p   
    
0 
    18 
26-
28K, 
unclust
ered 
  
Srpt_7p       6 6_30-41K         
Srpt_17
q       4 4_30-42K         
Srpt_un
loc 10     6     1     
                    
Srpt_tot
al 124     317     274     
                    
Acro1 3     5     3     
L1-
nohit       3           
No_MP 33     63     21     
                    
                    
Total 354     743     608     
Table 3.6 −  Subtelomere mapping distribution of mate-pairs of (CCCTAA)n reads from ABC7, ABC8, 
and ABC14 libraries.  Mate-pair sequences of telomere-containing end sequences from these three 
libraries, which  had the highest depth of coverage in identified telomere clones (Supplementary Table 3.5) 
were mapped to the human reference subtelomere assembly [5,7].  For the ABC7 library, a small set of 
additional reads identified by matches to (CCCTAA)2 and (CCCTAA)3 were added to those identified by 
(CCCTAA)4 to try and increase the depth of telomere clone coverage; but because of the high background 
of non-telomere clones identified with this strategy, it was abandoned after identifying about 50 additional 
bona fide telomere clones. Sequences from each library mapping uniquely were identified first, followed by 
those mapping to subtelomere duplicons known to exist on discrete pairs of telomeres (4p/4q, 4q/10q, 
7q/12q, 10p/18p). The 4p and the 4p/4q reads are also shared by the acrocentric short-arm subtelomeres 
[10].   
The remaining mate pair reads all contained SRE elements that cannot be mapped uniquely or to 
small discrete subtelomere subsets. These were characterized by mapping to SRE regions in the reference 
assembly in the following order, with matching mate pair reads removed from the remaining pool after each 
step:  Srpt Blocks 1 and 2 [7]; then SRE regions of 9p; 6q; 2q; 8p; 12p; 1p; 7p; and 17q.  The intent of the 
sequential mapping strategy was to compare the mapping patterns from each of the libraries and look for 
evidence of structural variation within the SRE regions. In addition, clustering of mate-pair mapping sites 
within the subtelomere assemblies was evaluated, again to gain insight into possible structural variation.  
While the clustering of mate-pair reads in SRE regions cannot define specific discrete structural variants 
(because the limited fosmid length does not permit mate-pair anchoring to single-copy DNA), the variable 
patterns of mate-pair mappings between genomes does provide confirmation of the high level of structural 
variation involving SRE regions [9] in these genomes.   
	  
Excel spreadsheet table available as table  S5 at 
http://genome.cshlp.org/content/24/6/1039/suppl/DC1 
Table 3.7 −  Clone-based Subtelomere Assemblies. For each subtelomere, the clone-based subtelomere 
assembly we used as well as its relationship to current GRC tpfs,  and to additional clones mapping to 
subtelomere regions,  are presented. See Separate Table 3.7 Excel Spreadsheet. 
	  
Chr	   Start	  (bp)	   End	  (bp)	   	   	  
	   	   	   	   	  
chr1	   1021369	   248615650	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chr2	   510263	   242625701	   	   	  
chr3	   553282	   197462429	   	   	  
chr4	   510158	   190543738	   	   	  
chr5	   511808	   180408075	   	   	  
chr6	   560001	   170563944	   	   	  
chr7	   510233	   158628563	   	   	  
chr8	   510001	   145798747	   	   	  
chr9	   510354	   140653430	   	   	  
chr10	   556360	   135024680	   	   	  
chr11	   560001	   134446463	   	   	  
chr12	   619742	   133341530	   	   	  
chr13	   1	   114600843	   	   	  
chr14	   1	   106792067	   	   	  
chr15	   1	   102021022	   	   	  
chr16	   560028	   89805666	   	   	  
chr17	   508889	   80695004	   	   	  
chr18	   510616	   77520492	   	   	  
chr19	   552164	   58618863	   	   	  
chr20	   560001	   62417956	   	   	  
chr21	   1	   47619786	   	   	  
chr22	   1	   50746323	   	   	  
chrX	   639412	   154759556	   	   	  
chrY	   589412	   58862562	   	   	  
Table 3.8 −  Hybrid genome joining coordinates of hg19.  Coordinates of hg19 to which the updated 500 
kb subtelomeric assemblies were added prior to the annotation described here. Coordinates were identified 
by BLASTing the last (most centromeric) 10kb of the subtelomere sequence to hg19.  The most internal 
coordinate plus one were the coordinates of hg19 sequence that was joined to the 500kb subtelomere 
seqeuence.  The p-arm sequence of each 500 kb subtelomere assembly as given was attached at the p-arm 
coordinate, and the reverse complement of the 500 kb q-arm sequences were attached at the indicated q-
arm coordinates. 
	  
Excel spreadsheet table available as table  S7 at 
http://genome.cshlp.org/content/24/6/1039/suppl/DC1 
Table 3.9 −  Datasets used in this study and quality metrics.  Table includes all data set tracks and 
information on data set origins, their matched control, and the specific companies and product numbers for 
antibodies used.  The abbreviations for the antibody-providing companies are: MIL, Millipore; sc,  Santa 
Cruz Biotechnology; ab, Abcam; and BL,  Bethyl Laboratories. Metrics include number of peaks called in 
hybrid genome using all reads, and only uniquely mapping reads.  FRiP (Fraction of Reads in Peak), for all 
reads: partial reads (mapping likelihood) was counted in peaks called using all reads.  FRiP for only unique 
reads is reads in peaks called using only uniquely mapping reads.  PBC (PCR Bottleneck Coefficient) is the 
number of genomic positions with one read mapping to it (uniquely mapping or partial mapping), divided by 
the total number of genomic positions with at least one read mapping (uniquely mapping or partial mapping). 
NSC (Normalized Strand Cross-correlation coefficient) is the ratio of maximal cross-correlation value over 
the background cross-correlation.  RSC (Relative Strand Cross-correlation coefficient) is the maximal cross 
correlation value minus the background cross-correlation, divided by the cross-correlation at the read length 
minus the background cross-correlation.  For detail see [292] and 
http://genome.ucsc.edu/ENCODE/qualityMetrics.html.   
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Excel spreadsheet table available as table  S8 at 
http://genome.cshlp.org/content/24/6/1039/suppl/DC1 
Table 3.10 −  SRE boundary enrichment statistics.  Raw Peak Counts of Subtelomere Boundary 
Enrichments.  All Tables have columns corresponding to different boundary categories, and total for all 
boundaries in the SRE region.  Boundary categories are 1copy/SRE (duplicon ends at unique subtelomere 
sequence), Gap (duplicon ends at most terminal complete sequence but not telomere), SRE/SRE (duplicon 
ends within SRE region), SRE/SD (duplicon ends at genomic duplicon), Terminal (duplicon ends at 
telomere), All_Bndries (all boundaries).  Rows correspond to datasets. A. Raw Counts - Counts of peaks in 
association with different boundary categories and total.  Additional row, Sequence, is the amount of 
sequence within the window of the boundary type, or the total SRE region.  B. Percent – This table shows 
the percent of total peaks associated with a boundary type, for the total column this is always 100%.  The 
additional row still corresponds to the amount of sequence within the window for the boundary type, the 
percent of sequence within the window of the boundary type out of the total SRE.  This is the expected 
percentage of peaks in association, if the peaks are distributed randomly in the SRE.  C. Enrichment – The 
ratio of percentage for a category and dataset over the expected percentage for that category.  D. P Value – 
The p value calculated using a binomial test with the expected percentage as the probability of success, and 
the associated number of peaks and total number of peaks as success and trials. 
	  
3kb	  
Raw	  Counts 
Cell	  Line	  
Cell	  
Description	  
SRE/SRE	  
(Internal)	   Terminal	   ITS	  
Total	  
Peak
s	  
HMEC	   Primary	   44	   24	   20	   114	  
MCF-­‐7	   Cancer	   45	   22	   16	   91	  
SAEC	   Primary	   46	   25	   19	   116	  
A549	   Cancer	   51	   26	   20	   113	  
HRE	   Primary	   51	   23	   17	   124	  
HEK293	   Cancer	   46	   26	   19	   109	  
HRPEpiC	   Primary	   40	   22	   18	   85	  
Weri-­‐RB	   Cancer	   46	   28	   17	   101	  
Sequence	   -­‐	   1457453	   90060	   309076	  
3770
157	  
	        
      
Percent	   	       
Cell	  Line	  
Cell	  
Description	   SRE/SRE	  Internal)	   Terminal	   ITS	  
Total	  
Peak
s	  
HMEC	   Primary	   38.60%	   21.05%	   17.54%	  
100.
00%	  
MCF-­‐7	   Cancer	   49.45%	   24.18%	   17.58%	  
100.
00%	  
SAEC	   Primary	   39.66%	   21.55%	   16.38%	   100.
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00%	  
A549	   Cancer	   45.13%	   23.01%	   17.70%	  
100.
00%	  
HRE	   Primary	   41.13%	   18.55%	   13.71%	  
100.
00%	  
HEK293	   Cancer	   42.20%	   23.85%	   17.43%	  
100.
00%	  
HRPEpiC	   Primary	   47.06%	   25.88%	   21.18%	  
100.
00%	  
Weri-­‐RB	   Cancer	   45.54%	   27.72%	   16.83%	  
100.
00%	  
Expected	   -­‐	   38.66%	   2.39%	   8.20%	  
100.
00%	  
	        
      
Enrichment	   	       
Cell	  Line	  
Cell	  
Description	   SRE/SRE	  Internal)	   Terminal	   ITS	  
Total	  
Peak
s	  
HMEC	   Primary	   1.00	   8.81	   2.14	   1.00	  
MCF-­‐7	   Cancer	   1.28	   10.12	   2.14	   1.00	  
SAEC	   Primary	   1.03	   9.02	   2.00	   1.00	  
A549	   Cancer	   1.17	   9.63	   2.16	   1.00	  
HRE	   Primary	   1.06	   7.76	   1.67	   1.00	  
HEK293	   Cancer	   1.09	   9.99	   2.13	   1.00	  
HRPEpiC	   Primary	   1.22	   10.84	   2.58	   1.00	  
Weri-­‐RB	   Cancer	   1.18	   11.61	   2.05	   1.00	  
	        
P_value	   	       
Cell	  Line	  
Cell	  
Description	  
SRE/SRE	  
(Internal)	   Terminal	   ITS	   	  
HMEC	   Primary	   0.540728025	   3.7319E-­‐16	   3.39208E-­‐05	   	  
MCF-­‐7	   Cancer	   0.023394174	   2.7681E-­‐16	   0.000117401	   	  
SAEC	   Primary	   0.44736285	   5.1024E-­‐17	   0.000128178	   	  
A549	   Cancer	   0.09468902	   2.1781E-­‐18	   2.00843E-­‐05	   	  
HRE	   Primary	   0.316283786	   2.9931E-­‐14	   0.003450501	   	  
HEK293	   Cancer	   0.252883536	   8.2942E-­‐19	   3.41008E-­‐05	   	  
HRPEpiC	   Primary	   0.070614004	   5.7555E-­‐17	   1.94656E-­‐06	   	  
Weri-­‐RB	   Cancer	   0.094350627	   4.5939E-­‐22	   6.87747E-­‐05	   	  
Table 3.11 −  CTCF boundary analysis for 4 primary and 4 immortalized cell lines. 
Boundary analysis for CTCF in additional cell lines. 
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Primer	  
Name	  
Sequence	   PCR	  
Assay	  	  
Number	  
of	  copies	  
with	  
amplicon	  
match	  
Known	  Loci	  
	   	   	   	   	  
	   	   Figure	  
4A	  
	   	  
6q-­‐1-­‐For	   GGCAGCAAACGGGAAAGA	   1	   10	   6q,1q,2q,5q,10q,13q,16q,2
1q,22q	  (Tel)	  
6q-­‐1-­‐Rev	   TGCCTGCCTTTGGGATAACT	   1	   	   	  
6q-­‐2-­‐For	   CAGAGACGAGTGGAACCTGAG
TAAT	  
2	   14	   6q,1q,2q,4q,5q,8p,10q,13q
,16q,19p,19q,21q,22q,(Tel)
;	  2qfus	  (internal)	  
6q-­‐2-­‐Rev	   TGGGCAAGCTGGTCCTGTAG	   2	   	   	  
6q-­‐4-­‐For	   GGCAGCTACGTCCTCTCTTGA	   4	   7	   6q,5q,1p,8p,17q,2q,16q	  
(Tel)	  
6q-­‐4-­‐Rev	   GCAAACTAAGCAACAATGAAA
CAGA	  
4	   	   	  
6q-­‐5-­‐For	   CCTGATGGAGTCTAAATGCAG
TGA	  
5	   5	   6q,5q,1p,8p,17q	  (Tel)	  
6q-­‐5-­‐Rev	   TCCATCCACCCCCTCCTT	   5	   	   	  
6q-­‐3-­‐For	   TTCTTACTTATCAGGGTGCTCA
TCTACT	  
3	   6	   6q,5q,1p,8p	  (Tel);	  
chr1,chrY	  (internal)	  
6q-­‐3-­‐Rev	   GTCCCTCCAAGGAAAATTCCA	   3	   	   	  
6q-­‐6-­‐For	   CCCTGGGTGCTTCACCATT	   6	   6	   6q,5q,1p,8p	  (Tel)	  chr1,chrY	  
(internal)	  
6q-­‐6-­‐Rev	   GAAGAATTTAGTGAAGGGTCA
GTTTACA	  
6	   	   	  
16q-­‐8-­‐For	   GGCAGCTACGTCCTCTCTTGA	   8	   3	   16q,2q,8p	  (Tel)	  
16q-­‐8-­‐Rev	   GCAAACTAAACAACAACAATG
AAACA	  
8	   	   	  
16q-­‐9-­‐For	   GGCTGCCACCTGCTGTTG	   9	   6	   16q,2q,1p	  (Tel);	  chr1,chrY,	  
chr10	  (internal)	  
16q-­‐9-­‐Rev	   TGCTCTCCAGTCCAGTGTTCTG	   9	   	   	  
16q-­‐10-­‐
For	  
CGGTGGATCTCCGAAGTTCA	   10	   4	   16q,7p,9q,3q	  (Tel)	  
16q-­‐10-­‐
Rev	  
GGCTTCAGCTGGTTTTTCAAA	   10	   	   	  
16q-­‐7-­‐For	   CTGGAAGCACCCCCACTTC	   7	   4	   16q,17p,11p,7p	  (Tel)	  
16q-­‐7-­‐Rev	   CAGTCATTTGGCCCCGTAA	   7	   	   	  
	   	   Figure	  
4B	  
	   	  
Xyq-­‐1-­‐For	   CCCCTTGCCTTGGGAGAA	   1	   3	   XqYq,9p,19p	  (Tel)	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Xyq-­‐1-­‐Rev	   GAAAGCAAAAGCCCCTCTGA	   1	   	   	  
XqYq-­‐2-­‐
For	  
GGTGGAACTTCAGTAATCCGA
AA	  
2	   5	   XqYq,9p,15q,16p,19p	  (Tel)	  
XqYq-­‐2-­‐
Rev	  
AGCAAGCGGGTCCTGTAGTG	   2	   	   	  
Xq-­‐3-­‐For	   TCCCCGTGCCCTAATGG	   3	   7	   XqYq,9p,12p,15q,16p,19p	  
(Tel);	  2qfus	  
(internal).WASH	  gene	  
Xq-­‐3-­‐Rev	   TGAGCCCCCTGCACACA	   3	   	   	  
Xq-­‐4-­‐For	   CACGCACCGCGTCTCA	   4	   2	   XqYq,16p	  (Tel)	  
Xq-­‐4-­‐Rev	   TCCTCATAGTGGCCGCAAA	   4	   	   	  
17p-­‐5-­‐For	   CAAGGATCTTGGTCTTCACAGA
GA	  
5	   2	   17p,11p	  (Tel)	  
17p-­‐5-­‐Rev	   GCTGATGGCATCCACATGAC	   5	   	   	  
17p-­‐6-­‐For	   CCCCCAGGGCCTTCAAC	   6	   2	   17p,11p	  (Tel)	  
17p-­‐6-­‐Rev	   GGCTTGAGGTACATCTTCCATC
A	  
6	   	   	  
17p-­‐7-­‐For	   CGGAGAAGGCTGCTATTGGA	   7	   1	   17p	  (Tel)	  
17p-­‐7-­‐Rev	   GAGCTCGCCACCTTCTTGTT	   7	   	   	  
17p-­‐8-­‐For	   GGGTTAAGCAGTGCACGAGAG
T	  
8	   1	   17p	  (Tel)	  
17p-­‐8-­‐Rev	   AACCTCCCGATGCATGGA	   8	   	   	  
	   	   	   	   	  
	   	   Supplem
entary	  
Figure	  5	  
	   	  
11q-­‐1-­‐For	   TGCGGCCCCGAATTG	   11q-­‐1	   1	   11q	  (Tel)	  
11q-­‐1-­‐Rev	   GTTTCTCAGCACAGACCTTGGA	   11q-­‐1	   	   	  
11q-­‐2-­‐For	   GAGACCTGATGTCCCAATTCTT
AAC	  
11q-­‐2	   1	   11q	  (Tel)	  
11q-­‐2-­‐Rev	   CTGTGTTCTTAGAGAGTGTTTC
TTGGA	  
11q-­‐2	   	   	  
19p-­‐1-­‐For	   TGAGGCAGTGAAGGACGTAG
AG	  
1	   11	   19p,1p,3q,7p,8p,	  
9q,11p,16q,19q,22q	  (Tel),	  
2qfus	  (internal).	  
19p-­‐1-­‐Rev	   AACGGGCTTCCAGGAGCTA	   1	   	   	  
19p-­‐2-­‐For	   TCCTGCCTCTGTCTCAAGTCTA
TG	  
2	   2	   19p,18p	  (Tel)	  
19p-­‐2-­‐Rev	   CAGGGACCTAAGGCAGTAGCA	   2	   	   	  
11p-­‐5-­‐For	   CACCAGCATTGTCCCCACTA	   5	   12	   11p,1p,3q,4p,4q,7p,8p,9q,
16q,17p,19p,19q,22q	  
(Tel),2qfus	  (internal)	  
11p-­‐5-­‐Rev	   CCACAACCCCGAGCATACTG	   5	   	   	  
11p-­‐6-­‐For	   GTGGCGCCATGGTTCAG	   6	   6	   11p,17p,7p,16q,3q,9q	  (Tel)	  
11p-­‐6-­‐Rev	   CACATCCGCCGAGAAACTG	   6	   	   	  
11p-­‐7-­‐For	   TACCCTGGCCACCTTGGA	   7	   6	   11p,17p,7p,16q,3q,9q	  (Tel)	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11p-­‐7-­‐Rev	   AAGATTAAGGACACGACCATG
ACA	  
7	   	   	  
11p-­‐8-­‐For	   CAACCCCAAGCCCTCCTT	   8	   2	   11p,17p	  (Tel)	  
11p-­‐8-­‐Rev	   GGGACAGGCTTGAGGTACATC
T	  
8	   	   	  
Table 3.12 −  ChIP-qPCR primers used. PCR primers used for ChIP-qPCR assays corresponding to the 
PCR fragments shown in Fig. 3.5 and Supp. Fig. 3.6.  Each primer is shown next to its mate with sequence 
and the name of the PCR product as indicated on the figure.  The number of distinct genomic loci matching 
the primer set computationally is given. The genomic locations of each of these loci are indicated; “Tel” 
indicates the SRE regions shown in Figure 3.1.  The number of non-subtelomeric duplicated sites (internal), 
where they exist for an assay, are as indicated. 
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CHAPTER 4: MOUSE SUBTELOMERE ANALYSIS 
4.1 Abstract 
Human subtelomeres contain sequences important for telomere length regulation and 
stability, including transcriptional regulatory sequences for telomeric repeat containing RNAs 
(TERRA). However, relatively little is known about the sequence organization and function of 
DNA adjacent to mouse telomeres. Here, we analyze mouse subtelomeric sequence features in 
the context of segmental duplications, annotated genes, and position relative to the mouse 
terminal telomere tract. We adapt our recently-described multi-read mapping pipeline for 
analyzing massively parallel short-read datasets to the mouse genome, and display the results of 
these annotations relative to the start of mouse telomeres in a custom mouse subtelomere 
browser (http://vader.wistar.upenn.edu/mousesubtel). We find very little similarity in mouse 
subtelomere sequence organization as compared to human. Mouse lacks the enrichment for 
telomere-adjacent co-localized CTCF/cohesin sites shown to be important for TERRA regulation 
and telomere protection in human, and also lacks internal telomere-like sequence (ITS)-
associated and subtelomeric repeat element  (SRE) boundary –associated CTCF/cohesin sites 
found in human subtelomeres. Instead of the Iarge, recently duplicated and telomerically oriented 
SREs typical of human subtelomeres, we found smaller, more ancient and more randomly 
oriented SREs at mouse subtelomeres.   We found very high enrichment of MurSatRep1and 
MM4SAT  interspersed repeat families at mouse subtelomeres, and mapping  of ribosome-
depleted RNAseq datasets from the mouse ENCODE project revealed clustering of  
MurSatRep1-containing transcripts near mouse telomeres. The MurSatRep1 repeat element  had 
previously been shown to be enormously enriched in mouse lincRNAs (Kelley and Rinn, 2012); 
interestingly, the recently-described  mouse TERRA  locus found in the 18q subtelomere [299] 
contains one of the  MurSatRep1-containing transcripts we detect here. Our results suggest little 
conservation between mouse and human subtelomeres and widely disparate mechanisms of cis-
regulation of telomere length and stability. 
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4.2 Introduction 
Telomeres are extraordinarily dynamic chromosomal structures. They are essential for 
genome stability and faithful chromosome replication, and mediate a host of key biological 
activities including cell cycle regulation, cellular aging, movements and localization of 
chromosomes within the nucleus, and transcriptional regulation of subtelomeric genes [300,301].  
Specialized functions involving telomeric and subtelomeric DNA have evolved in a wide range of 
eukaryotes: for example, frequent subtelomeric gene conversion provides diversity for surface 
antigens in Trypanosomes [302], and rapidly-evolving subtelomeric gene families confer selective 
advantages for closely-related yeast strains [303]. 
 A conserved, (TTAGGG)n tract forms the DNA component of each chromosome terminus 
in humans and other vertebrates [6,8].  Telomerase-associated and telomerase-independent 
pathways for maintaining (TTAGGG)n repeats exist; the major telomerase-independent pathways 
are recombination-based, sometimes involve co-amplification of subtelomeric sequences along 
with the simple repeat tracts found at chromosome termini (Bryan et al., 1995; Henson et al., 
2002; Lundblad and Wright, 1996; Marciniak et al., 2005) and can generate very long and 
heterogeneous stretches of (TTAGGG)n-containing repeats [305,308].  Transcription of 
subtelomeric genes can be regulated by (TTAGGG)n tract length [309,310] and by subtelomeric 
repeat content and abundance, possibly by contributing specific sequence elements necessary 
for local silencing[311,312] or by providing extended homology regions required for somatic 
pairing and heterochromatin formation [313].  
 Subtelomeric DNA, along with pericentromeric chromosome regions, are preferential 
sites of segmentally duplicated DNA.  Estimated to comprise approximately 5% of the human and 
mouse genomes [314,315], this class of low-copy repeat DNA is characterized by very high 
sequence similarity (90 % to >99.5 %) between homology tracts, and variable but sometimes very 
large tract lengths (1 kb  to > 200 kb). Segmental duplications can pre-dispose associated  
chromosome segments to genetic instability and have been connected with many genetic 
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diseases [316,317]. Evolutionarily recent duplicative transposition of these large DNA tracts has 
led to the generation of new gene families and to the formation of fusion transcripts with 
potentially new functions [166].  
 In the human genome subtelomeric DNA is highly enriched in segmental duplications 
[315,318]. These regions of human chromosomes contain mosaic patchworks of duplicons 
[162,319,320] apparently generated by translocations involving the tips of chromosomes, followed 
by transmission of unbalanced chromosomal complements to offspring [321]. Along with highly 
elevated sister chromatid exchange (SCE) rates in subtelomeres [322], these studies indicate that 
human subtelomeres are duplication-rich hotspots of DNA breakage and repair as well as rapidly-
evolving regions of the genome.  
A telomeric repeat-containing family of RNAs (TERRA) is transcribed from subtelomeres 
into the (TTAGGG)n tracts [323–325] and, along with telomere-associated shelterin proteins, is 
believed to form an integral component of a functional telomere; perturbation of its abundance 
and/or localization causes telomere dysfunction and genome instability [323,326].  Subtelomeric 
DNA elements regulate both TERRA levels and haplotype-specific (TTAGGG)n tract length and 
stability [326–330], with accumulating evidence for specific epigenetic modulation of these effects 
[326,327,331–333]. Heterogeneously-sized TERRA transcripts with as yet ill-defined transcription 
start sites and potential splice patterns originate in many, perhaps all human subtelomere regions 
[323,325,334,335], with the sizes of the larger transcripts (greater than 15 kb) suggesting 
structural overlap with some transcribed subtelomeric gene families [336,337].  While many 
details of the dynamic interplay between shelterin, telomere chromatin structure, TERRA 
expression, and telomere biology remain unclear, recent work from our group indicates that 
chromatin organizing factors CTCF and cohesin are integral components of most human 
subtelomeres and important for the regulation of TERRA transcription and telomere end 
protection [334]. 
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In contrast to human subtelomeres, relatively little is known about the DNA sequences 
adjacent to mouse telomeres. Here, we analyze mouse subtelomeric sequence features in the 
context of segmental duplications, annotated genes, and position relative to the mouse terminal 
telomere tract. We find very little similarity between mouse and human subtelomere sequence 
organization. Mouse lacks the enrichment for telomere-adjacent co-localized CTCF/cohesin sites 
shown to be important for TERRA regulation and telomere protection in human. We found very 
high enrichment of MurSatRep1and MM4SAT  interspersed repeat families at mouse 
subtelomeres, and mapping  of ribosome-depleted RNAseq datasets from the mouse ENCODE 
project revealed clustering of  MurSatRep1-containing transcripts near mouse telomeres. The 
MurSatRep1 repeat element  had previously been shown to be enormously enriched in mouse 
lincRNAs [338]; interestingly, the recently-described  mouse TERRA  locus found in the 18q 
subtelomere [299] contains a  MurSatRep1-containing transcript we detect here. Our results 
suggest little conservation between mouse and human subtelomeres and widely disparate 
mechanisms of cis-regulation of telomere length and stability. 
4.3 Methods  
4.3.1 Sequence Feature Annotation 
SRE and SD annotation were carried out as described previously [162]  Duplicon 
boundaries were defined as the end positions of duplicon blocks. Boundaries within 40 bp of each 
other were combined at a position corresponding to the weighted average of the number of 
boundaries they incorporate, and declared a single boundary for analysis purposes. Subtelomere 
sequence assemblies were analyzed with RepeatMasker [284] and Tandem Repeats Finder 
[285].  The ITS track was built from repeatmasker results, showing both (CCCTAA)n and 
(TTAGGG)n hits.  The MurSatRep1 and MMSAT4 track was also built from repeatmasker results. 
Ensembl transcripts [339], and RefSeq genes [340] were aligned to subtelomeres using 
Spidey  [288].  Refseq genes require a 99% identity match to be shown on the mm9 assembly, 
but when transferred using lift over coordinates to mm10 they did  not always retain the same 
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matching percentage with the new reference sequence.  For this reason we re-mapped the ref 
seq genes to mouse subtelomeres and provide a toggle for displaying those that match with 
different levels of sequence identity, with 98 % used as the default. 
4.3.2 Subtelomere Sequence Characterization 
Repeatmasker [284] results were used to characterize the repeat content of the mouse 
subtelomere and compare with the rest of the mouse genome.  Repeatmasker was run on the 
subtelomere sequences and combined with results for the remainder of the genome which is 
available from the UCSC browser for mm10.  Sizes of repeat regions were calculated from 
repeatmasker bed tracks, and the amount of segmentally duplicated DNA was calculated as the 
size of our defined duplicon blocks.  Total duplicated sequence counts each pairwise alignment 
relative to each query subtelomere sequence and calculates the % divergence from each, so this 
analysis permits some duplicons to be counted multiple times.  
Short-read-based Annotation.   Datasets analyzed in this study are listed with their 
specific sample and control GEO accessions, as well as the specific antibodies used and their 
sources as listed in their GEO entries, in Supplementary Table 2.  Data sets were downloaded as 
raw data FASTQ files from the ENCODE project [289] through the UCSC portal or the GEO 
database through the NCBI short read archive. The majority of the data sets are from the 
ENCODE labs of  Snyder (Sydh/Stanford) and  Ren  (LICR), .  Our previously described 
multimapping ChIP-Seq pipeline (Stong et al., 2014) was employed.  Briefly reads were aligned to 
the hybrid genome using BWA 0.6.2 [239], allowing multimapping up to 101 locations (-n 101).  A 
mapping likelihood (ml) weight was used to uniformly distribute a read to all possible mapping 
locations.  The mappings are then used to build a genome wide fragment density.  Signal tracks 
were built as the fold enrichment of signal over a control.  Peak calls were made using MACS 
2.0.10 using the sample and control bedgraphs.  First bdgcmp –m ppois, was called setting ppois 
as the method, calculating p value tracks.  Peaks were called using bdgpeakcall –l 50 –c 4, 
setting minimum peak length to 50, and a p value significance cut of 4 (10-4) [291].  Overall 
quality and mapping metrics for the datasets were determined as described [341] and are 
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included in Supplementary Table 2.  RNA-seq datasets were mapped using TopHat(Trapnell et 
al., 2009) which allows for multimapping reads.  Tracks were then built using the same uniform 
weighting of mapping postions and the ChIP-seq tracks and were normalized to reads per million. 
4.3.3 Subtelomere Browser 
The Subtelomere Browser can be found on a mirror site of the UCSC Genome Browser 
maintained by the Wistar Bioinformatics Facility (vader.wistar.upenn.edu/mousesubtel).  The 
entire subtelomere region of interest is displayed by typing it in the format chrNq:1-500000. The 
subtelomere browser has similar navigation and mapped dataset selection functionalities as the 
UCSC Genome Browser [293].  
4.3.4 Peak/boundary association enrichment calculation 
Peak/boundary association enrichments were defined as the ratio of the number of peaks 
observed in defined boundary window regions (across all SRE sequence space) to the expected 
number of peaks within these window regions if the total number of peaks in the SRE sequence 
space were distributed evenly.  Some boundaries were within the allowable window of each 
other; in these instances a peak was associated with more than one boundary, although no 
additional weighting was added to the boundary association of these peaks.  To calculate a p 
value a one sided binomial test was performed, using the expected percentage as the probability 
of success, the associated number of peaks as the number of successes, and the total number of 
peaks in the SRE as the number of trials. Terminal boundaries and their associated peaks were 
excluded when calculating P values for peak association with ITSs.   
4.4 Results 
4.4.1 Telomeres and subtelomeres in the mouse genome 
The current mouse genome assembly (Build 38/mm10) includes subtelomere DNA 
immediately adjacent to the (TTAGGG)n tract for all q-arm telomeres except 4q. Prior to the 
completion and release of build 38, we had isolated multiple telomere sequence-containing 
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clones for each of the 1q, 2q, 3q, 5q, 6q, 7q, 10q, 11q, 12q, 13q, 14q, 16q, 17q, 18q, 19q, and 
XqYq telomeres using either a novel telomere-junction-specific screen of the CH25 BAC library or 
a computational screen of end-sequences from two fosmid libraries (see Supplementary Figure 
4.7 and Supplementary Table 4.2). The same screen yielded singleton telomere-containing 
clones that contained telomere-adjacent DNA mapping to 8q, 9q, and 15q.  Single subtelomere 
localization sites were confirmed by FISH analysis of screened BAC clones from the 1q, 5q, 6q, 
7q, 13q, 14q, 18q and XqYq subtelomeres, and multiple localization sites including the expected 
subtelomere were found for clones from the 10q, 11q, 16q, 17q and 19q subtelomeres. 
Representative,  telomere-adjacent clones from this screen were fully sequenced and 
incorporated into build 38 (1q, 3q, 6q,7q, 8q, 9q, 10q, 11q, 12q, 13q, 14q, 15q, 16q, 17, 18q, 19q,  
XqYq;  Supplementary Figure 4.7 and Supplementary Table 4.2). Representative telomere-
adjacent DNA from the p-arm telomeres (all of which share a short subtelomeric sequence 
bridging from the telomere to the centromere) was taken from Choo and co-workers [342].  
Finally, three overlapping fosmid clones containing a telomere and members of the Vmn2r gene 
family were assigned to 4q (it being the only remaining telomere), and the longest of the three 
fosmid sequences was appended to the distal end of  the build 38 4q assembly.  
For all of the q-arm telomeres, the string of NNNs following the last clone sequence in 
Build 38 was removed, as was the distal telomere tract from the sequenced telomere clone, so 
that the last base at these telomeres corresponds to the start of the terminal repeat tract. Thus, 
upon display of the reverse complement of the last 500 kb of each chromosome q-arm, 
coordinate 1  corresponds to the start of the terminal (TTAGGG)n tract on the strand oriented 
towards the centromere  (to maintain a consistent starting coordinate for subtelomere annotation). 
Except for the addition of the p-arm subtelomere (represented by a single 13 kb sequence 
appended to build 38, where the telomere sequence was trimmed to coordinate 1 of the 
centromerically oriented  strand); and the above-mentioned addition of 29 kb of subtelomere 
sequence to 4q, the modified mouse genome analyzed here is identical to build 38 with the 
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telomere sequence trimmed to the start of the terminal repeat tract. It incorporates all mouse 
telomere-adjacent DNA .  
4.4.2 Subtelomere Annotation 
The modified mouse build 38 genome was used to annotate subtelomeric sequence 
features as described in Ambrosini et al (2007), and to map available mouse next-gen sequence 
datasets of potential interest for mouse subtelomere function based upon our previous studies of 
human subtelomeres [334]. Figures 4.1 and 4.2 illustrate these annotations for the first 175 kb of 
the mouse 8q, 13q, 2q and 17q telomeres; Supplementary Figure 4.8 displays these annotations 
for all of the mouse  subtelomeres, and the mouse subtelomere browser permits viewing and 
selection of tracks for these and additional datasets (http://vader.wistar.upenn.edu/mousesubtel).
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Figure 4.1 − Subtelomere Annotation Features. The first 175 kb of the 8q and 13q mouse  
subtelomeres are shown to illustrate key features of subtelomere sequence organization annotated on our 
browser.  Coordinate 1 on the browser corresponds to the centromeric end of the terminal repeat tract (i.e., 
the last (CCCTAA)n repeat unit before subtelomere DNA starts). The 140 kb long SRE region on 8q is 
subdivided into duplication modules (“duplicons”) defined by segments of similarity (> 90% nucleotide identity, 
> 1kb in length) between 8q and other subtelomeres (Ambrosini et al., 2007). Each rectangle represents a 
separate duplicon.  Duplicated segments are identified by chromosome (color) as described previously 
(Ambrosini et al., 2007); additional detail included on the live browser but omitted in Fig. 1 for the sake of 
clarity include the subject subtelomere identity, starting and ending coordinates of the duplicon in the subject 
subtelomere sequence, and % nucleotide sequence similarity of non-RepeatMasked sequences from the 
duplicon segment of the subject subtelomere to 8q (http://vader.wistar.upenn.edu/mousesubtel). The 13q 
subtelomere lacks SREs.  Segmental duplications (SD track; shown as compressed into single rectangle in 
Fig 4.2, can be separated into single duplicons in ‘full” mode on the browser) correspond to duplicons with 
non-subtelomeric localization sites. These can be in addition to SRE copies or exclusively non-subtelomeric 
copies (e.g., the SDs on 13q). The Internal Telomere-like sequence (ITS) islands as defined in Methods are 
indicated as  red tics on the ITS track. Gene models for transcripts included in the RefSeq (Pruitt et al., 2012) 
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Subtelomeric duplications were defined and displayed according to chromosome color as 
described in Ambrosini et al. 2007. The sequence of the most distal 500 kb of each mouse 
subtelomere region in the modified Build 38 genome was used to query the the entire mouse 
genome (see Methods). Adjacent and properly oriented BLAST matches with > 90 % nucleotide 
Figure	  4.2	  − 	  Examples	  of	  annotated	  subtelomeres	  2q	  and	  17q. Examples 
of annotated subtelomeres 2q and 17q.  Track descriptions are the same as for 
Figure 1. 
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sequence identity and > 1kb in size were assembled into chains as described Ambrosini et al. 
2007.  The query sequence and each aligned region identified in this manner were termed 
“duplicons” defined by that query, and this set of homologous sequences is a single “module”.  
Each module was thus defined by a set of pairwise alignments with the query subtelomere 
sequence, and a % nucleotide sequence identity of each chained pairwise alignment was derived 
from the BLAST alignments. If a duplicon identifies more than one subtelomere region these are 
displayed in the subtelomeric repeat element (SRE) track, and if it identifies non-subtelomeric 
copies these are displayed in the segmental duplication (SD) track.  
	  	   100kb	   500kb	  
	  	   mSubTel	   hSubTel	   mSubTel	   hSubTel	  
SRE	  only	   8.35%	   27.54%	   2.40%	   9.50%	  
SD	  only	   7.32%	   5.28%	   5.45%	   5.27%	  
SRE/SD	   19.80%	   24.63%	   5.01%	   7.08%	  
Total	  Duplicated	   35.47%	   57.45%	   12.86%	   21.85%	  
Table 4.1 −  Segmental Duplication Content of the Mouse Subtelomere.  Percent of most distal 100 and 
500kb that are either exclusily SRE, SD, or both, and the total segemental duplication amount. 
	  
A comparison of mouse and human subtelomeric duplications reveals several striking 
differences. First, mouse SRE regions are about half as abundant as human (7.41 % of 
subtelomere vs 16.58 % of subtelomere), whereas mouse SD regions cover about the same 
fraction of subtelomeres as do human SDs (10.45 % vs 12.34 %). (Table I). Second, whereas 
human SREs are nearly universally oriented in the same direction relative to the telomere 
(Linnardopoulou et al., 2005; Ambrosini et al., 2007), mouse SREs have a much higher fraction of 
duplicons oriented in the opposite direction as well (Figures 4.1 and 4.2, Supplementary Figure 
4.8; http://vader.wistar.upenn.edu/mousesubtel), which is inconsistent with the model  proposed 
for generation of human SREs [321].  Most striking, however, is the much greater part of the 
subtelomere occupied by very high similarity (less than 3 % divergence in pairwise alignments) 
SREs in human relative to mouse (Figure 4.3), indicating that most human SREs arose much 
more recently than mouse SREs.  
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Similarly, there are dramatic differences in the internal telomere-like sequence (ITS) 
distribution between mouse and human subtelomeres (Figure 4.4). Whereas in human 
subtelomeres most ITSs are in SRE regions, in mouse subtelomeres the vast majority of ITSs are 
in either 1-copy regions or in SDs, with only a handful localized to SREs. Human subtelomeric 
ITSs are distributed over a broader range of lengths and are highly enriched at subtelomeres 
relative to the rest of the genome, whereas mouse ITSs tend to be much shorter (especially those 
localizing to SREs) and not as enriched at subtelomeres relative to internal genomic sites.  
Figure 4.3 − Comparison of duplicated sequence in the mouse and human subtelomere. Total 
pairwise alignments of sequences involved in segmental duplications within the subtelomere (SRE) or 
internally in the rest of the genome (SD), in both  mouse and human..  Sequence count is grouped by 
percent divergence between aligned pairs of duplicated sequences, and total mouse subtelomeric sequence 
(in bp) is normalized to total human subtelomere sequence. 
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Similar to human subtelomeres [318], the overall GC content, SINE, LINE, and DNA 
transposon composition of murine subtelomeres was similar to the genome-wide average and not 
heavily skewed between SREs, SDs, and 1-copy DNA (Figure 4.5). LTR content was somewhat 
enriched (about double the genome average) in mouse SREs and SDs. Strikingly, there were 
very high enrichments of the frequently co-occuring MMSAT4 and MurSatRep1 repeat elements 
in both the SRE and SD regions (e.g., greater than 200-fold enrichment for MurSatRep1 in SREs; 
Figure 4.5). 
Figure 4.4 − Characteristics of interstitial telomere sequences in the mouse (A) and human (B) genome.  ITS 
counts are shown corresponding to their length (x axis), percent divergence (pattern), and location in the genome 
(color).  Sequences are identified as occurring within subtelomere repeat elements (SRE) subtelomere segmental 
duplication (SD), single copy subtelomere (1-copy), or internal genomic sequence.  Counts of internal genomic 
occurrences were normalized to the size of the subtelomere, and mouse subtelomere content was normalized to 
human.  Percent divergence shows the similarity of the ITS sequence to a perfect (TTAGGG)n sequence. 
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4.4.3 Annotation of subtelomeric CTCF and cohesin binding sites using 
ChIPseq datasets.  
Recent work from our group indicates that chromatin organizing factors CTCF and 
cohesin are integral components of most human subtelomeres and important for the regulation of 
TERRA transcription and telomere end protection [334]. Co-localized CTCF/cohesin sites map 
within 3 kb of the start of most human terminal repeat tracts, and associate with internal telomere-
like sequences and with SRE boundaries in at least some human cell types[334,343].  We 
therefore wished to determine whether CTCF/cohesin localized to similar features in mouse 
subtelomeres. We identified appropriate, existing CTCF and cohesin ChIP-seq datasets from 
mouse immortalized white blood cells (CH12), mouse erythroid leukemia cells (MEL), mouse 
Figure 4.5 − Sequence composition of murine subtelomeres.  The percent of sequence defined as GC 
content or an identified interspersed repeat for the entire genome (blue), and the specified subtelomere 
regions, Subtelomeric Repeat Elements (red), Segment Duplication (green), Single Copy (purple).  Genome 
wide averages were calculated from mm10. 
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embryonic stem cells (ES_E14), and mouse embryonic fibroblast cells (MEF) [344]; see 
Supplementary Table 2).As was the case with human subtelomeres, the mapping of short-read 
data sets to mouse subtelomere regions requires special consideration because of the segmental 
duplication content.  To deal with this challenge we used a strategy of assigning a mapping 
likelihood (ml tag) to reads equal to the inverse of its genome-wide mapping positions; in effect, 
splitting up a read and mapping an equal portion of it to all of its possible sites of true mapping 
[345,346].  Using this alternative mapping strategy we then build fragment densities to display on 
enrichment tracks and to call peaks (see methods).  Concurrently, a track for each sample was 
built using only uniquely mapping reads (with an ml tag of 1), for comparison with the multi-read 
track. The multiread tracks are shown in the figures; tracks for uniquely mapping reads can be 
found in the mouse subtelomere browser (http://vader.wistar.upenn.edu/mousesubtel).   
Immediately clear from the mapping data is the relative lack of CTCF and cohesin binding 
sites adjacent to mouse telomere tracts (Figs 4.1 and 4.2, Supplementary Figure 4.8; 
http://vader.wistar.upenn.edu/mousesubtel).; only the 12q and 13q telomeres had CTCF and 
cohesin peaks within 3 kb of the telomere tracts, in stark contrast to most  human telomeres 
[334,343]. Likewise, there was no association of CTCF and cohesin peaks with mouse ITSs or 
mouse SRE boundaries in any of the cell types (Supplementary Table 4.4), in contrast to what 
was observed in most human cell types [334,343]. Since the human telomere-adjacent 
subtelomeric CTCF/cohesin sites were associated with TERRA regulation and telomere 
protection, this suggests very different mechanisms for these functions have evolved at mouse 
telomeres.  
We also investigated mouse subtelomeric transcription by mapping RNA PolII binding 
sites using ChIPseq datasets and RNAseq reads in datasets from these same cell types, and 
displaying the subtelomeric regions on the mouse browser (Figs 4.1 and 4.2, Supplementary 
Figure 4.8; (http://vader.wistar.upenn.edu/mousesubtel).  The RNA PolII peaks indicate the 
positions of possible promoters and transcription pause sites, with smaller enrichments often 
visible along the gene bodies of actively transcribed loci.  The strand-specific enrichments on the 
	  98	  
RNAseq tracks show where reads from the sequenced RNA population accumulated. The minus 
strand RNAseq reads (Purple) are oriented towards the telomere, and the plus strand RNAseq 
reads are oriented away from the telomere (Blue). The RNAseq reads in these datasets were 
derived from ribosomal RNA-depleted, polyA+ and polyA-  RNA molecules from total RNA that 
yielded 300 to 350 bp cDNAs for sequencing (from GEO record associated with the RNAseq 
Datasets; see Supplementary Table 4.3), and so include most mRNA and lincRNA species but 
exclude small RNAs.   
As expected, some but not all of the RNA PolII peaks localize to known promoters (based 
upon the Refseq gene models), and the position and intensity of the peaks depend in many cases 
upon cell type (Figures 4.1 and 4.2, Supplementary Figure 4.8; mouse subtelomere browser 
(http://vader.wistar.upenn.edu/mousesubtel). In contrast to human subtelomeres, there are no 
RNA PolII enrichments immediately adjacent to telomere repeat tracts.  RNAseq enrichments can 
be seen for many annotated genes, but also for many unannotated stretches. Strikingly, the 
MurSatRep1 repeat element frequently overlaps with RNAseq enrichments in at least one of the 3 
cell types analyzed (see Supplementary Figure 4.8), and when it overlaps it is always in the 
sense orientation. Of the 30 MurSatRep1 clusters found in mouse subtelomeres, 19 overlap with 
RNAseq enrichments in the sense orientation. Three sites which do not overlap with RNAseq 
enrichments correspond to (TTAGGG)n –adjacent MurSatRep1 clusters oriented away from the 
telomere (9q, 16q, and 19q); a cluster immediately adjacent to the 6q telomere and oriented 
towards the telomere does overlap with a detectable RNAseq enrichment (Supplementary Figure 
4.8; also see 6q tracks on web browser  (http://vader.wistar.upenn.edu/mousesubtel).  
 de Silanes et al. (2014) recently described a mouse TERRA locus near the 18q telomere, 
and presented data suggesting that it was the major source of TERRA RNA in the mouse, with 
possible additional minor contribution from the 9q subtelomere. Figure 4.6 shows the 18q locus 
with our annotation, along with the positions of the putative TERRA promoter regions described 
by de Silanes et al. (2014); Supplementary Figures 4.9 and 4.10 show the same two 
subtelomeres with several additional CTCF, Cohesin, and RNA PolII ChIPseq datasets as well as 
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additional RNAseq datasets. RNA PolII peaks localize to the A3 and A2 promoters defined by de 
Silanes et al. (2014), and RNAseq enrichments on the strand oriented towards the telomere are 
clearly visible in both the CH12 and the ES datasets (Figure 4.6) as well as the MEL dataset 
(Supplementary Figures 4.9 and 4.10), although only the ES track shows additional enrichment 
downstream of that found in CH12 and MEL.  The putative TERRA-enriched datasets described 
by de Silanes et al. (2014) show only slight enrichments or no detectable enrichment over their 
control RNAseq datasets (Supplementary Figures 4.9 and 4.10). MurSatRep1 overlaps with the 
18q TERRA and is oriented on its sense strand (Figure 4.6). However, in contrast to human 
TERRA (Deng et al., 2012), there is no evidence for CTCF/cohesin colocalization with the 18q 
TERRA transcript promoters.
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Figure −  4.6 Subtelomere features of mouse 18q relative to TERRA-associated features as described 
by de Silanes et al. (2014). Track descriptions are as in Figure 1. The positions of TERRA promoter regions 
as defined in de Salines et al. (2014) are shown for reference points. 
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4.5 Discussion 
Since finished sequences from  the telomere-containing BAC and fosmid clones we 
identified, isolated, and initially characterized (see Supplementary Figure 4.7 and Supplementary 
Table 4.2) have already been incorporated into the current mouse assembly (Build 38/mm10), we 
used a mouse assembly very similar to that build as our reference genome. We appended two 
segments of subtelomeric DNA, one at 4q (for which we had identified the remaining q-arm 
subtelomere sequence) and the other a representative sequence from the highly similar p-arm 
subtelomeres (Kalitsis et al., 2006) in order to include all telomere-adjacent sequence for our 
analysis. By trimming the sequenced distal telomere repeats and the placeholder NNNNs 
representing the unsequenced telomere tracts at mouse telomeres, we provided a consistent 
coordinate system for mouse subtelomere annotations, which were thus set relative to the base 
at the start of each terminal repeat tract and oriented from the most distal base towards the 
centromere. This allowed subtelomere sequence features near individual telomeres to be 
analyzed and visualized on the mouse browser relative to the same position at the start of each 
terminal repeat tract. 
Our analysis indicates that human and mouse subtelomeres evolved via distinct 
mechanisms. Large, highly similar and identically oriented SREs that predominate at human 
subtelomeres are absent in the mouse. Instead, we observe smaller, more ancient and more 
randomly oriented SREs in the mouse. The current model for explaining human SRE structure -   
translocations involving the tips of chromosomes, followed by transmission of unbalanced 
chromosomal complements to offspring [321] – cannot explain SRE structure in mouse. While 
human SRE structure and chromosomal distribution evolved very recently and in fact is highly 
polymorphic in the population, mouse SREs are more divergent and, if they originally evolved in a 
manner similar to human SREs, their sequence organization has subsequently been disrupted by 
recombination or repair events resulting in locally inverted duplications. Since subtelomere 
regions are poorly assembled or absent in WGS assemblies, there is no reliable information 
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available on the subtelomere structure of multiple mouse species; this information would be quite 
valuable in understanding how these regions evolved and whether the unusually long telomere 
repeat tracts in mice played a role in suppressing recent subtelomeric duplication events or 
perhaps promoting inversions.  
A relatively large fraction of mouse subtelomeres lack SREs entirely (3q, 5q, 6q, 7q, 12q, 
13q, 14q, 15q), and for some of these subtelomeres known genes extend to very near the start of 
the terminal (TTAGGG) tracts (e.g., wntless homolog (Wls) at 3q,  bicaudal D homolog 1 (Bicd1) 
at 6q,   MAS-related GPR, member D (Mrgprd) at 7q, transmembrane protein 196 (Tmem196) at 
12q, and 2-cell-stage, variable group, member 3 (Tcstv3) at 13q). It is notable that each of these 
telomere-adjacent transcripts are oriented telomerically. 18q, which contains a relatively small 
SRE region, has recently been described as a major site for TERRA transcription in mouse (de 
Silanes et al., 2014). The position of the putative upstream promoter sites (A2 and A3, Figure 4.6) 
correspond to RNAPolII peaks in our analysis, whereas the downstream B3, C2, and D promoter 
regions overlap with properly oriented RNAseq read enrichments in the ES datasets but not the 
immortalized lymphocyte CH12  dataset (Figure 4.6). While TERRA molecules derived from non-
18q telomeres were not found (with the possible exception of 9q; de Silanes et al, 2014), other 
subtelomeres were neither exhaustively sampled, nor sampled in multiple cell types by de Salines 
et al. (2014); it is therefore  possible that some of the existing telomerically oriented transcripts 
could read through subtelomeres into telomeres to form TERRAs, as was suggested by recent 
TERRA-enriched  RNAseq mappings to human subtelomeres that overlap with the WASH 
transcript family [335].  
Strikingly, a mouse repeat element of unknown origin (MurSatRep1) which is known to be 
enormously enriched in mouse lincRNAs where it is almost always transcribed in the sense 
orientation [338] is very highly enriched in mouse SREs (>200 fold) as well as in subtelomeric 
SDs (98-fold). Of the 30 MurSatRep1 clusters we found in mouse subtelomeres, 19 overlap with 
RNAseq enrichments in the sense orientation. The 18q TERRA locus includes one of these 
overlap sites; additional telomerically oriented sites within 20 kb of the (TTAGGG)n tract are 
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found at 8q, 13q, 17q (Figures 4.1 and 4.2), as well as at 10q and 6q (Supplementary Figure 4.8, 
(http://vader.wistar.upenn.edu/mousesubtel). Each of these subtelomeric sites corresponds to a 
lincRNA potentially capable of extending into the telomere (TTAGGG)n tract, (thus giving rise to 
TERRAs), and merits further analysis. 
Waves of retrotransposon expansions have remodelled genome organization and CTCF 
binding in murine lineages [347]; these dramatic evolutionary changes, along with the very 
different segmental duplication evolution trajectories taken at mouse vs human subtelomeres, 
may together account for the completely different CTCF and cohesin binding site organization at 
mouse and human subtelomeres.  Our results showing a nearly complete lack of CTCF/cohesin 
near mouse telomeres and no association with SRE or ITS boundaries indicate radically different 
mechanisms for TERRA regulation, telomere protection and potential cis-regulation of telomere 
lengths in mouse relative to human. Given the differences in telomere lengths, overall lifespan, 
susceptibility to cancer, and other telomere-associated properties in the two species, this is 
perhaps not surprising. It may be one of many functional consequences of the accelerated 
evolution of subtelomeric genome regions, where a wide variety of lineage-specific and species-
specific functionalities have arisen [302,303,348,349]. 
4.6 Supplemental Figures 
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Large	  multipage	  figure	  available	  at	  https://shiek-­‐db.wistar.upenn.edu/riethman/suppfig48.pdf	  
Figure 4.8 −  Snapshots of Annotated Mouse Subtelomeres. Screenshots of the mouse subtelomere 
browser showing static versions of tracks specifically discussed in this paper are shown. See the live 
browser (http://vader.wistar.upenn.edu/mousesubtel) for custom track selection, zooming,  and track 
organization. 
	  
Figure 4.7 − Telomeric BAC Isolation. The CH25 BAC library was prepared using sheared DNA from  
strain c57bl/6j  and cloning into the vector pTARBAC6 (Osoegawa et al., 2007). The library was screened 
using labeled overgo probes (Vollrath, 1999) specific for the junction of vector and telomere repeat 
sequence in order to specifically identify clones which contain an insert fragment with the telomere repeat at 
one end. BAC clones thus identified were colony-purified, end-sequenced, and localized to metaphase 
chromosomes using FISH. The non-telomere BAC end sequences were mapped to the assembled mouse 
genome using BLAST (Altschul et al., 1990). The combination of FISH localizations (or multi-site 
localization) and end sequence match were used to select candidate telomere BACs for full sequencing. The 
telomeric BACs thus identified and the sequenced clones incorporated into Build38/mm10 are listed in 
Supplementary Table 1. 
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Figure 4.9 − Mouse 18q 
Subtelomere Annotated using 
additional datasets. Screenshots 
of the mouse subtelomere browser 
showing static versions of tracks 
specifically discussed in this paper 
are shown. See the live browser 
(http://vader.wistar.upenn.edu/mou
sesubtel) for custom track 
selection, zooming,  and track 
organization. 
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Figure 4.10 −  Mouse 9q 
Subtelomere Annotated using 
additional datasets. The same 
tracks as in Supplementary Figure 
3, as shown for 9q. 
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Table 4.2 −  Mouse Subtelomeric Clones. Telomeric BACs were identified as described in the legend to 
Supplemenary Figure 4.7, and are highlighted in Supplementary Table 4.2. Fosmid End Sequence (FES) 
mapping: An end-sequenced fosmid library derived from sheared mouse genomic DNA (WI-2; Church et al., 
2009) was screened for clones containing the telomere terminal repeat sequence (TTAGGG)n.  Because of 
the orientation of this repeat at all terminal repeat tracts, the distal end-sequence from a telomere-terminal 
fosmid will always contain a (CCCTAA)n pattern.  As for a similar computational screen of human fosmid 
libraries (Stong et al., 2014), requiring a perfect (CCCTAA)4  match reliably identified authentic telomere-
containing fosmid  clones. The mate pairs of (CCCTAA)-containing fosmid end sequences from the WI-2 
library were mapped back to reference subtelomere assemblies; all but a few mapped either uniquely to a 
known subtelomere assembly or to a known SRE.  These mappings identified fosmids that should bridge 
existing subterminal gaps in the reference sequence, and are identified in Supplementary Table 4.2. 
	  
Excel	  spreadsheet	  available	  from	  https://shiek-­‐db.wistar.upenn.edu/riethman/supptab3.xls	  
Table 4.3 −  Datasets used in this study and quality metrics.  Table includes all data set tracks and 
information on data set origins, their matched control, and the specific companies and product numbers for 
antibodies used.  The abbreviations for the antibody-providing companies are: MIL, Millipore; sc, Santa Cruz 
Biotechnology; ab, Abcam; and BL,  Bethyl Laboratories. Metrics include number of peaks called in hybrid 
genome using all reads, and only uniquely mapping reads.  FRiP (Fraction of Reads in Peak), for all reads: 
partial reads (mapping likelihood) was counted in peaks called using all reads.  FRiP for only unique reads is 
reads in peaks called using only uniquely mapping reads.  PBC (PCR Bottleneck Coefficient) is the number 
of genomic positions with one read mapping to it (uniquely mapping or partial mapping), divided by the total 
number of genomic positions with at least one read mapping (uniquely mapping or partial mapping). NSC 
(Normalized Strand Cross-correlation coefficient) is the ratio of maximal cross-correlation value over the 
background cross-correlation.  RSC (Relative Strand Cross-correlation coefficient) is the maximal cross 
correlation value minus the background cross-correlation, divided by the cross-correlation at the read length 
minus the background cross-correlation.  For detail see (Landt et al., 2012) and 
http://genome.ucsc.edu/ENCODE/qualityMetrics.html.   
	  
Excel	  spreadsheet	  available	  from	  https://shiek-­‐db.wistar.upenn.edu/riethman/supptab4.xls	  
Table 4.4 −  SRE boundary enrichment statistics. Raw Peak Counts of Subtelomere Boundary 
Enrichments.  All Tables have columns corresponding to different boundary categories, and total for all 
boundaries in the SRE region.  Boundary categories are 1copy/SRE (duplicon ends at unique subtelomere 
sequence), Gap (duplicon ends at most terminal complete sequence but not telomere), SRE/SRE (duplicon 
ends within SRE region), SRE/SD (duplicon ends at genomic duplicon), Terminal (duplicon ends at 
telomere), All_Bndries (all boundaries).  Rows correspond to datasets. A. Raw Counts - Counts of peaks in 
association with different boundary categories and total.  Additional row, Sequence, is the amount of 
sequence within the window of the boundary type, or the total SRE region.  B. Percent – This table shows 
the percent of total peaks associated with a boundary type, for the total column this is always 100%.  The 
additional row still corresponds to the amount of sequence within the window for the boundary type, the 
percent of sequence within the window of the boundary type out of the total SRE.  This is the expected 
percentage of peaks in association, if the peaks are distributed randomly in the SRE.  C. Enrichment – The 
ratio of percentage for a category and dataset over the expected percentage for that category.  D. P Value – 
The p value calculated using a binomial test with the expected percentage as the probability of success, and 
the associated number of peaks and total number of peaks as success and trials. 
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CHAPTER 5: TELOMERE ANALYSIS USING 
TASER 
5.1 Abstract 
 In order for a cell to gain limitless replicative potential it must have an activated telomere 
maintenance pathway that compensates for the telomere shortening induced by DNA replication 
attrition or by DNA damage induced rapid telomere deletion, either of which can create a 
dysfunctional telomere.  Telomere maintenance pathway reactivation occurs in developing cancer 
cells through activation of telomerase expression or by the recombination based ALT pathway.  
Both mechanisms cause changes to the telomere sequence in a cell.  The dynamics of these 
changes over time in a developing cancer are not well understood, in part because studying 
these changes requires focused assays to measure telomere length.  A number of cancer 
genome sequencing projects have extensively sampled and sequenced tumors and 
corresponding adjacent normal tissue.  These whole genome sequencing datasets contain 
telomere sequence reads that can be leveraged to study the changes in telomeres that occur in 
cancer.  We have developed a pipeline, TASeR, to capture this information and used it to identify 
short and potentially dysfunctional telomeres in cancer samples.  TASeR was used to analyze 
samples from the prostate cancer sequencing genome project.  We found prostate cancers have 
shortened telomeres relative to paired normal samples, specifically a loss of perfect telomere 
sequence.  These changes in telomere sequence content were used to build a classifier to 
separate samples as either cancer or normal.  
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5.2 Introduction 
 Carcinogenesis is a multistep process in which the accumulation of mutations in a cell 
allows it to evade a number of checks and deficiencies to gain the ability and drive to proliferate 
uncontrollably[128,134,135].  Telomere maintenance plays a central role in this development.  In 
a precancerous but DNA damage repair deficient context dysfunctional telomeres contribute to a 
mutator phenotype[350,351].   Telomeres too short to bind a sufficient density of shelterin 
components can no longer form a functional protective structure.  In a normal context DNA 
damage response elements lead the cell to senescence or apoptosis.  In the absence of a 
functional allele of these elements the perceived damage of a DNA double strand break will be 
“repaired”[74].  This creates telomere telomere fusions or an unbalanced translocation between 
chromosomes.  When these cells divide it leads to aneuploidy.  These changes in copy number 
can disrupt repressive mechanisms or amplify growth pathways progressing the cell towards 
malignancy.  Short dysfunctional telomeres that accumulate with age can contribute to a mutator 
phenotype enabling cancer[352].   
 Telomeres also play a vital role in enabling the unlimited proliferative potential of cancer 
cells.  As precancerous cells begin to divide their telomeres shorten with each cell division due to 
the end replication problem, exonucleic activity, and DNA breaks in telomeres caused by 
replicative stress.  Once the telomere is insufficiently long the cell will enter crisis and some small 
subset of cells in crisis will emerge with an activated telomere maintenance mechanism[123,124].  
Approximately 85% of cancer types have active telomerase expression and the remaining 15% 
activate the ALT pathway[125,126].  In cells that have activated the ALT pathway the 
recombinatory mechanism of elongating telomere results in transfer of large sections of sequence 
between telomeres resulting in heterogeneous telomere lengths including extremely long 
telomeres[82].  In sharp contrast telomeres in telomerase activated cancer cells remain extremely 
short, bordering on dysfunctional[129].   
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 The dynamics of telomere length through the initiation and progression of cancer is 
unclear.  At which point in the development of cancer telomeres need to be elongated can lead to 
important understanding of how telomeres contribute or are swept into carcinogenesis.  In order 
to study these dynamics two major methods to measure telomere length are used telomere 
repeat fragment (TRF)[142,143] analysis or quantitative PCR (qPCR)[150].  Telomere Repeat 
Fragment analysis depends on gel electrophoresis of genomically digested DNA, allowing the 
large telomere fragment to be shown on a gel.  The highest throughput telomere length 
measurement is a quantitative PCR method.  By comparing the fluorescence signal from 
telomere primers to those from a single copy locus provides a ratio that is highly proportional to 
the telomere length.  These methods are relatively easy to perform, however have the limitation 
of measuring the average telomere length in a sample.  Chromosome specific telomere length 
measurements require metaphase arrest, or can only be performed on a select number of 
telomeres where unique subtelomere sequence exists[147,148,151].  In order to study telomere 
dynamics these specific methods are employed, using samples to focus on this limited aspect of 
cancer development. 
 Cancer sequencing genome projects are making available large numbers of whole 
genome sequencing (WGS) data sets for many different cancer types.  These datasets have 
initially been used to investigate the single nucleotide and copy number mutations to identify 
changes that are consistently found in a certain cancer type.  Prostate cancer is a highly 
occurring heterogeneous disease where the majority of patients respond well to treatment, but 
those with advanced disease at the time of diagnosis have a poor prognosis[353].  Prostate 
cancers are known to have a characteristic genome instability with a recurrent TMPRSS2-ERG 
fusion, with the second partner being a member of the ETS family[354].  A prostate cancer 
genome effort has focused on this genome instability, finding coordinated rearrangement leading 
to large scale genome restructuring, which they term chromoplexy[355].   
The library preparation techniques used to generate the data sets from these sequencing 
efforts captures telomeric sequence that was inevitably screened out from downstream analyses.   
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It is impossible to map these sequences, as there is no useful reference sequence for the 
telomere, and if it did exist a telomere read would map to thousands of positions throughout the 
telomere sequences.  Instead of attempting to align a read to a specific genomic index, we took 
the approach of “aligning” a read to a portion of the telomere based on its sequence content.  
Here we present a pipeline Telomere Analysis from Sequencing Reads (TASER) to capture the 
telomere content of a WGS sample allowing for comparison between samples. 
5.3 Methods 
5.3.1 Use and Optimization of RepeatMasker 
 The problem of repeat identification was solved early on for genome masking.  Repetitive 
sequence was masked in sequences to simplify the alignment of matches by avoiding searching 
through the many possible matches in repetitive sequence.  RepeatMasker[284] is the most 
widely used tool for this task however it was not made with the short sequences generated by 
high throughput sequencing in mind.  Repeatmasker was run with options to only search for 
simple repeats, and alignments were reported in the orientation of the repeat to mark at which 
base in the telomere repeat possible mutations occur (-nocut -no_is -noint -a –inv).  To further 
optimize the use of RepeatMasker samples were parallelized using GNU Parallel[356].  Samples 
were split into 1 million read portions and run simultaneously up to the number of cores available.  
RepeatMasker results were parsed to categorize reads.  Reads with an identified telomere repeat 
were identified as TR (telomere repeat).  A telomere repeat with a point mutation was classified 
as TRPM (telomere repeat point mutation).  Point mutations with a PHRED score of less than 10 
were ignored as these were low quality base calls that were likely to actually conform to the 
telomere repeat.  After initial tests analyzing the number of mutations per read it appeared that 
reads with up to 7 mutations included reads which were actually perfect telomere reads 
(SupplementalFigure 5.17).  These reads with up to 7 mutations were reclassified as perfect 
telomere reads.  Reads with repeat patterns CCCGAA, CCCCAA, CCCTAG, TTAGGC (each of 
which had been characterized previously in the proximal regions of terminal repeat tracts; 
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[336,357]for review) were classified as TLSR (telomere like simple repeat).  Reads containing 
more than one identified simple repeat were classified as mixed.  Reads with some other simple 
repeat identified were classified as other.  Reads with no simple repeat identified by 
RepeatMasker were mapped to the 15kb telomere reference[265] with bowtie[238].  Reads with 
an alignment were classified as mapped, and the remaining reads were classified as unknown.  
Mate pairs are classified separately before being re-paired with their corresponding mate.  Total 
read counts for all paired categories were counted.  The counts are then normalized to	  account	  
for differences in sequencing depth by dividing the count by the total library size.  They are further 
normalized to account for PCR duplicates.  The PCR duplicate rate of mapped reads were 
calculated by finding,counting, and determining the average rate of read pairs with the exact 
same mapping positions reported within the 15kb subtelomere regions.  The telomere read 
counts were then normalized by this duplicate rate.   
5.3.2 Summary Statistics 
 Summary statistics for telomere reads were calculated based upon the known structure 
of human telomere terminal repeat tracts (Fig 5.1) and our biological expectation for how that 
might change in cancer (Fig 5.2).  Total telomere is the sum of all TR, TRPM, and TLSR reads 
without regard to mate pair information.  The boundary statistic is the count of reads where one 
read is classified as mapped, in pairing with a TR, TRPM, or TLSR read.  Percent perfect 
telomere is the TR reads divided by the total telomere reads.  The mutation interspersion ratio is 
the ratio of TR reads in pairing with TR reads to TR reads in pairing with either TRPM or TLSR 
reads.  R was used to calculate summary statistics for the data analyzed and to generate the box 
plot figures. 
5.3.3 Dataset 
 The prostate cancer genome sequencing project data is available from dbGaP under 
accession number phs000447 and its corresponding SRA entry SRP011021.  Samples were 
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sequenced on Illumina HiSeq 2000[358,359]. 
Classifier 
 A binary classifier was built to classify a sample as tumor or normal based on it’s 
telomere characteristcics catptured by TASER.  Logistic regression was performed using 
generalized linear models tool in R[360] setting the family to binomial.  The only significant factor 
was found to be the TR_TR measurement.  A conditional logistic regression was also performed 
but resulted in similar coefficients.  For simplicity the logistic regression was used to measure 
Figure	  5.1	  − 	  Idealized telomere structure..  The telomere structure is known to end in perfect 
telomere repeat (TTAGGG)n (green), while closer to the subtelomere mutations in the telomere 
repeat and simple repeats similar to the telomere are found interspersed with the canonical 
perfect telomere sequence (orange).  The beginning of the telomere is adjacent to the 
subtelomere sequence, which includes the subtelomere repeat elements and the telomere 
associated repeats (blue).  The subtelomere also contains the transcription start sites of TERRA 
which is transcribed through the telomere. 
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cross validation using the boot package in R[361,362].  Analysis of variance was used to look for 
significant differences in the features measured between different tumor stages for both direct 
tumor measurements and the change (log ratio) between normal and cancer of a sample. 
5.4 Results 
5.4.1 Motivation  
In the absence of a reference sequence we consider an ideogram of telomere terminal 
repeat sequence based upon experimental analysis (Baird et al., 1995; summarized in Riethman, 
2008; Figure 1).  The telomere sequence is known to end in perfect repetition of the canonical 
telomere sequence, TTAGGG.  However all sequencing efforts extending from the subtelomere 
into the telomere tract include mutation events and telomere like simple repeats (i.e. TTAGGGG).  
Instead of aligning reads to a reference and obtaining a mapping position we instead classify 
reads as containing a perfect telomere repeat, or a mutated telomere sequence.  In this way we 
capture some positional information, as a mutated sequence is more likely to have originated 
closer to the subtelomere.  TASER was also developed for use on paired sequencing data.  By 
considering the categorization of both mate pairs, you gain further insight to the sequence 
structure of the telomeres in the sample.  In comparing TASER results from different samples 
changes in telomere sequence content and structure can be observed.  For example comparing 
TASER results between a normal and tumor sample you would expect (in a telomerase positive 
tumor) for there to be a decrease in total telomere content, and an increase in the proportion of 
mutated telomere reads (Figure 2). 
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In order to evaluate whether the reported telomere state was consistent with our 
biological expectations we first calculated intuitive summary statistics which summarize the 
telomere state captured in a way that we have some expectation for the difference between a 
normal sample and a cancer sample.  We calculated four intuitive summary statistics, total 
telomere, boundary, percent perfect telomere, and interspersion ratio.  Total telomere is the sum 
of all telomere reads, ignoring mate pair relationships.  This is proportional to the total telomere 
sequence in the cell.  The boundary statistic is the number of reads where a read that maps to 
the proximal 15kb of the subtelomere is in pairing with a telomere read.  The number of these 
reads will vary with changes in the number of telomeres in a cell, i.e. cells with aneuploidy and an 
abnormal karyotype will have changes in this metric in comparison to a normal cell.  Percent 
Figure	  5.2	  − 	  Changes in TASER measurement distribution due to telomere 
shortening.  TASER classifies reads as containing some type of telomere sequence 
which is paired with a read that is also classified.  In the case of a shortened telomere 
the distribution of these categorized reads changes. 
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perfect telomere is the amount of telomere reads that are perfect out of the total telomere reads, 
which includes perfect and mutated telomere reads.  In samples with shortened telomeres the 
mutated telomere repeats will make up a larger portion of the total.  The mutation interspersion 
ratio measures the overall integrity of telomeres.  This is expected to degrade with telomere 
shortening, but it is not clear how this metric would be affected by ALT, which could potentially 
disperse proximal telomere sequences throughout telomeres by recombination.   
5.4.2 Prostate Cancer has short dysfunctional telomeres 
 TASER was run on 53 paired tumor normal prostate cancer WGS data generated 
at the Broad (106 samples total).  After normalization for dataset size and PCR duplicate rate, the 
total telomere content, while a small portion of the total sequenced library, shows an overall 
difference between the normal and cancer samples (Figure 3).  The cancer samples have less 
total telomere content indicating they have shorter telomeres, which should be reflected in the 
standard measurement techniques using TRF or a qPCR measurement.  This overall result is 
very consistent with the individual pairwise analysis of normal and tumor samples (Sup Fig 5.9), 
where only 2/53 normal-cancer pairs show an increase in telomere length (Sup Fig 5.13).  
There is no significant difference in the boundary reads between normal and cancer 
samples overall (Figure 4), reflecting no globally consistent changes in telomere number in 
prostate cancer.  However, an increase in the spread of the box plot indicates increased variation 
in the sample set which could be due to increased genomic instability in the cancer cells or 
heterogeneity in the tumor samples sequenced.  When individual normal-cancer pairs are 
examined using this metric (Sup Fig 5.10), there are subsets of tumors where this metric 
increases, decreases, and stays roughly the same/increases slightly (Sup Fig 5.14). These 
results thus suggest distinct subclasses of tumors with increased telomere number, decreased 
telomere number, and slight to no difference in telomere number. This more granular analysis of 
the boundary metric might therefore be useful in distinguishing telomere number change subsets 
within tumor types and thus could be a useful new parameter for tumor classification.   
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There is also a significant decrease in both the percent perfect reads (Figure 5) and 
mutation interspersion ratio (Figure 6).  This indicates that the cancer samples have more 
mutated telomere sequence relative to the total telomere, and that it is more interspersed in the 
remaining perfect telomere sequence.  This is most simply explained by the preferential loss of 
distally located perfect telomere repeat tracts in cancer cells. These global results are generally 
supported by the individual pairwise analyses of these metrics (Sup Fig 5.11 and Sup Fig 5.12), 
but there are a substantial number of outliers where these two metrics are increased in cancer 
relative to normal (SupFig 5.15 and Sup Fig 5.16), which merits more detailed experimental 
analyses.  
These changes we see in telomere sequence content can play an important role in the 
alteration of telomere function in cancer.  The loss of perfect telomere sequence, and an 
increased proportion and interspersion of telomere like sequence, might be expected to 
destabilize the binding of TRF1 and TRF2 to the telomere. This could affect the overall stability of 
the shelterin complex, with consequent loss of telomere integrity and increased genome 
instability. Thus the quality as well as the quantity of telomere repeat tract may be important for 
telomere integrity in cancer.   
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Figure	  5.3	  − 	  Box plot of total telomere measurement for normal and cancer samples.  Box 
plots show the distribution of values in tumor and normal samples.  Values are percent of library, 
number of reads normalized by library size.  The number of reads for total telomere is the sum of 
all telomere categories, TR, TRPM, and TLSR. 
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Figure	  5.4	  − 	  Box plot of boundary measurement for normal and cancer samples.  Box plots 
show the distribution of values in tumor and normal samples.  Values are percent of library, 
number of reads normalized by library size.  Boundary reads are any category of telomere reads, 
TR, TRPM, or TLSR, in pairing with a mapped read. 
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Figure	  5.5	  − 	  Box plot of percent perfect measurement for normal and cancer samples.  Box 
plots show the distribution of values in tumor and normal samples.  Values are the percent of the 
telomere reads that perfect, TR, out of total telomere reads TR, TRPM, and TLSR. 
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Figure	  5.6	  − 	  Box plot of mutation interspersion ratio measurement for normal and cancer 
samples.  Box plots show the distribution of values in tumor and normal samples.  Values are the 
calculated ratio.  A higher value indicated more perfect/perfect telomere read pairs or less 
perfect/mutant telomere read pairs. 
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5.4.3 Telomere metrics can be used to identify cancer 
The normalized read amounts for paired read categories were used as features in a 
logistic regression to classify cancer and normal samples based on the telomere information 
contained in their WGS data.  Pruning of the full feature set resulted in one feature being 
responsible for the separation of tumor and normal samples, the perfect telomere reads in pairing 
with perfect telomere reads (Figure 7).  This is consistent with the expected changes between 
normal and cancer samples.  Cancer cells after dividing hundreds of times would have shortened 
telomeres, losing the perfect sequence known to be found at the end of telomeres.  For the 
comparison between tumor and normal samples this single feature is quite powerful at separating 
tumor and normal samples, properly classifying samples with 87% accuracy (Figure 8).  Changes 
in the presence of mutated telomere reads could play an important role in separating different 
cancer clonal populations or stages of disease.  A logistic regression was also performed on 
tumor samples considering the TMPRSS2-ERG fusion status (with fusion, or without), as the two 
groups.  An ANOVA was also performed considering the various pathological stage 
classifications and grouping samples by the age of the patient.  The change in telomere state for 
samples (normal minus tumor) was also considered for both these analyses.  These analyses 
were unable to separate different groups within the tumor samples sequenced.   
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Figure	  5.7	  − 	  Fitted logistic regression model for tumor classifier.  Fitted logistic function used 
to separate tumor and normal samples bases on the amount of TR_TR reads in the sample.  The 
model line is shown with samples falling on it indicating the likelihood that a sample is normal.  
Along the bottom tumor samples are shown, along the top normal samples are shown both at the 
position of their TR_TR content.	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Figure	  5.8	  − 	  ROC curve of tumor classifier.  Receiver operator characteristic curve for tumor 
classifier.  Area under the curve is 0.87.  	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5.5 Discussion 
	   TASER is able to capture the information about both telomere sequence and 
interspersion of telomere like sequences in the (TTAGGG)n tract from WGS data.  Here we 
applied it to 53 paired normal prostate cancer data sets and were able to recapitulate expected 
telomere differences between the normal and cancer samples.  We were unable to find significant 
differences between the telomere state of cancer samples that correlated with reported stage or 
age of the patient.  The samples analyzed were collected during surgery, requiring that they were 
advanced to a certain stage for them to be included in this data set.  Additionally they are paired 
with limited phenotypic data that is available publically.  The use of WGS on diverse types of 
datasets, including studies looking at clonal evolution, and in cancers where a broader range of 
stages of disease can be sampled, will allow for extensive investigation of the dynamics of how 
telomeres change in the progression of a cancer and between clones in a tumor.  As WGS cost 
continues to decline it will become an integral part of cancer treatment.  We show here the 
potential of telomere information in WGS to be used to distinguish cancer from normal samples.  
It could also be a useful feature in further sub-classifying tumor types and aggressiveness; for 
example, more extensive sampling of tumors in different stages of progression, or isolation of 
cellular subsets from tumors by microdissection or sorting of tumor cell subpopulations followed 
by WGS could reveal telomere state distinctions detectable by TASER. These studies will be 
greatly facilitated by an increasing ability to inexpensively acquire WGS data from small cell 
numbers. 
5.6 Supplemental Figures 
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Figure	  5.9	  − 	  Box plot of total telomere measurement for normal and cancer samples with 
individual sample points.  Box plots show the distribution of values in tumor and normal 
samples.  Values are percent of library, number of reads normalized by library size.  The number 
of reads for total telomere is the sum of all telomere categories, TR, TRPM, and TLSR.  Individual 
samples are shown as a uniquely colored and shaped point. 
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Figure	  5.10	  − 	  Box plot of boundary measurement for normal and cancer samples with 
individual sample points.  Box plots show the distribution of values in tumor and normal 
samples.  Values are percent of library, number of reads normalized by library size.  Boundary 
reads are any category of telomere reads, TR, TRPM, or TLSR, in pairing with a mapped read. 
Individual samples are shown as a uniquely colored and shaped point. 
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Figure	  5.11	  − 	  Box plot of percent perfect measurement for normal and cancer samples with 
Individual sample points.  Box plots show the distribution of values in tumor and normal 
samples.  Values are the percent of the telomere reads that perfect, TR, out of total telomere 
reads TR, TRPM, and TLSR. 
	  
129	  
	  
 
Figure	  5.12	  − 	  Box plot of mutation interspersion ratio measurement for normal and cancer 
samples with individual sample points.  Box plots show the distribution of values in tumor and 
normal samples.  Values are the calculated ratio.  A higher value indicated more perfect/perfect 
telomere read pairs or less perfect/mutant telomere read pairs. Individual samples are shown as 
a uniquely colored and shaped point. 
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Figure	  5.13	  − 	  Histogram of difference in total telomere measurement between normal and 
cancer samples.  Box plots show the distribution of values in tumor and normal samples.   
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Figure	  5.14	  − 	  Histogram of difference in boundary measurement between normal and 
cancer samples.  Box plots show the distribution of values in tumor and normal samples.   
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Figure	  5.15	  − 	  Histogram of difference in percent perfect measurement between normal and 
cancer samples.  Box plots show the distribution of values in tumor and normal samples.   
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Figure	  5.16	  − 	  Histogram of difference in mutation interspersion ratio measurement 
between normal and cancer samples.  Box plots show the distribution of values in tumor and 
normal samples.   
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Figure	  5.17	  − 	  Plots	  showing	  the	  number	  of	  reads	  for	  increasing	  numbers	  of	  point	  mutations.  
The number of reads with increasing number of point mutations for tumor samples, normal samples and 
combined in total.  Because we cannot distinguish a point mutation from a sequencing error in single reads, 
and there are a potentially large number of Illumina reads with multiple sequencing errors, we elected to 
categorize otherwise perfect telomere reads with up to a few point mutations/sequencing errors as “perfect” 
telomere reads. To estimate a cut-off threshold for this category we plotted the number of reads for 
increasing numbers of point mutations.  There is an inflection point in the points of the curves at seven point 
mutations.  This suggests that the counts for reads with less than 7 point mutations might include reads that 
have been misclassified and called point mutations but are actually sequencing errors, although this cannot 
be determined for a given read. .  
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CHAPTER 6: Conclusion 
In	  this	  dissertation	  I	  have	  presented	  the	  novel	  computational	  methods	  I	  have	  developed	  
which	  are	  necessary	  to	  analyze	  the	  repeat	  rich	  telomere	  and	  subtelomere	  using	  HTS	  data.	  	  While	  
different	  strategies	  are	  needed	  to	  deal	  with	  differing	  numbers	  of	  copies	  in	  the	  genome,	  
incorporating	  multimapping	  reads	  allows	  the	  use	  of	  HTS	  methods	  to	  study	  telomere	  biology.	  	  
Without	  these	  methods	  multimapping	  reads	  generated	  from	  the	  telomere	  and	  subtelomere	  are	  
filtered	  out	  of	  the	  analysis,	  leaving	  this	  important	  region	  of	  the	  genome	  unanalyzed.	  	  	  
In	  chapter	  2	  I	  presented	  the	  findings	  of	  our	  initial	  mappings	  to	  the	  15kb	  adjacent	  to	  the	  
telomere	  in	  the	  human	  genome.	  	  This	  analysis	  showed	  that	  CTCF	  and	  cohesin	  colocalized	  
immediately	  adjacent	  to	  most	  human	  telomeres,	  and	  layed	  the	  groundwork	  for	  subsequent	  
functional	  studies	  by	  our	  collaborators,	  who	  demonstrated	  the	  importance	  of	  CTCF	  and	  cohesin	  
binding	  for	  TERRA	  transcription	  and	  telomere	  stability.	  	  In	  chapter	  3	  I	  presented	  my	  completed	  
ChIP-­‐seq	  analysis	  pipeline	  and	  the	  results	  of	  extending	  the	  mapping	  of	  ChIP-­‐seq	  data	  sets	  to	  the	  
entire	  500kb	  subtelomere.	  	  We	  analyzed	  a	  number	  of	  additional	  data	  sets,	  finding	  stable	  
patterns	  of	  regulation	  in	  cell	  types	  of	  differing	  developmental	  stages.	  	  Using	  significance	  calls	  
from	  the	  completed	  ChIP-­‐seq	  pipeline	  we	  were	  able	  to	  find	  an	  association	  of	  CTCF	  and	  cohesin	  
binding	  with	  boundaries	  within	  the	  subtelomere	  repeats,	  and	  with	  ITS	  sites	  throughout	  the	  
genome.	  	  Both	  CTCF	  and	  cohesin	  are	  known	  to	  reorganize	  the	  3D	  structure	  of	  the	  genome.	  	  In	  
the	  subtelomere	  CTCF	  and	  cohesin	  colocalization	  in	  the	  subtelomere	  repeats	  may	  be	  responsible	  
for	  DNA	  looping	  to	  bring	  distal	  enhancer	  elements	  into	  proximity	  with	  TERRA	  promoters.	  	  ITS	  
sites	  are	  hotspots	  of	  recombination,	  which	  may	  also	  be	  mediated	  by	  the	  structural	  changes	  
induced	  by	  CTCF	  and	  cohesin.	  	  Investigation	  of	  long	  range	  interaction	  in	  the	  subtelomere	  and	  at	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ITS	  sites	  will	  enhance	  understanding	  of	  the	  role	  of	  CTCF	  and	  cohesin	  at	  these	  loci.	  	  The	  use	  of	  Hi-­‐
C	  and	  Chia-­‐pet	  libraries	  in	  combination	  with	  strategies	  incorporating	  multimapping	  reads	  will	  
enable	  this	  investigation.	  
In	  chapter	  4	  I	  describe	  the	  sequence	  characteristics	  of	  the	  mouse	  subtelomere.	  	  I	  show	  
the	  mouse	  subtelomere	  has	  less	  duplicated	  sequence,	  and	  the	  sequence	  that	  exists	  appears	  to	  
have	  arisen	  by	  a	  mechanism	  different	  than	  that	  in	  human	  subtelomeres.	  	  Parallel	  to	  the	  human	  
subtelomere	  analysis	  CTCF	  and	  cohesin	  subunit	  ChIP-­‐seq	  data	  sets	  were	  mapped	  using	  my	  novel	  
pipeline	  for	  datasets	  from	  a	  number	  of	  cell	  types	  representing	  different	  developmental	  stages.	  	  
There	  is	  little	  subtelomere	  CTCF	  and	  cohesin	  colocalization	  immediately	  adjacent	  to	  the	  mouse	  
telomere,	  showing	  TERRA	  transcription	  is	  regulated	  through	  different	  mechanisms	  in	  the	  mouse	  
genome.	  	  The	  expanded	  use	  of	  directional	  RNA-­‐seq	  data	  revealed	  possible	  evidence	  of	  TERRA	  
transcription	  as	  it	  allows	  observation	  of	  transcripts	  being	  transcribed	  towards	  the	  telomere,	  
overlapping	  with	  known	  lincRNA	  sequence	  elements.	  	  Further	  investigation	  of	  TERRA	  
transcription	  is	  necessary	  to	  find	  factors	  regulating	  its	  transcription.	  
In	  chapter	  5	  I	  present	  the	  TASER	  pipeline	  which	  captures	  telomere	  sequence	  content	  
from	  WGS	  data	  sets.	  	  In	  TASER	  I	  have	  optimized	  existing	  tools	  for	  their	  use	  in	  studying	  changes	  in	  
telomere	  read	  distribution	  between	  samples.	  	  TASER	  was	  used	  on	  53	  paired	  tumor	  normal	  pairs	  
from	  the	  prostate	  cancer	  genome	  sequencing	  project.	  	  I	  was	  able	  to	  show	  expected	  changes	  in	  
the	  prostate	  cancer,	  less	  telomere	  sequence,	  particularly	  the	  perfect	  telomere	  sequence	  found	  
at	  the	  end	  of	  the	  telomere.	  	  The	  information	  captured	  by	  TASER	  was	  also	  used	  to	  distinguish	  
normal	  and	  cancer	  samples.	  	  While	  it	  was	  not	  possible	  with	  the	  samples	  analyzed,	  the	  telomere	  
state	  captured	  by	  TASER	  could	  be	  used	  to	  better	  stratify	  tumors	  into	  types	  of	  disease	  or	  
treatment	  groups;	  this	  will	  be	  greatly	  facilitated	  by	  sampling	  tumors	  at	  different	  stages	  of	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progression,	  and	  by	  an	  increasing	  ability	  to	  inexpensively	  acquire	  WGS	  data	  from	  small	  cell	  
numbers.	  	  
This	  dissertation	  brings	  the	  advances	  in	  HTS	  to	  the	  study	  of	  telomere	  biology	  in	  the	  
application	  of	  data	  sets	  generated	  by	  WGS,	  ChIP-­‐seq,	  and	  RNA-­‐seq.	  	  While	  other	  telomere	  
studies	  have	  incorporated	  computational	  work,	  here	  I	  comprehensively	  approach	  the	  problems	  
that	  arise	  in	  studying	  the	  telomere	  and	  subtelomere,	  developing	  two	  novel	  methods	  to	  enable	  
proper	  consideration	  of	  the	  data	  being	  analyzed.	  	  This	  has	  led	  to	  important	  findings	  in	  the	  
regulation	  of	  TERRA	  transcription,	  and	  telomere	  dynamics	  in	  cancer.	  	  The	  subtelomere	  analysis	  
has	  also	  created	  a	  valuable	  resource	  as	  all	  subtelomere	  analysis	  and	  other	  characterization	  is	  
available	  online,	  for	  both	  the	  human	  and	  mouse	  subtelomere.	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